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ABSTRACT
A multipurpose receptor module for 9-substituted adenines has been developed. The receptor makes use of
imides derived from Kemp's triacid attached to 3,6-diaminocarbazole to provide simultaneous Watson-Crick and
Hoogsteen base-pairing to an adenine stacked on the carbazole moiety. The combination of hydrogen-bonding
and aromatic stacking interactions provides strong binding in the full range of solvents from non-polar organic to
aqueous. The substitutent on the secondary amine of carbazole (N) can be varied to customize the function of
the receptor:
A flexible tail whose conformation is induced by an additional hydrogen-bond to adenine N3 and aromatic
stacking to the free face of the adenine. With an affinity for adenine of over -8 kcal/mol in chloroform, this
receptor has the highest affinity for 9-ethyladenine yet reported.
A rigid phenyl substituent with a guanidinium group suspended from it for recognition of cyclic adenosine
monophosphates in methanol. Molecular modeling studies led to the prediction that 2',3'-cyclic adenosine
monophosphate would be bound preferentially of the basis of a more favorable salt-bridge geometry. This
manifests itself as 0.5 kcal/mol stronger binding to 2',3'-cAMP than to 3',5'-cAMP.
An isophthaloyl substituent that can be used to construct a receptor for the adenosine trinucleotide by
providing divergent attachment points for adenosine monophosphate receptors. Preliminary results on the
transport of ApApA through liquid membranes suggests that the affinity of this receptor for the
trinucleotide in organic solvents is so high that transport efficiency is comprimised.
A biphenyl substituent for a self-replicating system designed to reduce the involvment of competing non-
autocatalytic pathways. The high binding affinity of the adenosine module is designed to allow autocatalysis
to occur in polar solvents, but complicates analysis of the system.
Molecular modeling studies and stochastic dynamics simulations were an integral part of the design and analysis
process. Solution structures were deduced from control studies and both variable temperature and two-
dimensional 1H NMR experiments.
This receptor architecture was exploited for the determination of the strength of an intramolecular base-pair.
From this, the strength of a hydrogen-bond in chloroform was deduced to be 1.5 kcal/mol.
Re-investigation of the complexation behavior of an earlier diimide receptor, one based on 2,7-
diaminonaphthalene, led to discovery that 2:1 binding of adenine competes with 1:1 chelation. This behavior is
not observed with diaminocarbazole-based receptors due to a lower propensity for aromatic stacking.
The syntheses were reported for both a structure-less receptor designed to be driven into its binding
conformation by hydrogen-bonding and aromatic stacking interactions and a water-soluble autocatalytic system.
Limited solubility prevented the analysis of these systems.
Thesis Supervisor: Dr. Julius Rebek, Jr.
Title: Camille Dreyfus Professor of Chemistry
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A. ADENINE BINDING: COMPLEXATION THROUGH INDUCED BINDING GEOMETRY
1. INTRODUCTION
Molecular recognition of nucleic acid components has attracted considerable attention in recent years, and all of
the naturally-occurring nucleosides have been the focus of such studies. Successful strategies typically employ
receptor surfaces that simultaneously interact with the target through hydrogen bonding and aromatic stacking,
while such additional features as salt bridges assist in the recognition of phosphate derivatives.'-' 0 In aqueous
solution, interactions among the nucleosides are weak and primarily involve aggregation through base-stacking
forces1l whereas hydrogen bonding dominates in nonpolar organic solvents. 12,13 Correspondingly, molecular
recognition studies have predominately been carried out in organic solvents in order to exploit hydrogen-
bonding as the major contributor to binding.
Hoogsteen
Watson-Crick
R
Figure A.1.1. The hydrogen-bonding modes of adenine.
Because of the vital role it plays as a component of a number of important biological cofactors, adenosine has
been the focus of especial attention in molecular recognition studies. In addition to the aromatic system,
adenosine presents two separate hydrogen-bonding surfaces for recognition. Base pairing with these two faces
results in two modes of binding - the Watson-Crick mode typically seen in DNA and the Hoogsteen mode. A
number of widely different receptor designs are possible with these multiple binding modes, including
macrocycles, 2 tweezers,4 and clefts.' 4 Refinement of these designs has resulted in receptors with very high
affinity for adenosine derivatives. This laboratory has previously reportedl5 the synthesis of a cleft based on 2,7-
diaminonaphthalene able to complex in both the Hoogsteen and Watson-Crick modes at once while
simultaneously providing additional stabilization through aromatic stacking. This receptor binds to 9-
ethyladenine with an affinity of 105 M-1 (-6.7 kcal) in CDC13.15 Preliminary reports with extraction16 suggest that
this is the most efficient receptor to date.
The significant advantage of biological receptors over synthetic ones is their ability to strongly bind substrates in
aqueous solution. This is due to hydrophobic binding pockets within the structure of the protein. The entropy
gained from the release of water from these pockets is an important driving force for complexation.l7 A
practical strategy for the construction of binding pocket models would involve modification of the skeleton of
HI, 
22 Al Induced Bindinu
the most efficient pre-existing receptor. Ideally, this would be synthetically simple and general to allow rapid
assembly of clefts for structure-function studies. While 2,7-diaminonaphthalene does not lend itself to this
easily, a receptor based on 3,6-diaminocarbazole allows facile functionalization of the aromatic moiety while
maintaining optimum orientation of the hydrogen-bonding surfaces. We have recently reported the use of this
binding motif, coupled with a guanidinium unit, for the complexation of the adenine dinucleotide18 and cyclic
adenosine monophosphates.19
2. DIIMIDE CLEFTS
The bulk of this section has previously appeared in print.20
Figure A.2.1. Schematic of scorpion cleft geometry.
In this work, we introduce a family of receptors designed to bind adenosine derivatives within a pocket formed
through induced fit. The architecture of these receptors consists of a 3,6-diaminocarbazole-based receptor
functionalized with a pendant tail which can stack on top of an adenosine within the hydrogen-bonding cleft.
This 'scorpion-like'2l binding geometry is shown schematically in Figure A.2.1 and provides a mechanism of
sequestering the bound nucleoside from the bulk solvent. This work discusses the behavior of these receptors
in polar and nonpolar organic solvents. In aqueous solution, such an architecture could both protect the
hydrogen bonding surface from competition with water and introduce a favorable entropic contribution to
binding through the release of bulk water.
The receptors in this study were readily assembled using standard synthetic methods. Scheme A.2.1
summarizes the assembly of the core adenine-binding unit. Dinitrocarbazole (Al) was alkylated and reduced to
give diaminocarbazole A3. This hydrogenation step was extremely difficult and proceeded with erratic yield.
The diaminocarbazole is a highly air- and light-sensitive compound and was used immediately following
reduction. The hydrogenation conditions were designed to stabilize the diamine as it formed to prevent
decomposition, by protonation with acetic acid. However, in later studies (Sections A.3, A.5, B and C)
hydrogenation in pure THF, that is in the absence of alcoholic solvent, resulted in significantly greater stability of
22 Al InducedBinding
Athe diamine. Acylation of the diamine with the tripropyl derivative of the Kemp's triacid imide acyl chloride,22
gave the diimide cleft A5 after considerable purification. Hydrolysis yielded the adenine binding unit A6 ready
for condensation with the tail subunits.
0 2N NO 2 02
K2 CO3 , BrCH2COOCH3
N DMF
Al H
H2N NH2
A3 O
OCH 3
H
N
Pr COC
Pr
pyridine
pivaloyl chloride
pyridine
0 0
HN-H
A4 O
OCH 3
N NO2
H
A2 OCH
OCH 3
2, Pd-C
OAc, MeOH
Pr
OR
NaOH (aq), A5, R=CH 3
THF, EtOH A6, R=OH
Scheme A.2.1. Synthesis of diimide cleft.
A7
A7 OCH3
OCH3
LiAIH 4 /
THF N
R
phthalimide, PPh 3 1 A8, R=OH
DEAD, THF A9, R=N-phthalimide hydrazine,
A10, R=NH 2 -' THF, EtOH
Scheme A.2.2. Synthesis of cap fragment.
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2 D----d- VVeJh
COOH
NHCI
All
SOCI2 ,
MeOH
COOCH 3
bNHR
A12, R=CBz
A13, R=H -
COCI
SOCI2 A8 or A'
py, CH,
Bz NHCBz
A14
PrNH2, py
CH2CI2
0 NHPr
H2, Pd-C ITHF, EtOH NHR
DI'4 1 n
A17, X=O, R=CBz_ H2, Pd-C
A18, X=O, R=H - THF, EtOH
A19, X=NH, R=CBz H2, Pd-C
A20, X=NH, R=H THF, EtOH
A15, R=CBz- H2, Pd-C
A16, R=H THF, EtOH
Scheme A.2.3. Synthesis of tail fragments.
A5
A12, A15, A17, A19 Pr
A21, R=(
A22, R=l
A23, R=
A24, R= H
Figure A.2.2. Synthesis of scorpion clefts.
The cap fragments used were synthesized by alkylation of carbazole, followed by reduction to alcohol A8
(Scheme A.2.2). Mitsunobu inversion23 of the alcohol with phthalimide, followed by hydrazinolysis gave amine
A10.
The tail of the receptor is based on 3-aminobenzoic acid. The synthetic manipulations required for the assembly
24 A2 Diimide Cle&
f 25
of the tail are summarized in Scheme A.2.3. Condensation of the tail fragments with diimide A5 gives the fully
articulated receptors A21-A24 (Figure A.2.2). Receptors A21-A23 are incremental derivatives of A24 that
feature one-by-one removal of various elements expected to contribute to binding. These are analogous to site-
specific protein mutations designed to elucidate the contribution of individual elements to binding affinity. 24,25
A set of additional clefts was assembled and their association constants measured by Ghislain Deslongchamps to
evaluate additional contributions to binding (Figure A.2.3). The tail of receptor A27 is longer than that of A24
by one carbon and features inverted directionality of the distal amine group.
Pr Pr
H H aO
A25 Co
OBn
,Pr
gll
,Pr
'Pr
Pr
Figure A.2.3. Additional diimide clefts.
2.1 Extraction Studies
Adenosine-binding clefts based on Kemp's triacid imide have been previously used for transport of nucleoside
derivatives across liquid membranes.16 The receptors in this study were examined to evaluate the affinity of
these receptors for adenosine derivatives at the chloroform-water interface. Receptors A24 and A27 are able
to extract up to aftdl equivalent of adenosine derivatives from aqueous solution into chloroform (Table A2.1).
Extraction efficiency depends strongly on the water-chloroform partition coefficient of the target.26 This
dependence manifests itself as a decrease in extraction with increasing hydrophilicity (Table A.2.1) - a pattern
A2 Dimide Clefts 25
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which mirrors that from our earlier study, despite the higher binding affinity of the receptors in this work. In this
case, it seems that formation of a binding pocket around the purine base is not sufficient to overcome the
unfavorable effect of partition coefficients on extraction.
nucleoside A24 A27 none
adenine 1.12 1.00 0
2-deoxyadenosine 0.64 0.80 -0.1
adenosine 0.3 0.30 0
guanosine - 0 -
3',5'-cAMP 0
Table A.2.1. Equivalents of nucleoside derivatives extracted from aqueous solution
2.2 Induced Binding Geometry
In chloroform, NMR spectra of the larger scorpions (A21-A24, A27) are extremely broadened and show
concentration dependence. Low temperature NMR (-53 °C) in CDC13 failed to resolve any identifiable species.
In contrast, spectra in CD30D are well-resolved at room temperature, indicating that the broadening seen is a
result of the slow tumbling of intermolecular aggregates formed through hydrogen bonding.
Addition of 9-ethyladenine to a 10 mM solution of scorpion receptor A24 in CDCl 3 causes a dramatic
conformational reorganization, giving a single species by NMR (Figure E.1). The substrate-receptor complex
exists as a pair of exchanging enantiomers, based upon the position of the N9-substituent of adenine relative to
the pendant tail of the receptor (i.e. to the right versus the left of the tail - Figure A.2.4). Because of this, the
chemically equivalent protons become diastereotopic (magnetically nonequivalent) in the complex. The
racemization process requires at least partial opening of the complex, so the bound adenine can leave and re-
enter in the opposite orientation. However, the protons on the carbazole lid can exchange by a rotation without
adenine leaving the cleft. NMR signals due to these protons are noticeably sharp.
Racemization can be easily slowed at subambient temperature (Figure E.2). The barrier to conversion between
diastereotopic protons at the coalescence temperature can be estimated from the maximal frequency difference
in the signals, according to A.2.1 and A2.2.27 This frequency difference can be approximated as 110 Hz by the
difference observed at low temperature (-10 °C). The rate of exchange at the coalescence temperature
(approximately 10 °C), then, is 244 s- (G - 13.6 kcal/mol). No unbound 9-ethyladenine is observed at this
temperature.
k, - v (A.2.1)
AG' = RTc In( kT) (A.2.2)
k,h
In addition to the splitting of the diastereotopic proton signals, the two imide protons display different chemical
26 A2 Diimide Clefts
2shifts at low temperatures, reflecting the different chemical environments of the Watson-Crick and Hoogsteen
modes. Another significant feature evident is the downfield movement of the amide proton NH2, suggesting
its participation in hydrogen-bonding with N3 of the 9-ethyladenine.
d
/~~~~
g
Figure A.2.4. Geometry and proton identification of the complex of A24 and 9-ethyladenine.
Two-dimensional 1H NMR studies in CD2C12were used to obtain information on the geometry of the one-to-
one complexes of A24 and A27 with 9-ethyladenine. Peak assignments were made using cross-correlations in
TOCSY28 (Figure E.3) and intramolecular correlations in NOESY29 experiments (Figure E.4). The
intermolecular contacts observed seen for the complexes of A24 and A27 are summarized in Table A.2.2. For
both of these complexes, there is an NOE correlation between the imide protons and both adenine aromatic
protons (C8H and C2H). This is direct evidence of the chelation of adenine within the cleft. In addition, there
are through-space correlations between protons on the adenine and in the tail of the receptor. Since there is no
pre-organization of the conformation of the receptor prior to binding, the tail can explore a wide range of
conformational space. That the adenine CH2 and protons on the tail are in close proximity to each other
indicates that there is a fold where these protons are driven up close to the adenine nucleus. Figure A.2.4 is a
tantalizing interpretation of this. We propose, in fact, that amide NH2 is hydrogen-bound to adenine N3 based
on these through-space correlations. This is supported by the large chemical shift change in the 1H NMR
spectrum of the signal due to this amide when the temperature is reduced.
A24 and 9-ethyladenine A27 and 9-ethyladenine
NH4 and C8H NH4 and C8H
NH4 and C2H NH4 and C2H
He and CH2 He and CH2
NH2 and CH2 NH2 and CH2
Hh and CH2
Table A.2.2. Intermolecular NOESY correlations in CD2C12 solution.
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No NOE correlations could be observed between any of the aromatic rings or, in particular, to the topmost
carbazole. Rather than a failure of the complex to assume the geometry of Figure A.2.4, this is due to a limitation
of the experiment imposed by the size and conformational dynamics of the complex. The nuclear Overhauser
effect is a function of the frequency of NMR spectrometer, co, and the correlation time, tc, of the molecule
(Figure A.2.5).30 At a given frequency, the observed NOE is a function of the tumbling rate of the molecule.
For small, rapidly tumbling molecules, Tc is very small and cn, is much less than one. As spectral lines are usually
narrow from rapid averaging of signals, this is referred to as the extreme narrowing limit. The maximum
possible NOE in this situation is +50%. For large molecules, cotc>l. This is referred to the extreme
broadening limit and the maximum NOE is -100%. Molecules whose tumbling rate is near the crossover point
(mct=1.12) will show NOE enhancements that are sensitive to field strength, temperature, or solvent viscosity.
u.0
0
NOE
-0.5
-1
).o
Figure A2.5. Variation of NOE with tumbling rate.
In CD2C12, all of the NOE correlations observed are positive, indicating that the tumbling rate of the complex is
that of a small molecule. The size of the complex (1400 amu) and the breadth of the 1H NMR signals suggest
however that the complex is approaching the intermediate region between small and large molecule behavior.
For instance, when the complex is dissolved in CDCI3, only intramolecular correlations can be observed - the
less-favored intermolecular pathways were not observed. This strongly suggests that in this solvent the
molecule has moved closer to the boundary between the extreme broadening and extreme narrowing limits.
Rotating frame NOESY experiments (ROESY31) have been used to give stronger through-space correlations for
molecules in this intermediate range, but could not be used. The ROESY experiment is complicated by several
additional relaxation pathways including homonuclear Hartmann-Hahn correlations. 30 ,32 -34 In this highly
aromatic system, it was impossible to separate ROE interactions from these interfering TOCSY-like correlations.
__
2Despite the absence of interaromatic NOE's, indirect evidence for stacking of the cap over bound adenine was
obtained from a titration of scorpion A24 with 9-ethyladenine (a 'forward' titration) in CD30D. The proton
NMR signals due to the carbazole cap showed significant (0.05-0.1 ppm) upfield shifts during the titration.
Since control studies show that medium effects cause much smaller shifts (section A.2.3), this is consistent
with complexation-induced stacking of the carbazole on bound adenine. This same study, by way of downfield
shifts of carbazole proton k, also indicates inward orientation of the carbonyls of the amides that link the
carbazole and Kemp's moieties.
The variable temperature studies of the complex of A24 and 9-ethyladenine in CDCl3 showed that considerable
stiffening of the complex occurs at -50 C. It should be possible to cause the molecule to shift well into the
extreme broadening range at this temperature to enhance the observed NOE in NOESY experiments. The
small driving force for aromatic stacking in non-polar organic solvents makes the stacked geometry only one of
multiple stable conformations for the carbazole cap. By reducing the temperature, the conformational dynamics
are reduced such that the residence time of the cap in this geometry is significantly increased.
At -50 °C, all of the observed NOE correlations within the complex of A24 and 9-ethyladenine are large and
negative -- as typically seen for large molecules at the extreme broadening limit. The complexation-induced
diastereotopicity of chemically equivalent protons makes these spectra extremely complicated; only partial peak
assignment of the 1H NMR spectrum at this temperature (Figure E.2a) is possible from TOCSY (Figure E.5)
and intramolecular NOESY correlations (Figure E.6). The conformational dynamics of the complex have been so
severely limited at this temperature, in fact, that chemically equivalent protons on the bottom carbazole have
different chemical shifts by virtue of being under either the imidazole ('right) or pyrimidine ('left) rings of the
bound 9-ethyladenine.
A number of through-space correlations are observed that are consistent with the binding geometry predicted in
Figure A2.4. There are correlations between the imide protons and proton k, on the lower carbazole, as well as
to proton d, on the upper carbazole, consistent with a 'three-tiered' geometry. Through-space correlations can
be observed from CH2of 9-ethyladenine both to protons ir andjr but only very weakly to i orjl. The CH2 signal
also shows cross-relaxation to proton a on the upper carbazole ring and to NH2. The adenine aromatic protons
show preferential through-space correlation to their corresponding superimposed carbazole protons. That is,
C8H shows a strong NOE withjr but only very weakly withji. C2H shows strong correlation tojl, but no NOE
withjr. In addition, proton C2H shows an NOE to amide proton NH1; there is also a weak CH2 to NH1
correlation. This indicates that NH' may also participate in a hydrogen-bonding interaction with adenine N3.
In addition, the two imide signals can be assigned as corresponding to the Watson-Crick and Hoogsteen
hydrogen-binding modes. The imide at 13.4 ppm shows correlations to the adenine C2H proton, to proton il
and a strong correlation to jl and kl. This is consistent with the Watson-Crick base-pairing mode. The imide at
13.65 ppm shows correlation to jr and to the adenine C8H proton, consistent with the Hoogsteen-bound mode.
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3The complexity of the spectrum at this temperature does not entirely rule out the possible presence of multiple
conformations of the upper carbazole section. The two signals at 6.7 ppm and 6.77 ppm both show crosspeaks
consist with that expected for amide NH1, but only the proton at 6.7 ppm was identified as such.
Figure A.2.6. Lowest energy conformation of A24 complexed with 9-ethyladenine (stereoview).
These structural features were modeled through a stochastic dynamics simulation at 300 K of the complex of
A24 and 9-ethyladenine using chloroform solvation (see Experimental Section for details). Throughout the
simulation, the adenine remains bound between both imides and shows hydrogen bonding to one or both of
the amides in the tail. As the simulation proceeded, the carbazole cap moved away from the adenine (about 31
ps into the simulation), simulating the observed solution behavior. The lowest energy conformer, generated by
minimization of structures periodically sampled from the simulation, is shown in Figure A.2.6. This structure is
consistent with all experimental data - chelated hydrogen bonding of adenine, hydrogen bonding to N3, and
stacking of the carbazole lid. The flexibility of these receptors is such that it is unlikely that there is only one
solution conformation of the complex. There are, in fact, a number of low energy conformations from the
dynamics simulation. Rotation of a Kemp's imide moiety so that the adenine is bound in a bifurcated sense14 on
one edge and tilting of the adenine so that hydrogen bonding can occur to NH1 constitute the major forms of
conformational variation. Conformations that show the carbazole lid not stacking onto adenine lie more that 20
kJ/mol above the lowest energy conformer.
2. 3 Binding Studies
The choice of 3,6-diaminocarbazole as the scaffolding from which to build receptors involves some sacrifice in
binding ability. There is an intramolecular hydrogen bond between the two imide groups which must be broken
for binding to occur. Molecular modeling indicates that the curvature of the carbazole groups allows the two
imides to interact with each other by rotating into the plane of the aromatic surface. Indeed, the imide protons
of A5 in CDCl 3 are shifted downfield (10.7 ppm) relative to unbound imide signals (7.6 ppm14) in the proton
NMR spectrum. This behavior is not observed with the naphthalene diimide receptor as the geometry of
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2,7-diaminonaphthalene does not allow close approach of the imide groups.
Binding constants were determined from 1H NMR titrations, through the incremental addition of a solution of
'guest' to a solution of'host' while following the chemical shift of protons on the host molecule. The 'host' and
'guest' are defined solely by their status in the titration protocol. In these cases, the 'host' is the adenosine
derivative and the 'guest' is the receptor in question. This 'reverse' titration protocol was performed because of
the extreme broadening of the 1H NMR spectra of the larger receptors examined. The chemical shift of the
host as a function of concentration of guest added forms a rectangular hyperbola known as the 1:1 binding
isotherm.26 From the equilibrium defined in k2. 1, the equilibrium constant can be defined as in A.2.2. The
corresponding mass balance equations are shown in A.2.3 and A.2.4.
H + G H G(A.2.1)
[H][G] (A.2.2)
H, = [H] + [HG] (A.2.3)
G, = [G] + [HG] (A.2.4)
H is the 'host', G is the 'guest', and HG is the noncovalent complex between the two. Ht and Gt are the total
concentrations of the two species in solution. The observed chemical shift of protons on the host is a weighted
average of the chemical shifts of the free and bound host. This is mathematically expressed in Equation A.2.5.
6 = H [H] + HG [HG] (A.2.5)H, H,
By substituting for the concentration of free host from Equation A2.3, the chemical shift can be expressed solely
in terms of the concentration of the complex, as in A.2.7.
5 = H (1 _ [ HG] [HG] (A.2.6)
< = 8H + ( HG - ) HG] (A.2.7)
The concentration of complex can be expressed as a function of the total host and guest equations by
substitution of the mass balance equations A2.3 and A.2.4 into the equilibrium expression A2.2 to give:
K = [HG] (A.2.8)
(H, - [HG])(G, - [HG])
Simplification of this gives a quadratic expression,
[HG]2-(H + G. + 1K )[HG] + HG, = (A.2.9)
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and the concentration of complex can be expressed according to Equation A2.10.
(H G,+ K + -+ + 4HG
[HG] 2 (A.2.10)
Realistic (i.e. non-negative) values of concentrations are obtained only with addition of the square root
expression. Equations A.2.10 and A.2.7 can be combined to give the observed chemical shift expressed as a
function of the equilibrium constant, the total concentrations of host and guest, and the initial and final chemical
shifts (Equation A.2.11). In this expression, the host concentration, guest concentration, and observed chemical
shift are experimentally known. The concentration of the host can be maintained at a constant value by
dissolving the guest in a stock solution of the host. This is of benefit only for weak association constants, where
successive dilution will adversely affect the concentration of the complex or in situations where the NMR
spectrum of the host is concentration-dependent. The use of constant host conditions avoids the participation
of host aggregation in the shaping the binding isotherm. The chemical shift within the complex and the
equilibrium constant are variables. The chemical shift of the host is an experimentally-known number only if the
host exists purely as a monomer at the start of the titration. This is true for 9-ethyladenine in chloroform and
methanol and 6H is simply the observed chemical shift when no guest has been added.
(H + G + K + H,+G,+ K, 4HG (A.2.11)
2Hi
The equilibrium constant, Ka, and the chemical shift of the complex, HG, can be determined by non-linear least
squares regression curve-fitting of the experimental data to Equation k2.11 using Systat. 35 This program uses
either Simplex or Newton-Raphson algorithms to find the values of Ka and 6HG which allow the best fit to
Equation k2.11.
The limitations of the NMR method for determination of association constants have been conscientiously
summarized and elaborated by Wilcox. 3 The important lesson from this is that the maximum amount of
information in a NMR titrations resides in data points from the range where the concentration of the complex is
20-80% of the maximum possible concentration of complex. That is, when the complex concentration is 20-
80% of the lesser component in solution, host or guest. This imposes a practical determination limit of
approximately 50000 M-1, for the sensitivity of NMR.
A series of empirical studies on the effect of variation in concentration as a result of experimental error,
evaporation, or impurity by Ghislain Deslongchamps 36 highlighted important experimental considerations that
allow for accurate curve-fitting at the extreme edge of this limit. The conclusion from these studies was that
experimental error in the concentration of the guest solution had a greater effect on Ka than error in the host
concentration. However, the effect on the calculated association constant is approximately three times the
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amount of variation in both host and guest concentration; that is, experimental error of ±5% in both guest and
host concentration results in +15% variation in the calculated association constant. In order to compensate for
this, Equation A.2.11 was modified so that the initial concentration of the host solution could be considered a
variable to be fit during regression analysis. That is,
H, = ViH i (A.2.12)
V1 + V.
where Hi is the variable initial host concentration and Va is the volume of guest added, from the experimental
data. The initial volume of the host solution, Vi, is a constant. The chemical shift is then expressed as a function
of Va and Gt with Hi, Ka, and 8HG as variables to be determined (Equation A.2.13). By allowing the initial host
concentration to vary, significantly improved fitting of experimental data can be achieved with concentration
variations of less than 5%. This modification of the 1:1 binding isotherm provides an empirical scaling factor to
compensate for poor data that can cause large error in cases where the binding constant is very large (i.e. Ka >
10000 M-1), such as the association constants determined in chloroform. While an extra parameter virtually
guarantees improved curve-fitting, the experimental basis for the modification and its small magnitude justify
judicious use of Equation A2.13. This correction was only employed for the determination of the association of
receptors A5, A25, A26 in CDCl3.
+VOH + 1V.+ +, + -4 G
(VS+( + VG +G.) + ) + Vi V+a V13 + V
Vi + Va
The association constants determined in CDC13 for the full complement of diimide receptors are listed in Table
A.2.3. All of these association constants were determined by monitoring the 1H NMR signals of a dilute solution
of 9-ethyladenine (1-2 mM) during addition of the receptor (4-6 mM). The CH2 quartet and C8H were
monitored. Concentration variations from 1-5% using Equation A.2.13 resulted in significantly improved
agreement between the values determined for each signal. Because of the smaller size of 9-ethyladenine
relative to the cleft, along with the greater mobility of the ethyl group, the CH2 signals to remain sharp. In
contrast, the aromatic signals of the adenine broaden during the titration. In all of the titrations in chloroform, a
sharp break in the titration curve is seen when one equivalent of the cleft has been added to 9-ethyladenine.
This is an indication of the 1:1 binding stoichiometry in the complex.
While C8H can be monitored, the C2H proton is usually not visible at all during the titration. This may be due to
the differential effects that the environment of the 'bound' 9-ethyladenine has on the relaxation of
magnetization.30 The spontaneous decay of excited magnetization does not occur rapidly enough to occur at all
on the NMR time scale - relaxation must be facilitated. The longitudinal relaxation of magnetization, T1, arises
from the fluctuation of local magnetic fields of similar strength as the excited proton. This relaxation process is
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aligned along the applied magnetic field and, by returning the excited proton to the ground state, is the process
by which the FID is observed. Essentially, this results from the interaction of a proton with others - on the same
or nearby molecules -- through translation, rotation, conformational flexibility, or intramolecular dipole-dipole
coupling. The C8H, CH2, and CH3 protons of 9-ethyladenine can all relax through dipole-dipole coupling, scalar
(or spin-spin) relaxation, and spin rotation relaxation mechanisms, but the C2H proton is too isolated to
participate efficiently through these pathways. When the translational and rotational movement of the adenine is
reduced by complexation (the complex will have a much slower tumbling rate than the free molecules), both
intermolecular dipole-dipole coupling and the chemical shift anisotropy relaxation are restricted. The effect of
this is greater for C2H than for the other protons of 9-ethyladenine. In this case, then, transverse relaxation, T2,
will dominate. This relaxation process, which occurs perpendicular to the applied magnetic field, involves the
dephasing of individual contributions to the overall magnetization. This results in a broadening of the signal due
to that proton. An additional contribution to the broadening of the C2H proton may come from quadrupolar
relaxation through the 14N of the imide to which it is hydrogen-bound. Quadrupolar relaxation is the dominant
relaxation mechanism for 14N and acts to increase the transverse relaxation rate of coupled protons. This is the
reason that NH protons typically have larger bandwidths than CH protons.
receptor Ka ( l ) AG295 (kcal/mol)
A24a 106 -8
A23a 105 -7
A22 a 106 -8
A2 1a 106 -8
A27 a 106 -8
A26b 53000 -6.4
A25b 21000 -5.8
A5b 50000 -6.3
Table A.2.3. Estimates of association constants of receptors with 9-ethyladenine in CDC13.
acrude estimates only bdetermined by G. Deslongchamps using concentration correction
The core unit, A5, has an association constant of 50000 M-1 (-6.3 kcal/mol).36 This value is different from that
reported earlier,20 which was based on a titration following the imide proton as 9-ethyladenine was added to the
receptor. The revised number is based on the 'reverse' titration protocol followed for the rest of the table. This
association is the inherent binding affinity from the chelation of 9-ethyladenine along with stacking to carbazole.
By altering the methyl ester to a benzyl ester (A25), the association constant decreases by 0.5 kcal/mol due to
steric interaction within the complex between the ester and 9-ethyladenine.
Mutation of ester A25 to amide A26 leads to a 0.6 kcal/mol increase in binding energy in chloroform. As seen
in the structural studies, this increase can be ascribed to a hydrogen bond between the amide and N3of the
adenine. Molecular modeling shows the hydrogen bond in a non-optimum geometry, which is also suggested
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by the magnitude of the interaction (the strength of a base-pair hydrogen bond in chloroform has been
estimated at between 1 and 1.5 kcal/mo12' 1437). There are, in addition, two nearly free rotors that are
restricted by forming this hydrogen bond - a negative contribution estimated to be worth -1 kcal/mol each.38
The fully elaborated receptors (A21-A24, A27) show extremely large binding affinities (Table A.2.3) for 9-
ethyladenine in CDCl 3 -- up to an order of magnitude greater than anything previously observed. 41 5,39 The
apparent binding constants were derived from curve fitting of 9-ethyladenine peak shifts upon addition of
receptor and lie far outside of the range for which NMR titration is expected to provide accurate association
constants. 3 Remarkably, these numbers likely represent lower limits on the binding constants, since no attempt
was made during the curve-fitting procedure to correct for aggregation of the receptors in solution.
The inaccuracy of the binding constants determined in CDCl3 is too great to allow any comparison between
them. For that reason, the association constants of the 'scorpion' receptors with 9-ethyladenine were
determined in CD30D (Table A2.4). Despite competition from the increased dipole moment and hydrogen-
bonding capability of the solvent, these receptors demonstrate significant affinity for adenosine derivatives. All
titrations were again performed using the 'reverse' titration protocol due to the flexibility inherent in these
receptors. By monitoring purine signals, binding constants are derived from protons in similar environments in
each of the different receptor-nucleoside complexes, thus reducing the effects of difference in local movement.
Nevertheless, based on previous multiple determinations,14 the association constants are expected to be
accurate only within 10% (+ 0.1 kcal/mol). No concentration correction was incorporated in the determination
of the binding constants.
receptor Ka (M-1 ) AG295 (kcal/mol)
A24 351 -3.4
A23 278 -3.3
A22 296 -3.3
A21 150 -2.9
A27 a 425 -3.5
A26a 209 -3.1
A25a 115 -2.8
Table A.2.4. Estimates of association constants of receptors with 9-ethyladenine in CD30D.
adetermined by G. Deslongchamps
Despite the hydroxylic nature of the solvent, there is only modest propensity for aromatic stacking interactions in
methanol. Titration of both 9-ethylguanine and 9-ethyladenine (1.5 mM) with 20 equivalents of the 'declawed'
scorpion A4 in CD30D resulted in less than 0.004 ppm upfield shifts of the purine aromatic signals.
The involvement of hydrogen bonding as a driving force for complexation was confirmed by a binding study
performed with A24 and 9-ethyladenine in CD3OH. Binomial solvent suppression40 was used to reduce the
signal from the solvent hydroxyl protons. Upon addition of 2 equiv of 9-ethyladenine at -20 °C, the imide proton
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signals of A24 broadened and shifted 1.5 ppm downfield (10.7 ppm to 12.2 ppm). While broadening may be
due to base-catalyzed exchange by adenine,41 the sizable downfield imide shifts provide convincing evidence for
hydrogen bond interaction. This type of protocol is now used routinely in our laboratory to measure the
association of water-soluble diimide clefts and adenosine derivatives in water.4243
Comparison of the binding affinities of receptors A24 and A27 and their incremental derivatives (A21-A23,
A25, A26) allows an estimate of the contributions to binding in methanol by various structural elements (Table
A.2.4). Energy differences of 0.1 kcal/mol are at the limit of experimental error, but changes greater than this
are expected to be significant. A large proportion of the binding energy is derived from the simplest carbazole
diimide motif (A5). The simultaneous Watson-Crick and Hoogsteen hydrogen-bonding 'chelation' of adenine
provides the greatest stabilization with some contribution from aromatic stacking to the carbazole. The
involvement of a hydrogen bond between the adenine N3 and amide NH2 (A26) stabilizes complex formation
by an additional 0.3 kcal/mol.
Elucidating the exact individual contribution by the upper amide (NH1) and the aromatic cap is not possible.
While the aromatic lid would be expected to provide stabilization through aromatic stacking interactions, the
amide could be expected to participate in a hydrogen bond to N3, in a fashion similar to NH2. Singly, though,
each element appears to have a minor role in stabilizing the complex (0.1 kcal/mol, A23 - A24 and A22 -
A24). When the two are added together (A21 -* A24 or A26 - A27), significant stabilization (0.4-0.5
kcal/mol) results. The non-additivity of these 'mutations' complicates the analysis but suggests that both
binding elements contribute to the binding energy of complexation, though not simultaneously. As a result,
removal of one group allows the other to participate more fully, partially compensating for the loss.
There is a 0.2 kcal/mol increase in binding energy associated with the movement of the pendant phenyl ring one
carbon away from the 3,6-diaminocarbazole (A21 - A26). It is tempting to speculate that this is due to
stabilization from edge-to-face aromatic interaction of the benzyl ring with the bound adenine. Theoretical
studies suggest that this is more favorable for aromatic interactions than the planar stacked geometry.44
Molecular modeling indicates that in the complex of 9-ethyladenine and A21, the geometry of the phenyl amide
derivative precludes any interaromatic interaction when the amide NH2-N3 hydrogen bond is formed.
Examination of the magnitude of the binding energies in methanol (as compared to chloroform) allows an
estimate of the strength of a hydrogen bond in this solvent. Both the overall affinity of A25 for 9-ethyladenine
and the increase in binding energy associated with the amide NH2-N 3hydrogen bond (A26) are reduced to
one-half in methanol solution. This leads to the inference that the strength a single base-pair hydrogen bond
contributes approximately 0.5-0.75 kcal/mol to binding in this solvent - half of the contribution in chloroform
solution.
The selectivity of the carbazole-diimide motif was probed by titration of different nucleoside derivatives with
A24 in CD30D (Table A.2.5). The 0.3 kcal/mol increase in binding energy on complexation of 2'-
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deoxyadenosine is likely due to additional hydrogen-bonding interactions between amide groups in the tail and
the polar functionalities in the ribose group. The range of possible hydrogen-bonding patterns and
conformational flexibility make this difficult to determine.
guest Ka (M-1) AG295 (kcal/mol)
9-ethyladenine 351 -3.4
9-ethylguanine 105 -2.7
2'-deoxyadenosine 577 -3.7
2'-deoxyguanosine 72 -2.5
Table A.2.5. Selectivity of A24 for various nucleoside derivatives in CD30D.
While there is a distinct preference for adenine over guanine (3- to 8-fold), receptor A24 shows surprisingly
high affinity for guanosine derivatives. Molecular modeling studies indicate that the geometry of the imides may
allow a three-hydrogen-bond interaction between carbazole bis-imide receptors and guanosine derivatives
(Figure A2.7). The reorientation of the imides and the subsequently different positioning of guanine within the
cleft is likely responsible for the greater preference of the receptor for adenine in the nucleoside series versus
the alkyl series (via altered hydrogen bonding to ribose). These studies suggest that for absolute selectivity,
receptors must either have extreme rigidity or be specifically designed to select against the amino group on the
guanine ring.
'10
H 0
R
n
Figure A2.7. Possible binding modes for guanosine derivatives.
3. DETERMINING HYDROGEN-BOND STRENGTH
The hydrogen bond is one of the fundamental forces for biomolecular recognition.45 As such, there is
tremendous interest in the contribution of a hydrogen bond to the stability of biological structures. Previous
studies have attempted to determine this from model systems1214 or from protein mutagenesis
studies.24 ,46,47 The carbazole-diimide architecture can be exploited to provide a measure of this. Comparison
of the binding affinity of diimide A5 and the corresponding monoimide will allow an estimation of the enthalpy
of a hydrogen bond.
Using the representation of Jencks 48,49 as adapted by Williams,46 ,47 the free energy of an interaction can be
broken down into contributions from i) intermolecular translational and rotational entropy, AGt+r; ii) entropy
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loss from the restriction of rotors, AGr; iii) hydrophobic interactions, AGh; iv) the sum of the interactions
between polar functional groups, ZAGp; v) van der Waals interactions, AGvdW, and vi) the change in
conformational free energy between bound and free states. This is summarized in Equation A.3.1.
AG = AGt+r + AG, + AGh + E AGp + AGdW + AGcof (A.3.1)
For the comparison of diimide A5 and monoimide A30, a rotor must be restricted for the second imide to bind
to adenine. All other conformational, van der Waals, intermolecular, and hydrophobic terms are nearly identical
between the two. In this case, then, the change in association free energy from A30 to A5 can be represented
as:
AAG = AAGr + AAGp (A.3.2)
Or, more simply put:
AGdiimide = AGonoimide + AGbase-pair (A.3.3)
where,
AGbase-pair = AGHbond + AGrotor (A.3.4)
The monoimide receptor based on carbazole was required in order to examine these effects. Following
alkylation of carbazole, A7 could be quite cleanly mono-nitrated with copper(U) nitrate 50 to give 3-nitro-9-
alkylcarbazole A28. While the second nitration step to 3,6-dinitrocarbazole is much slower than the first, the
stoichiometry of reactions with traditional nitration reagents (e.g HNO3) are much more difficult to control than
with this reagent. Additionally, the copper(l) nitrate reaction takes place a moderate temperatures (30 C).
Hydrogenation to the amine proceeded rapidly and cleanly with THF as solvent. This is in contrast to the original
N 02 N H2
\ / \ 1. H2, Pd-C, THF 
A28 02 As 0
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Scheme A3.1. Synthesis of carbazole monoimide.
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conditions used in Section k2 (HOAc/MeOH). Though the logic at that time was that protonation of the amine
as it formed would increase its stabilization and reduce decomposition, methanol itself appears to contribute
significantly to the decomposition of the amine. Condensation with the tripropyl derivative of Kemp's imide acid
chloride22 gave monoimide receptor A30 (Scheme A.3.1).
The affinity of the monoimide receptor for 9-ethyladenine was measured in CDC13by monitoring the shift of
the imide proton from 7.67-12.57 ppm during addition of 9-ethyladenine. The concentration of the imide was
not kept constant through the course of the titration. Curve-fitting of the imide chemical shift to the 1:1 binding
isotherm to give an association constant of 165 M-1 (-3.0 kcal/mol). As described in the previous section, the
diimide cleft A5 has an association constant in CDC13with 9-ethyladenine of 50000 M-1 (-6.4 kcal/mol). This is
the sum of the intermolecular interaction of 9-ethyladenine with a single imide, followed by intracomplex
binding by the second. The 3.4 kcal/mol increase in binding energy of the diimide over the monoimide can be
attributed solely to the hydrogen bonding of second imide within the complex. This energy difference is
AGbase-pair.
The bond that is restricted during binding of the second imide is the bond between carbazole C6H and the
amide nitrogen. However, because of the steric and electronic nature of the amide group, this bond is
somewhat less than a 'free' rotor. There are, in fact, only two low energy conformations expected for this
torsion angle - 'above' and 'below' the carbazole plane. The only other non-bicyclic single bond in the second
imide moiety is the cyclohexane-carbonyl bond which is so restricted by its proximity to the rigidly-held imide
that itcan be considered already fully 'restricted'.
The free energy change associated with the 'free' rotor can be estimated at:
AGro,or = -TSrotor = -RTln /2 = 0.4kcal/mol (A.3.5)
It is not surprising that this crude approximation for the restriction of a hindered rotation is somewhat less than
the value of - 1 kcal/mol proposed by Williams for the restriction of afiree rotor.38
It follows, then, that AGHI-bond is 3 kcal/mol, 1.5 kcal/mol per hydrogen bond. It can be argued that by using the
factorization approach, this value reflects the enthalpy of hydrogen-bonding. There are no surprises, though,
from this determination. This value is very much similar to previous estimates determined by us and
others. 12,14,37
There is considerably more controversy over the strength of a hydrogen-bond in water. Based on the binding of
vancomycin antibiotic derivatives, Williams proposes an interaction energy of only 0.2-1 kcal/mol for an
intermolecular hydrogen bond46 whereas Fersht has concluded that a hydrogen-bond contributes 0.8 to 1.5
kcal/mol, based on analyses of protein and RNA mutations.17,24 It must be mentioned that the environment of
protein interior is far different from aqueous solution, and may more accurately be expressed as resembling an
organic solvent.
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The same analysis as carried out on the chloroform-soluble system will be performed in aqueous milieu in
collaboration with Yoko Kato. For the preparation of water-soluble imide receptors,42 amine A29 was
condensed with tris((benzyloxy)methyl) Kemp's imide acid chloride 42 to give the benzyl-protected ester A31.
The debenzylated ester was not sufficiently water-soluble for purposes of 1H NMR titration, however propyl
amide A34 was found to dissolve easily, despite have two additional methylene groups. The large increase in
water-solubility in the amide derivative serves as an important highlight of the hydrogen-bonding ability of
amides over esters as a result of greater polarization between the nitrogen and carbonyl. An amide in this
position is known to make a weak hydrogen bond to N3 of adenine in organic solvents (Section A.2.3), so this
substitution must be maintained in the diimide to maintain the equivalence of the receptors. The synthesis of
the diimide receptor and the measurement of binding affinity for these derivatives in aqueous solution will be
performed by Yoko Kato.
imide acid chlorideA29
DMAP, pyridine
NaOH (aq) r- A31, R=
THF. EtOH A32 R=
R
-.... , OR
1. (COCI) 2, DMF, THF
2. propylamine, THF
HBr(g), HCOOH E_ A33, FA34, F
Scheme A.3.2. Synthesis of water-soluble carbazole monoimide.
4 REINVESTIGATION OF NAPHTHYL-DIIMIDE RECEPTORS
The method for determining hydrogen-bond strength in water described in Section A3 was initially applied to
the receptor based on 2,7-diaminonaphthalene. 51 It was found however, that in water there is almost no triplex
hydrogen-bonding to adenine by the naphthalene-based receptor. The two imides appear to act almost
completely independently as they each bind an adenine moiety. That is, the naphthalene-diimide functions to
non-cooperatively bind two molecules of adenine. In contrast, the carbazole-based diimide receptor has been
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shown to bind 9-ethyladenine and adenosine derivatives with triplex-like hydrogen bonding.43
'chelation'
'chelation'
Figure A.4.1. The different binding modes of naphthalene-diimide receptor.
Though this suggests that the naphthalene framework is not optimum for simultaneous chelation of adenine,
this type of behavior had not been initially observed for the 2,7-diaminonaphthalene-based receptors in organic
solvents. 14,15 While the early trimethyl Kemp's imide receptors were studied in mixtures of acetonitrile and
chloroform,14 a more soluble version, A36, based on the tripropyl Kemp's triacid22 was calculated to have an
association constant of 105 M-1 (-6.75 kcal/mol) in CDC13 by titration of the cleft with 9-ethyladenine. This
titration was complicated by appreciable broadening of the imide signal and very little data could be taken for the
early part of the titration curve. As a result, the majority of the data was obtained where the concentration of the
complex was well over 80%.52 The poor quality of the data lowers our confidence in the curve-fitting results.
o
A03
A35
Pr
) Pr
)Pr
Pr
mPr
`H H-h N <A38
A36
Figure A4.2. Naphthyl-based imide clefts.
Receptors A35 and A36 were synthesized as previously described 14,15 by coupling the commercially available
amines with tripropyl Kemp's imide acid chloride. 22 The association of A36 and 9-ethyladenine was re-
examined in CDCl3 to ascertain the extent to which chelation occurs relative to 2:1 binding in this solvent
system.
The association constant of monoimide A35 and 9-ethyladenine was determined to be 188 M-1 (-3.06
kcal/mol) in CDC13by monitoring the 1H NMR chemical shift of the center of the CH2 quartet as the receptor
(49.8 mM) was added to a solution of 9-ethyladenine (maintained at 1.00 mM) in CDC13. A dimerization
constant of 13.8 M-1for the imide was incorporated into the calculation using equations developed by Brian
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Murray. 53 Namely, curve fitting (Systat 35)of the chemical shift of the naphthalene C1H proton over a
concentration range of 0.1-33 mM in CDC13 to Equation A.4.1 gave the dimerization constant, Kd, where 8m is
the chemical shift of the monomer, d is the chemical shift of the dimer, and Ht is the concentration of the
receptor. Both chemical shifts are asymptotes of the hyperbolic dimerization isotherm and must be calculated
from the regression analysis. Incorporation of Kd as a constant into Equation A.4.2 allowed curve-fitting of the
1:1 titration curve between A35 and 9-ethyladenine. The concentration of 9-ethyladenine, Ht, was a constant in
this case. All other variables are defined as in Equation A.2.12 and A.4.1.
H,·( d tm)j+H -4 K)(Ht + 15/Kdi -HJ (A.4.1)
(A.4.2)
(3- H31 (5 -f 5H 1 ( - H
G, = H,( ) + 2G,+H
3HG H Ka Ka . HG H K. aHG H
In order to observe the complete saturation curve during titration of diimide A36 and 9-ethyladenine, the
'reverse' titration protocol of section kA.2 was performed - the diimide cleft was added to 9-ethyladenine and the
1H NMR shift of the center of the CH2 quartet was monitored. These titration conditions increase the influence
of 2:1 binding on the saturation curve. The magnitude of the apparent binding constant is so much larger than
the monoimide receptor that some amount of chelation must be occurring. In order for 2:1 binding, which is
assumed to occur with the same affinity as the monoimide receptor, to compete with chelation, a large excess of
9-ethyladenine must be present (in the original titration procedure, an excess of 9-ethyladenine was present
n _
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Figure A4.3. Titration of 9-ethyladenine with naphthyl diimide does not fit 1:1 binding model.
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only near the endpoint of the titration curve, where the imide signal is almost completely saturated). The data
from this titration are shown in Figure A.4.3 along with the best fit from the 1:1 binding isotherm (Equation
A.2.12). It is abundantly clear from this plot that the experimental data does not fit the purely 1:1 binding
isotherm. In contrast, titration of 9-ethyladenine with carbazole diimide receptors gives no indication of this
behavior.
The generalized binding scheme for mixed 1:1 (chelation) and 2:1 binding is outlined in Figure A.4.4. There are
five equilibrium constants and three bound species in solution. No attempt is made to correct for the
dimerization of either guest or host in chloroform. Even with judicious use of assumptions, this is a very difficult
situation to describe mathematically. A solution for a similar binding situation has recently been described by
Anslyn. 54 The approach outlined here was solved by Belinda Tsao,55 who also performed the curve-fitting itself.
Kch S H·G
Hc
Ks1 Ks2
Hs HsG HSG2
Figure A4.4. Mixed 2:1, 1:1 chelation.
As the conformational and stoichiometric behavior of the receptor and target are dissimilar, the convention of
the 1:1 binding isotherm that guest and host are determined by the titration protocol no longer applies. For this
derivation, then, the host, H, is the receptor A36 and the guest, G, is 9-ethyladenine. Given that Hc is the 'C-
shaped' conformation of the host and Hs is the 'S-shaped' conformation, then the equilibrium constants
depicted in Figure A.4.2 are defined in Equations A.4.3 to A.4.7.
[HG]
K =[H] (A.4.4)Kch [H]G] (A.4.4)[H ][G]
/, [H3G] (A.4.5)[H,][G]
= [HG 2] (A.4.6)[HG][G]
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Kc-s Kc [HG] (A.4.7)
There are a number of assumptions which can be made to simplify this description. There is no interaction
between the imides of A36 that would be predicted to shift the equilibrium between the C-shaped and S-
shaped conformations from unity. Accordingly, the value of KCs can be taken as 1, leading to the approximation:
[Hs] =[H]- [H] (A.4.8)
where [H] is the generalized concentration of free host.
The equilibrium between the chelated adenine and non-chelated adenine would be expected to liefar in favor
of the chelated form so Kc can be assumed to be extremely small and the pathway corresponding to Equation
A.4.7 can be neglected in further calculations. This assumption is implicit in the determination of hydrogen-
bond strength of Section A.3. Also, since the monoimide binding of 9-ethyladenine is likely unaffected by
previous association, Ks1 and Ks2 can be considered as essentially equivalent.
Manipulation of the equilibrium expressions gives the following equations for the variously bound species of
receptor (Equations A4.9 to A.4.11).
[HcG] = KCh[H][G] (A.4.9)
[H/G] = K/[H][G] (A.4.10)
[HG2 ] = K2[H][G] 2 (A.4.11)
The mass balance equations are, then:
H, =[H]+[HG]+[HhG]+ [HG 2] (A.4.12)
G, = [G] + [HG] + [HCG] + 2[HsG 2] (A.4.13)
The chemical shift of the 9-ethyladenine (maintained at constant concentration, Gt) is represented as a
weighted average of the adenine chemical shifts in the unbound, singly-bound (chelated), singly-bound
(monoimide), and doubly-bound complexes. That is,
= [G] [H Gh] + [ HG] G5HS G + [ 3SHSG2 (A.4.14)
G, G, ,, G,
By expressing the chemical shift as the chemical shift difference according to Equations A.4.15 to A.4.18,
followed by simplification, the change in chemical shift can be represented as in Equation A.4.19.
A = G - (A.4.15)
AHG = G - SHChG (A.4.16)
AH,G = HG - SH
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A H,G2 = G - H,G 2 (A.4.18)
A G[HCh] A + [HGG] AHG+ 2[HG ]A (A.4.19)
Incorporation of the equilibrium expressions (Equations A.4.4 to A.4.6) into the above equation gives Equation
A.4.20, which expresses the chemical shift change as a function of the concentrations of free 9-ethyladenine and
diimide.
(KSAH G +KchAHG +2K [G]AHG2 )[H] (A.4.20)
1 + (K + KC + 2K,2[G])[H]
Since both Ks (188 M-1) and AHsG (0.6077 ppm) are approximately known from the monoimide titration, this
equation contains three variables. If the environment of the methylene group of 9-ethyladenine is considered to
be in approximately the same environment in both HsG and HsG2, then
AH,G, = AH,G (A.4.21)
This simplifies Equation A.4.20 to:
(KSAHG + KhH,,G + 2K2s [G]HG)[H] (A.4.22)
1+(K + K + 2K2[G])[H]
There are now only two variables in the expression, Kch and AHchG. However, a complication must now be
addressed. This equation requires simultaneous knowledge of thefree concentration of both host and guest.
These values can be obtained from the mass balance equation A.4.13 with some manipulation. Multiplication of
the multi-component terms by Ht/Ht and expanding the denominator gives an expression relating the free
concentration of 9-ethyladenine to the equilibrium constants and total concentration of adenine and diimide at
each point in the titration (A.4.23). With these values, the free host concentration can be calculated for each
data point from the mass balance equation A.4.12 by substitution of equilibrium expressions A.4.9 to A.4.11 and
knowledge of all binding constants.
G, =[G] + ((Kch + Ks)[G] + K2[G]2)[H],
1+(KG]h +K 3)[G]+K~[G] 2 (A.4.23)1 +(Kc + KJG] + K,2[G]2
The curve-fitting procedure, then, requires simultaneous regression analysis of two non-linear equations.
Approximate values for the free host and guest concentrations are obtained by regression analysis of A.4.23
using an estimate for Kh. The concentrations obtained are coupled with the experimental chemical shift data
and used in the regression analysis of Equation A.4.22 to yield an 'improved' estimate of Kch. This new estimate
is, in turn, used for a second curve-fitting of Equation A.4.23. The iterative curve fitting of A.4.22 and A.4.23 is
repeated until stable values for Kh, AHG and the free host and guest concentrations are obtained.
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The results of this iterative non-linear regression analysis are shown graphically in Figure A4.5. The association
constant is calculated to be 44000 M-1 (-6.3 kcal/mol) and AHchG predicted to be 0.2202 ppm. The fit of the
calculated data to the experimental numbers is very good ( 2 = 3.3 x 10-5).
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Figure A4.5. Titration of 9-ethyladenine with diimide A36 fits combined 1:1/2:1 model.
Despite the energetic barrier imposed by the intramolecular hydrogen bond between the two imides, the
chelation binding affinity of A5 (Section A.2) is approximately the same as the naphthalene-based receptor.
This suggests that the intrinsic binding affinity of the carbazole-diimide architecture may be greater than the
naphthalene-diimide by as much as the strength of a hydrogen bond, 1.5 kcalmol.
While the angle imposed between the two imides on carbazole might be expected to have greater
complementarity to adenine, an overlay of minimized conformations of the complexes shows that there is little
difference in the positions of the imide groups as they bind to adenine (Figure A.4.6). In the structure of the
carbazole-diimide complex with 9-ethyladenine, the Hoogsteen-bound imide is rotated in the plane of the
aromatic to form a bifurcated bond to N6H2. This type of interaction has previously been seen for simple
monoimide amides, but not for the analogous imide esters, likely due to greater charge density on the amide
carbonyl.56 Though this would seem to lend only a minor increase in binding affinity, it may be a contribution the
greater intrinsic affinity of the carbazole-based receptors.
As there would seem to be little difference between the hydrogen-bonding in the naphthalene- and carbazole-
based diimide receptors, then the participation of 2:1 binding from the naphthalene system would appear to be
linked to the aromatic stacking propensity of 2,7-diamidonaphthalene. From Figure A.4.7, which shows the
superimposed aromatic region in both complexes, there is significantly more aromatic overlap in the complex
with naphthalene, rather than carbazole. Additionally, the electron-rich nature of the carbazole group is not at all
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like the electron-poor aromatic groups that typically intercalate into DNA. It is interesting to note that models
based on offset aromatic stacked geometry,57 and overlap of complementary aromatic point charges58 would
seem to predict that the carbazole moiety should stack more favorable with adenine than naphthalene.
Figure A.4.6. Superimposed A5 and A36 complexes of 9-ethyladenine.
Figure A.4.7. Adenine superimposed on carbazole (left) and naphthalene (right) as in the complexes.
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5. MONOIMIDE RECEPTORS
Figure A.5.1. Schematic of symmetric bis(imide)-adenine binding.
In Section A2, a receptor was designed with an induced binding geometry. That is, the bound conformation of
the receptor was defined by the binding event itself. The complex formed was a three-tiered aromatic
'sandwich', with aromatic stacking providing the driving force for the stacking of the third tier onto the complex.
While in aqueous solution, the hydrophobic effect would provide a strong force for this in aqueous solution,
there is very little driving force for aromatic stacking in organic solvents. It seemed appropriate, then, to design a
similar receptor such that both top and bottom aromatic surfaces possessed similar affinity. This is outlined
schematically in Figure A5.1. This receptor is designed to bestructure-less until the binding event occurs.
Here, each aromatic surface contains a single Kemp's imide, so that the driving force for complexation is
hydrogen-bonding with concomitant aromatic stacking providing additional stabilization. This type of binding
would also be predicted to be successful in water, where the hydrophobic effect provides the major contribution
to binding while specificity for adenine contributed by hydrogen-bonding. Additionally, with a water-solubilizing
tris(hydroxymethyl) Kemp's imide on each of the very hydrophobic carbazole moieties, the water-solubility
might be enhanced relative to a two-imide/no-imide structure, as in Section A2.
Figure A.5.2. Predicted geometry of mono-imide clefts induced by binding (stereoview).
Molecular modeling was used to estimate the most favorable spacer for connecting the two aromatic surfaces
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(Figure A.5.2). The lessons of Section A.2 led to the incorporation of an amide in the spacer to provide
additional hydrogen bonding to adenine N3. Two units of carbazole monoimide A30 are linked through an
ethylenediamine chain to form the bis(monoimide) cleft A38. Base pairing can take place to the adenine,
Watson-Crick from below and Hoogsteen from above, with coplanarity of all three aromatic surfaces. The
backbone is arranged so that two partial hydrogen bonds are formed to adenine N3. The receptor has a C2-like
conformation in the complex
Pr
OHoo
NaOH (aq) N7 _ 1. (COC)2, DMF, THF
THF, EtOH SO 2. (CH2NH2)2, TEA, THF
A37 H
'2
Scheme A.5.1. Synthesis of induced-binding cleft.
The receptor was assembled from monoimide A30 by hydrolysis, conversion to the acyl chloride, and
condensation with ethylenediamine to form bis(imide) A38 (Scheme A.5.1). The solubility of A38 is
extremely poor. Though 9-ethyladenine solubilized the cleft somewhat, the receptor could not be studied
effectively. The flexibility of the spacer apparently allows an extensive intermolecular hydrogen-bonding
network to form which is not adequately solvated by chloroform.
R
R
1. (COC1)2, DMF, THFA32
2. (CH2 NH2 )2, TEA, THF
A39, R=Bn _- HBr(g), HCOOH
A40, R=H
Scheme A.5.2. Synthesis of water-soluble induced-binding cleft.
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Despite this, a water-soluble version of this cleft was synthesized with the hope that the greater solvating ability
of water would break up the hydrogen-bond network to provide sufficient solubility and, as stated above, that
the hydrophobic effect would provide adequate driving force for association. Acid A32, the
tris((benzyloxy)methyl) version of the carbazole monoimide, was converted to the acid chloride and condensed
with ethylenediamine. Deprotection with HBr(g) in HCOOH produced quantitative yield of the
tris(hydroxymethyl) bis(imide) A40. Despite the breakup of the self-association, this cleft fell victim to the
notoriously poor water solubility of carbazole and was insufficiently soluble in water (< 0.1 mM) for solution
studies by proton NMR. Ultraviolet/visible spectroscopy is unsuitable for titrations because the accessible
concentration range is too low to sample an adequate portion of the binding curve for the small binding
constants expected in aqueous solvent.
6. EXPERIMENTAL SECTION
6.1 General
1H NMR measurements were performed on Bruker AC-250 and AMX-300 and Varian XL-300, GE-300, UN-
300, and VXR-500 spectrometers in solvents as indicated. Chemical shifts are reported as parts per million (6)
relative either to tetramethylsilane or to residual solvent peak. Melting points were obtained on an
Electrothermal IA9100 digital melting point apparatus and are calibrated. IR spectra were recorded on a Mattson
Cygnus 100 FT-IR spectrometer. High resolution mass spectra were obtained on a Finnegan MAT 8200 mass
spectrometer. HPLC was performed on a Waters 600 Multisolvent Delivery System equipped with a Lambda
Max Model 481 LC spectrophotometer using a Waters p-Porasil column.
All commercially available compounds (Aldrich) were used without further purification unless otherwise
indicated. cis,cis-1,3,5-Tripropylcyclohexane-1,3,5-tricarboxylic acid imide chloride was prepared according to
Jeong et al.22 CD30D (99.8% D, Cambridge, Isotope Labs), CD30H (99% D, Cambridge Isotope Labs),
CD2C12 (99.6% D, Aldrich Chemical), and DMSO-d6 (99.9% D, MSD Isotopes) were used from freshly opened
vials. CDCl3 (99.8% D, MSD Isotopes) was stored over molecular sieves and passed through dry basic alumina
just prior to use. Tetrahydrofuran and ether used in anhydrous conditions were distilled from sodium-
benzophenone ketyl; dichloromethane and pyridine were distilled from calcium hydride; and N,N-
dimethylformamide was dried over molecular sieves for several days. Thin layer chromatography was performed
on Merck Silica 60 F-254 precoated TLC plates. Column chromatography was performed on Merck Silica Gel 60
(230400 mesh) according to Still et al.59 Glassware used for anhydrous conditions either was baked overnight
at 150 C, assembled hot, cooled under vacuum, and filled with argon; or was flamed dry under vacuum, cooled
and filled with argon before use. Standard inert-atmosphere techniques were used for syringe and cannula
transfers of liquids and solutions.
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6.2 Synthesis
3,6-Dinitrocarbazole (Al)
was synthesized according to Grotta et al 60 and was purified by dissolving the crude mixture in hot 5:1
DMF/MEK (8 mL/g), filtering, cooling overnight at 3 °C, filtering and washing with cold 5:1 DMF/MEK, 5:3
DMF/MEK, and ether. The recovered solid was dried under vacuum (hot water bath) to yield the pure 3,6-
dinitrocarbazole.
N-(Methoxycarbonylmethyl)-3,6-dinitrocarbazole ()
3,6-Dinitrocarbazole Al (10.12 g, 39 mmol) was stirred with dry K2CO3 (11 g, 2 equiv) in dry DMF (130 mL) at
40-60 °C for 1.5 h under argon. Methyl bromoacetate (8 mL, 2.2 equiv) was added to the dark red solution.
The resulting cloudy orange mixture was stirred for 2 h at room temperature and for 1 h at 45-55 oC. The
reaction was quenched with water (130 mL) and cooled on ice. The yellow product was filtered, washed with
water, sucked dry overnight, and dried under vacuum (hot water bath) to yield A2 (12.73 g, 99%) as a yellow
solid: mp 314-315 °C; IR (KBr) 1750, 1340, 1310 cm-1; 1H NMR (300 MHz, DMSO-d6) 8 9.538 (d, 2 H, J =
2.4 Hz), 8.445 (dd, 2 H,J = 9, 2.4 Hz), 7.924 (d, 2 H,J = 9 Hz), 5.639 (s, 2 H), 3.708 (s, 3 H); HRMS (El) calcd
for C15HllN306, 329.06478 found, 329.0645.
N-(Methoxycarbonylmethyl)-3, 6-diaminocarbazole (
A mixture of dinitro compound A2 (2.41 g, 7.3 mmol), 10% Pd-C (520 mg, 22 wt %), MeOH (500 mL), and
HOAc (50 mL) was hydrogenated at atmospheric pressure under a balloon for 5.5 h. The product mixture was
filtered through a cake of Celite and the methanol removed by rotary evaporation under reduced pressure.
Saturated NaHCO 3 was added to neutralize the acetic acid and the crude suspension was extracted with
chloroform. The combined organic layers were washed with saturated NaHCO 3, and dried over anhydrous
Na2SO4. Evaporation of the solvent under reduced pressure yielded 1.52 g (77%) of white solid A3, which
darkens rapidly on exposure to light or air. The crude product is extremely sensitive to air and light and was used
without further purification. 1H NMR (product only) (300 MHz, CDC13) 6 7.314 (dd, 2 H,J = 2.1, 1.2 Hz), 7.079
(dd, 2 H,J = 8.7, 1.5 Hz), 6.865 (dd, 2 H, J = 8.4, 1.8 Hz), 4.879 (s, 2 H), 3.695 (s, 3 H), 3.596 (br s, 2 H).
N-((Methoxycarbonyl)methyl)-3,6-bis(pivaloylamino)carbazole (A)
Diamine A3 (770 mg, 2.86 mmol) in pyridine (50 mL) was treated with pivaloyl chloride (370 pL, 1.05 equiv)
and stirred under argon at room temperature for 70 h. The solvent was removed by rotary evaporation under
reduced pressure, and the residue was dissolved in chloroform, washed with 4% HC, saturated NaHC0 3, and
brine, and dried over MgSO4. After concentration under reduced pressure, the crude product was purified by
flash chromatography (3% MeOH/CHC13), trituration in cold methanol, and flash chromatography (10%
EtOAc/CH2CI2) to give 211 mg (17%) of an off-white powder: mp 242 °C dec; IR (KBr) 3425, 3297, 2963,
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1732, 1657, 1529, 1479, 1198 cm-1; H NMR (250 MHz, DMSO-d 6) 6 9.22 (s, 2 H), 8.34 (d, 2 H,J = 1.4 Hz),
7.55 (dd, 2 H, J = 8.7, 1.6 Hz), 7.44 (d, 2 H, J = 8.8 Hz), 5.29 (s, 2 H), 3.65 (s, 3 H), 1.26 (s, 18 H); HRMS (FAB
in 3-nitrobenzyl alcohol) calcd for C25H32N304 (M+H), 438.3293; found, 438.2391.
N-((Methoxycarbonyl)methyl)-3,6-bis[((cis, cis-2, 4-dioxo-1,5, 7-tripropyl-3-azabicyclo[3.3. 1]non-7-yl)
carbonyl)amino]carbazole (AS)
Diamine A3 (0.4 g, 1.5 mmol) and cis, cis-1,3,5-tripropylcyclohexane-1,3,5-tricarboxylic acid imide chloride
(1.055g, 2.06 equiv) were refluxed in dry pyridine under argon for 6.5 h. Solvent was removed by rotary
evaporation, and the crude was suspended in chloroform (100 mL). The organic layer was washed with 10%
HCI (100 mL) and brine (60 mL), and the layers were back extracted with chloroform (100 mL). The combined
organic layers were concentrated by rotary evaporation to give a brown oil, which was triturated with cold
methanol (6 mL) to give a beige powder, which was filtered and sucked dry. A second crop was recovered from
the filtrate. Both crops of crystals and the final filtrate were purified by column chromatography to yield A5 as a
pale beige powder (520 mg, 39%): mp 227-229 C; IR 3450, 3381, 3227, 3111, 2960, 2935, 2873, 1700, 1492,
1467, 1198 cm-1; 1H NMR (250 MHz, DMSO-d6) 6 10.40 (s, 2 H), 9.16 (s, 2 H), 8.11 (s, 2 H), 7.43 (dd, 4 H),
5.30 (s, 2 H), 3.63 (s, 3 H), 2.66 (d, 4 H, J = 13.7 Hz), 2.03 (d, 2 H,J = 12.3 Hz), 1.8-0.77 (m, 48 H); HRMS
(El) calcd for C51H69N508, 879.5146 found, 879.5146.
N-(Carboxymethyl)-3,6-bis[((cis, cis-2,4-dioxo-1,5, 7-tripropyl-3-azabicyclo[3.3.1]non- 7-yl)carbonyl)
amino]carbazole (A6)
To a solution of ester A5 (499 mg, 0.57 mmol) in THF (20 mL) was added 95% ethanol (60 mL), followed by
1 N NaOH (20 mL). The reaction solution was stirred under argon for 30 min and acidified to pH 1 with
concentrated HCl. Solvent was removed by rotary evaporation and the crude material was triturated in water (20
mL) on ice, filtered, washed with cold water, sucked dry, and dried under vacuum to yield a pale beige solid
(421.7 mg, 85%) which was used without further purification: 1H NMR (300 MHz, DMSO-d6) 6 10.39 (s, 2 H,
imide), 9.16 (s, 2 H, amide), 8.11 (s, 2 H), 7.43 (dd, 4 H,J = 14.4, 9 Hz), 5.16 (s, 2 H), 2.67 (d, 4 H,J = 13.2
Hz), 2.03 (d, 2 H,J = 12.6 Hz), 1.6-0.7 (m, 48 H).
N-(Methoxycarbonylmethyl)carbazole (AD
Carbazole (10.11 g, 60.5 mmol) was stirred with dry K2CO3 (22.24 g, 2.7 equiv) in dry DMF (100 mL) under
argon for 45 min at 50 °C before methyl bromoacetate (17 mL, 3 equiv) was added portion-wise over 3.5 h.
The reaction mixture was stirred at this temperature for 14 h and cooled. The reaction was quenched with cold
water (200 mL) and triturated for 1 h on ice. The precipitate was filtered, washed with cold water (200 mL),
and sucked dry. The product was dried under vacuum to yield white, crystalline A7 (13.24 g, 91%): mp 97-98
°C; IR (KBr) 3054, 2936, 1731, 1457, 1328, 1267 cm-'; 1H NMR (300 MHz, CDC13) 6 8.103 (d, 2 H, J = 8.1
Hz), 7.493 (t, 2 H, J = 6.9 Hz), 7.293 (m, 4 H), 5.02 (s, 2 H), 3.718 (s, 3 H); HRMS (EI) calcd for C15H13NO2 ,
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239.0946; found, 239.0944.
N-(2-Hydroxyethyl)carbazole (A)
An anhydrous THF (30 mL) solution of the carbazole ester A7 (5.3 g, 22 mmol) was cannulated over 15 min
into an ice-cooled suspension of LiAIH4 (0.94 g, 1.14 equiv) in THF (35 m). The reaction mixture was stirred
at room temperature for 1.75 h and was quenched with water (1 m), 10% NaOH (1 m), and water (3 mL).61
After the reaction mixture was stirred on ice for 10 min, the inorganic salts were removed by vacuum filtration
and washed with ether (100 m). The combined organic layers were washed with water to neutrality and with
brine, and were dried over anhydrous MgSO 4. Solvent was removed by rotary evaporation under reduced
pressure, and the residue was pumped free of solvent under vacuum. The crude brown oil recovered (4.48 g,
96%) was purified by column chromatography (25% ethyl acetate/hexanes) to yield white crystalline AS (3.06 g,
66%): mp 83-84 °C; IR (KBr) 3199, 3047, 1592, 1452, 1324 cm-l; 1H NMR (300 MHz, CDC13) 6 8.108 (dd, 2
H,J = 6.3, 1.2 Hz), 7.474 (d, 2 H, 3.9 Hz), 7.254 (m, 4 H), 4.486 (t, 2 H,J = 5.4 Hz), 4.062 (apparent q, 2 H,J =
4.5 Hz), 1.530 (s, OH); HRMS (EI) calcd for C14H13NO, 211.0997; found, 211.0995.
N-(2-Phthalimidoethyl)carbazole (A)
DEAD (2 mL, 1.02 equiv) was added to a stirred solution of alcohol AS (2.62 g, 12.4 mmol), triphenylphosphine
(3.29 g, 1.01 equiv), and phthalimide (1.88 g, 1.03 equiv) in anhydrous THF (150 mL) under argon. The
reaction solution was stirred at room temperature for 22 h, refluxed for 4 h, and stirred at room temperature for
an additional 44 h. Solvent was removed by rotary evaporation and the crude mixture pumped free of solvent
under vacuum. The crude solid was triturated with ice-cold methanol (100 mL), and the off-white precipitate
was filtered, washed with cold methanol, and dried to give crystalline A9: mp 143.1-143.6 °C; IR (KBr) 1772,
1710, 1598, 1384 cm-l; 1H NMR (300 MHz, CDC13) 8 8.082 (d, 2 H, J = 7.5 Hz), 7.816 ( apparent dd, 2 H, J =
5.4, 3 Hz), 7.712 (apparent dd, 2 H,J = 5.7, 2.7 Hz), 7.534 (d, 2 H,J = 8.4 Hz), 7.437 (td, 2 H,J = 6.9, 1.5 Hz),
7.222 (td, 2 H, J = 7.5, 1.2 Hz), 4.595 (t, 2 H, 7.5 Hz), 4.124 (t, 2 H, 7.8 Hz); HRMS (FAB in 3-nitrobenzyl
alcohol) calcd for C22H16N202, 340.1212; found, 340.1213.
N-(2-Aminoethyl)carbazole (AMQ)
The phthalimido compound A9 (1.81 g, 5.3 mmol) was dissolved in THF (50 mL) and 95% ethanol (50 mL)
with hydrazine monohydrate (530 iL, 2 equiv) and the resulting solution was refluxed for 18 h. Water (25 mL)
was added, and the mixture was concentrated by rotary evaporation. Additional water (50 mL) and ether were
added, and the mixture was brought to pH 14. The aqueous layer was extracted with ether, and the combined
organic layers were washed with water and brine, and dried over anhydrous MgSO4. The solvent was removed
by rotary evaporation, and product was dried under vacuum to give off-white crystalline A10 (1.16 g, 100%): mp
68-70 °C; IR (KBr) 3350, 1886, 1594, 1455, 1229 cm-l; 1H NMR (300 MHz, CDC13) 6 8.120 (dd, 2 H, J = 7.2, 1
Hz), 7.448 (d, 4 H, J = 3.9 Hz), 7.253 (m, 2 H), 4.413 (t, 2 H,J = 6.3 Hz), 3.229 (t, 2 H,J = 6 Hz), 1.152 (br s, 2
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H); HRMS (El) calcd for C14H 14N2, 210.1157; found, 210.1156.
3-(((Benzlyoxy)carbonyl)amino)benzoic acid (A)
Benzyl chloroformate (1.15 mL, 1 equiv) in anhydrous THF (30 mL) was added to 3-aminobenzoic acid (1 g, 7.3
mmol) and dry pyridine (0.7 mL, 1.2 equiv) in anhydrous THF (200 mL) under argon. The reaction was stirred
at room temperature for 2.5 h and solvent removed by rotary evaporation. The crude was triturated in water,
acidified, filtered, sucked dry, and dried under vacuum to yield white crystalline product (1.945 g, 98%): mp
217.6-218.7 °C; IR (KBr) 3292, 1696, 1594, 1542, 1443, 1242 cm-1; 1H NMR (300 MHz, d6-acetone) 6 8.97 (s,
1 H), 8.307 (s, 1 H), 7.82 (d, 1 H,J = 9 Hz), 7.70 (d, 1 H,J = 8 Hz), 7.415 (m, 5 H), 5.189 (s, 2 H); HRMS (EI)
calcd for C15H13NO4, 271.0844; found, 271.0843.
Methyl 3-(((Benzyloxy)carbonyl)amino)benzoate (A12)
Thionyl chloride (4 mL) was added to a suspension of acid All (431.3 mg, 1.59 mmol) in dry methanol (40
mL). The mixture was stirred under a drying tube at room temperature for 5 h. Solvent was removed under
reduced pressure, and the crude product was purified by flash chromatography (chloroform) to give white solid
ester A12 (349 mg, 77%): mp 124-124.6 °C; IR (KBr) 3344, 1736, 1697, 1547, 1211 cm-1; 1H NMR (250
MHz, CDC13) 6 7.97 (s, 1 H), 7.71-7.76 (m, 2 H), 7.36-7.42 (m, 6 H), 6.81 (br s, 1 H), 5.22 (s, 2 H), 3.90 (s, 3
H); HRMS (FAB in 3-nitrobenzyl alcohol) calcd for C16H16NO4 (M+H), 286.1079; found, 286.1077.
Methyl 3-Aminobenzoate (AI.)
CBz-protected ester A12 (230 mg, 0.81 mmol) was hydrogenated at balloon pressure for 10.5 h in THF (10
mL) and 95% ethanol (15 mL) with 10% palladium on carbon (40.5 mg, 18 wt %). Catalyst was removed by
filtration through Celite and solvent removed by rotary evaporation under reduced pressure. The residue was
dissolved in chloroform and dried over MgSO4. Removal of solvent under reduced pressure followed by
evacuation yields 98.8 mg (81%) of a pale-brown oil which was used without further purification: 1H NMR (250
MHz, CDC13) 6 7.43 (d, 1 H, J = 7.6 Hz), 7.35 (t, 1 H, J = 1.8 Hz), 7.22 (t, 1 H, J = 7.8 Hz), 6.86 (dd, 1 H,J =
7.8, 2.3 Hz), 3.89 (s, 3 H), 3.77 (br s, 2 H).
3-(((Benzlyoxy)carbonyl)amino)benzoyl Chloride (AL4)
Acid All (510.2 mg, 1.88 mmol) was refluxed in fresh SOC12 (15 mL) for 3 h. Thionyl chloride was removed
by rotary evaporation with addition of benzene and dried under vacuum to give white crystalline A14 (545 mg,
100%), which was used without further purification: IR (CHC13) 3430, 2253, 1793, 1745, 1741, 1606, 1593,
1530, 1489, 1439, 1431 cm-1; 1H NMR (300 MHz, CDCl 3) 6 8.083 (s, 1 H), 7.775 (d, 2 H,J = 7.2 Hz), 7.352
(m, 5 H), 7.113 (s, 1 H), 5.195 (s, 2 H).
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N'-Propyl-3-(((benzyloxy)carbonyl)amino)benzamide (A15)
Acid chloride A14 (985 mg, 3.4 mmol) was dissolved in anhydrous CH2C12 (150 mL) under argon. Pyridine
(280 gL, 1.02 equiv) and propylamine (560 pL, 2 equiv) were added. The solution was stirred at room
temperature for 8 h and then washed with 5% (w/v) citric acid (50 mL), saturated NaHCO 3 (50 mL), and brine
(50 mL). The organic layer was dried over anhydrous MgSO 4 and concentrated under reduced pressure. The
crude product was recrystallized from ether/CH 2CI2 to give 636 mg (60%) of fluffy white crystals: mp 145.4-146
°C; IR (KBr) 3334, 3299, 2961, 1736, 1624, 1553 cm-l; 1H NMR (250 MHz, CDCl3) 7.84 (s, 1 H), 7.61 (d, 1
H, J = 7.8 Hz), 7.45-7.33 (m, 7 H), 7.07 (br s, 1 H), 6.18 (br s, 1 H), 5.21 (s, 2 H), 3.39 (q, 2 H, J = 7.5 Hz),
1.609 (q, 2 H, J = 7.3 Hz), 0.964 (t, 3 H, J = 7.3 Hz); HRMS (FAB in 3-nitrobenzyl alcohol) calcd for
C18H21N203 (M+H), 313.1552; found, 313.1550.
N'-Propyl-3-aminobenzamide (A6)
The CBz-protected amine A15 (361 mg, 1.16 mmol) was hydrogenolyzed using the same procedure as for
A13 to give colorless oil A16 (203 mg, 99%), which darkened rapidly on exposure to light and air and was used
without further purification: 1H NMR (250 MHz, CDCl3) 6 7.27 (s, 1 H), 7.16 (s, 1 H), 7.04 (br t, 1 H), 6.90 (m,
1 H), 4.15 (br s, 2 H), 3.49 (q, 2 H,J = 7.3 Hz), 1.08 (t, 3 H,J = 7.4 Hz).
N'-(2-(9-N-Carbazolyl)ethyl)-3-(((benzyloxy)carbonyl)amino)benzoate (A17)
Acid chloride A14 (515 mg, 1.78 mmol) and alcohol A8 (375.8 mg, 1 equiv) were condensed using the
procedure of A15. Recrystallization from chloroform gave 375 mg (45%) of A17 as a white solid: mp 200-
200.3 °C; IR (KBr) 3295, 3126, 1700, 1545, 1214 cm'; 1H NMR (250 MHz, CDCI 3) 6 8.12 (d, 2 H, J = 7.9 Hz),
7.8 (d, 1 h, J = 8 Hz), 7.54-7.24 (m, 9 H), 6.5 (s, 1 H), 5.24 (s, 2 H), 4.73-4.67 (m, 4 H); HRMS (FAB in 3-
nitrobenzyl alcohol) calcd for C29H24N204, 464.1736; found, 464.1733.
N'-(2-(9-N-Carbazolyl)ethyl)-3-aminobenzoate (A)
The CBz-protected ester A17 (199 mg, 0.428 mmol) was hydrogenolyzed using the procedure for A13 to give
129.3 mg (91%) of A18 as a colorless oil which was used without further purification: 1H NMR (250 MHz,
CDCl3) 88.12 (d, 2 H,J = 7.8 Hz), 7.48-7.55 (m, 2 H), 7.22-7.37 (m, 5 H), 7.12 (t, 1 H,J = 7.8 Hz), 6.92 (t, 1 H,
J = 1.9 Hz), 6.80 (dd, 1 H,J = 7, 2 Hz), 4.68 (m, 4 H), 3.62 (br s, 2 H).
NK-(2-(9-N-Carbazolyl)etbyl-3-(((benzyloxy)carbonyl)amino)benzamide (A9)
Amine A10 (316.6 mg, 1 equiv) and acid chloride A14 (435.8 mg, 1.5 mmol) were condensed using the same
procedure as for A15 to give off-white solid A19 (686.3 mg, 99%), which was used without further purification:
mp 207-211 C dec; 1H NMR (250 MHz, CDC13) 6 8.1 (d, 2 H, J = 6 Hz), 7.1-7.6 (m, 15 H), 5.200 (s, 2 H),
4.619 (t, 2 H,J = 6 Hz), 3.89 (apparent q, 2 H,J = 6 Hz).
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N'-(2-(9-N-Carbazolyl)ethyl-3-aminobenzamide (A2)
The CBz-protected amide A19 (586 mg, 1.26 mmol) was hydrogenolyzed using the procedure for A13.
Following column chromatography (3.3% MeOH/CHC13), aromatic amine A20 was recovered as an off-white
foam (-50%), which resisted recrystallization attempts and was used without further purification: H NMR
(250 MHz, acetone-d6) 68 .129 (d, 2 H,J = 8 Hz), 7.82 (br m, 1 H), 7.613 (d, 2 H,J = 8 Hz), 7.419 (t, 2 H, = 8
Hz), 7.189 (m, 2 H), 7.043 (t, 1 H, J = 7 Hz), 6.92 (d, 1 H,J = 8 Hz), 6.75 (dd, 1 H,J = 8, 2 Hz), 4.645 (t, 2 H,J
= 6 Hz), 3.811 (apparent q, 2 H,J = 6 Hz).
Scorpion A21
Acid A6 (253 mg, 0.29 mmol) was condensed with amine A13 (67.2 mg, 1.52 equiv) using the method of
scorpion A24. The product was purified by flash chromatography (2% MeOH/CHCl3 and 2.3% MeOH/CHCl 3)
followed by preparative HPLC (2% MeOH/CHCl3) to remove residual A5. Pale beige A21 (47.6 mg, 16%) was
isolated: mp 193 °C dec; IR (KBr) 3380 (br), 2934, 2872, 1700, 1494, 1468, 1301, 1197 cm-l; H NMR (300
MHz, DMSO-d6) 610.71 (s, 1 H, amide), 10.37 (s, 2 H, imide), 9.16 (s, 2 H, amide), 8.27 (d, 1 H,J = 1.8 Hz),
8.12 (s, 2 H), 7.82 (dd, 1 H,J = 7.8, 1.2 Hz), 7.64 (d, 1 H,J = 8.1 Hz), 7.45 (m, 5 H), 5.22 (s, 2 H), 3.81 (s, 3 H),
2.67 (d, 4 H, J = 13.5 Hz), 2.02 (d, 2 H, J = 12.6 Hz), 1.9-0.8 (m, 48 H); HRMS (FAB in 3-nitrobenzyl alcohol)
calcd for C58H75N609 (M+H), 999.5595; found, 999.5600.
Scorpion A22
Under argon, BOP-CI (66 mg, 1.11 equiv) was added to acid A6 (203 mg, 0.234 mmol) and triethylamine (33
,uL, 1 equiv) in CH2C12 (20 mL) on ice. After 15 min stirring, the solution was allowed to come to room
temperature and stirred for an additional 3 h. Amine A16 (50 mg, 1.2 equiv) in CH2C12 (10 mL) was added with
triethylamine (35 ,.L, 1.1 equiv) and the reaction mixture was stirred for 19 h at room temperature. The product
solution was diluted with CH2Cl2 (100 mL), washed with 4% (v/v) HCI (50 mL), saturated NaHCO 3 (50 mL),
and brine and was dried over MgSO4. After removal of solvent under reduced pressure, the beige powder was
purified by flash chromatography (EtOAc/CHCl 3 gradient) and preparative TLC (50% EtOAc/CHC13) to give
pure A22 as a beige powder (66 mg, 28%): mp 200 °C dec; IR (KBr) 3379, 2959, 2872, 1696, 1533, 1196 cm-
1; 1H NMR (250 MHz, DMSO-d6) 6 10.62 (s, 1 H, amide), 10.37 (s, 2 H, imide), 9.17 (s, 2 H, amide), 8.42 (t, 1
H,J = 7.3 Hz, amide), 8.12 (s, 2 H), 8.01 (s, 1 H), 7.73 (d, 1 H,J = 7.4 Hz), 7.51-7.33 (m, 6 H), 5.22, (s, 2 H),
3.17 (q, 2 H,J = 6.6 Hz), 2.67 (d, 4 H,J = 13.7 Hz), 2.02 (d, 2 H,J = 13.8 Hz), 1.9-0.78 (m, 48 H); HRMS (FAB
in 3-nitrobenzyl alcohol) calcd for C60H80N708 (M+H), 1026.6068; found, 1026.6055.
Scorpion A23
Acid A6 (193.5 mg, 0.22 mmol), amine A18 (83 mg, 1.13 equiv), N,N-bis(2-oxo-3-oxazolidinyl)phosphinic
chloride (BOP-Cl, 64 mg, 1.13 equiv), and triethylamine (69 iL, 2.21 equiv) were mixed in anhydrous CH2C12
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(20 mL), stirred under argon for 5 h, and refluxed for 16 h. The reaction solution was diluted with CH2C12 (50
mL) and washed with 5% (w/v) citric acid (25 mL), saturated NaHCO 3, and brine, and dried over MgSO 4. After
removal of solvent by rotary evaporation under reduced pressure, the crude product was purified by flash
chromatography (2.4% MeOH/CHCl 3) and preparative TLC (4% MeOH/CHC13) to give 33.2 mg (13%) of a
beige powder: mp 180 °C dec; IR (KBr) 3378 (br), 2959, 2872, 1700, 1485, 1461, 1300, 1194 cm-1; 1H NMR
(300 MHz, DMSOAd6) 8 10.64 (s, 1 H, amide), 10.36 (s, 2 H, imide), 9.16 (s, 2 H, amide), 8.15 (m, 5 H), 7.7 (m,
1 H), 7.67 (d, 2 H,J = 8.1 Hz), 7.46 (m, 4 H), 7.35 (m, 4 H), 7.15 (t, 2 H,J = 6.7 Hz), 5.22 (s, 2 H), 4.79 (br s, 2
H), 4.60 (br s, 2 H), 2.67 (d, 4 H, J = 13.5 Hz), 2.02 (d, 2 H, J = 12.3 Hz), 1.9-0.75 (m, 48 H); HRMS (FAB in
glycerol) calcd for C71H84N709 (M+H), 1178.6330; found, 1178.6328.
Scorpion A24
To a solution of acid A6 (422 mg, 0.49 mmol) in anhydrous THF (40 mL) under argon was added CDI (88.9
mg, 1.12 equiv). The solution was stirred at room temperature for 1.6 h and amine A20 (188.9 mg, 86% pure, 1
equiv) in anhydrous THF (10 mL) was added. The reaction solution was stirred at room temperature for 23 h
and at 55 C for 3.5 h. Solvent was removed by rotary evaporation. The residue was dissolved in chloroform,
washed with 4% HCI, and brine and dried over anhydrous Na2SO4. Solvent was removed by rotary evaporation
and the crude was purified by column chromatography (3% MeOH/CHCl 3and 40% EtOAc/hexanes) to give
A24 as a pale brown foam (163.3 mg, 28%): mp 280 °C dec; IR (KBr) 3377 (br), 2959, 2932, 2872, 1700,
1485, 1465, 1195 cm-l; H NMR (250 MHz, DMSO-d6) 6 10.607 (s, 1 H, amide), 10.377 (s, 2 H, imide), 9.169
(s, 2 H, amide), 8.624 (apparent t, 1 H, amide), 8.131 (s, 2 H), 8.115 (d, 2 H,J = 8.2 Hz), 8.036 (s, 1 H), 7.685
(m, 2 H), 7.578 (d, 2 H,J = 8.2 Hz), 7.454 (s, 4 H), 7.380 (t, 2 H,J = 7.3 Hz), 7.319 (d, 1 H,J = 4.9 Hz), 7.153
(t, 2 H,J = 7.4 Hz), 5.220 (s, 2 H), 4.536 (apparent t, 2 H), 3.606 (apparent q, 2 H), 2.667 (d, 4 H,J = 13.6 Hz),
2.023 (d, 2 H, J = 12.6 Hz), 0.772-1.9 (m, 48 H); HRMS (FAB in 3-nitrobenzyl alcohol) calcd for C71H85N808
(M+H), 1177.6490; found, 1177.6482.
N-((Methoxycarbonyl)methyl)-3-nitrocarbazole (28)
Alkyl carbazole A7 (2.20 g, 9.194 mmol, purified by flash chromatography, 25-100% CHCl3/hexanes) was added
all at once to a solution of Cu(NO3) 2* 2.5H 20 (4.6 mmol, 1 equiv) in Ac20 (10 mL) and AcOH (15 mL) at 32
°C under a drying tube. Additional AcOH (5 mL) was added to thin the suspension and the reaction was stirred
for 5 h before being poured into water (300 mL). The mononitro product was isolated by filtration and drying to
give 2.485 g (95%) of yellow solid which was used without further purification: 1H NMR (300 MHz, acetone-d6)
8 9.114 (d, 1 H, J=2.4 Hz), 8.401 (dd, 1 H,J=8.4, 0.6 Hz), 8.366 (dd, 1 H,J=9.0, 2.4 Hz), 7.738 (d, 1 H, J=9.0
Hz), 7.660 (d, 1 H,J=8.1 Hz), 7.589 (dd, 1 H,J=7.6, 1.1 Hz), 7.385 (dd, 1 H, 7.3, 1.5 Hz), 5.431 (s, 2 H), 3.727
(s,3H).
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N-((Methoxycarbonyl)methyl)-3-aminocarbazole (A)
Nitrocarbazole A28 (478 mg, 1.681 mmol) was dissolved in THF (50 mL) and hydrogenated at balloon
pressure for 1.6 h with 10% Pd-C (218 mg, 46 wt%). The suspension was filtered through Celite and solvents
removed by rotary evaporation and then under vacuum. The unstable solid was carried on immediately without
further purification.
N- ((Methoxycarbonyl)m ethyl)-3-[((cis, cis-2, 4-dioxo-1,5, 7-tnipropyl-3-azabicyclo[3.3. 1]non- 7-yl)
carbonyl)amino]carbazole (A O)
Amine A29 (428 mg, 1.681 mmol) and tripropyl Kemp's acyl chloride22 (1.05 equiv) were refluxed with
catalytic DMAP (0.034 equiv) in pyridine (11 mL) under a drying tube for 4.5 h and at room temperature for 16
h. After cooling, the reaction was taken up in EtOAc (150 mL) and washed with 1 N HCl (4 x 25 mL) and brine.
The organic layer was dried over Na2SO4, concentrated, and purified by flash chromatography (2%
MeOH/CH 2Cl2) to give 817 mg (87%) of imide A30: IR (KBr) 3378, 2958, 1728, 1699, 1466, 1198, 746 cm-l;
1H NMR (500 MHz, CDC13) 8.240 (d, 1 H, J=2.0 Hz), 8.059 (d, 1 H, J=8.0 Hz), 7.737 (br s, 1 H, imide), 7.436
(t, 1 H,J=7.7 Hz), 7.390 (dd, 1 H,J=8.5, 1.5 Hz), 7.310 (s, 1 H, amide), 7.252 (d, 1 H,J=8.0 Hz), 7.227 (t, 1 H,
J=7.7 Hz), 7.127 (d, 1 H,J=8.5 Hz), 4.905 (s, 2 H), 3.686 (s, 3 H), 2.651 (d, 2 H, J=14.0 Hz), 2.249 (d, 1 H,
J=13.0 Hz), 2.003 (td, 2 H, J=13.0, 4.2 Hz), 1.55 (m, 2 H), 1.4-1.1 (m, 11 H), 0.95 (t, 6 H,J=7 Hz), 0.86 (t, 3 H,
J=7 Hz); HRMS (EI) calcd for C33H41N305, 559.3046; found, 559.3041.
N-((Methoxycarbonyl)methyl)-3-[((cis, cis-2,4-dioxo-1,5, 7-tris((benzyloxy)methyl)-3-azabicyclo[3.3. 1]
non-7-yl)carbonyl)amino]carbazole (Ail)
In an analogous fashion as A30, tris((benzyloxy)methyl) Kemp's imide acid chloride42 (1.036 g, 1.799 mmol)
was refluxed with aminocarbazole A29 (1.5 equiv) in pyridine to yield 953 mg (67%) of the monoimide A31
after gravity chromatography (10-15% EtOAc/CHC13), which was used without further purification: 1H NMR
(500 MHz, d6-DMSO) 6 10.670 (s, 1 H, imide), 9.357 (s, 1 H, amide), 8.067 (d, 1 H,J=7.1 Hz), 7.5-7.2 (m, 21
H), 5.331 (s, 2 H), 4.511 (s, 2 H), 4.511 (s, 2 H), 4.506 (s, 2 H), 4.476 (s, 2 H), 3.772 (d, 2 H,J=9.0 Hz), 3.650
(s, 3 H), 3.458 (s, 2 H), 3.404 (d, 2 H, J=9.0 Hz), 2.545 (d, 2 H,J=14.4 Hz), 2.338 (d, 1 H, J=12.5 Hz), 1.608
(d, 2 H,J=13.7 Hz), 1.596 (d, 1 H,J=12.9 Hz).
N- (Carboxymethyl)-3-[((cis, cis-2,4-dioxo-1,5, 7-tris((benzyloxy)methyl)-3-azabicyclo[3.3. 1]non- 7-yl)
carbonyl)amino]carbazole (A2)
Imide A31 (953 mg, 1.20 mmol) was hydrolyzed with 1 N NaOH (2 equiv) in THF (3.6 mL) and EtOH (2 mL)
and stirring at room temperature for 6.5 h. Organic solvents were removed by rotary evaporation and the
residue suspended in water (10 mL). After acidification with 10% HCI, the solid was isolated by filtration and
dried under vacuum to give 831 mg (89%) of white powder which was used without further purification: HRMS
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(ED calcd for C47H45N308, 779.3207; found, 779.3210.
N-(((Propylamino)carbonyl)methyl)-3-[((cis, cis-2, 4-dioxo-1,5, 7-tris(benzyloxy)methyl)-3-azabicyclo
[3.3.1]non-7-yl) carbonyl)amino]carbazole (E3)
Acid A32 (102 mg, 0.131 mmol) was dissolved in anhydrous THF (4 mL) under argon. Catalytic DMF (<1 pL)
was added via a glass capillary, followed by oxalyl chloride (80 gIL, 7.0 equiv). The reaction was stirred at room
temperature for 45 min, and solvent was removed by rotary evaporation. The residue was dried under vacuum
and re-dissolved in anhydrous THF on ice under argon. Propylamine (150 gL, 13.9 equiv) was added. The
reaction was allowed to come to room temperature and stirred for a total of 53.5 h. Solvent was removed by
rotary evaporation,. The residue was taken up in chloroform (50 mL), washed with 1 N HCI (50 mL), and brine
(25 mL), and dried over Na2SO4. Evaporation of solvent followed by chromatography (30-50% EtOAc/CH 2Cl2)
yielded A33 (80 mg, 75%) as a white powder: IR (KBr) 3356, 1701, 1533, 1493, 1465, 1363, 1323, 1201, 1099,
746, 698 cm-1; 1H NMR (500 MHz, DMSO-d6) 6 10.660 (s, 1 H, imide), 9.348 (s, 1 H, amide), 8.233 (br t, 1 H,
amide), 8.063 (s, 4 H), 7.487 (d, 2 H, J = 8.5 Hz), 7.41-7.25 (m, 18 H), 7.185 (t, 1 H,J = 7.3 Hz), 4.969 (s, 2
H), 4.511 (s, 2 H), 4.505 (s, 2 H), 4.476 (s, 2 H), 3.772 (d, 2 H,J = 9.0 Hz), 3.461 (s, 2 H), 3.403 (d, 2 H,J = 8.8
Hz), 3.042 (q, 2 H,J = 6.1 Hz), 2.545 (d, 2 H,J = 13.9 Hz), 2.346 (d, 1 H,J = 12.5 Hz), 1.606 (d, 3 H,J = 13.7
Hz), 1.426 (q, 2 H, J = 7.3 Hz), 0.840 (t, 3 H, J = 7.3 Hz); HRMS (FAB in 3-nitrobenzyl alcohol) calcd for
C50H53N407 (M+H), 821.3914; found, 821.3914.
N-(((Propylamino)carbonyl)methyl)-3-[((cis, cis-2,4-dioxo-1,5, 7-tris(hydroxymethyl)-3-azabicyclo
[3.3.1]non-7-yl) carbonyl)amino]carbazole (4)
Benzyl-protected imide A33 (72 mg, 87.7 prnol) was dissolved in HCOOH (4.6 mL) and stirred, stoppered, on
ice for 40 min. HBr (g) was bubbled through the solution for 9 min, followed by Ar (g) for 2 h. Solvent was
removed by rotary evaporation. The residue was dissolved in MeOH with benzene and rotavapped dry. This
was repeated twice and the residue dried in vacuo with a KOH trap. The waxy solid was dissolved in MeOH (1
mL) and precipitated by addition of ether (5 mL). The product was triturated briefly, filtered and dried under
vacuum to give A34 (40.5 mg, 84%) as a white solid: IR (KBr) 3326 (br), 1693, 1540, 1492, 1466, 1432, 1325,
1204, 1056, 804, 749 cm-l; 1H NMR (300 MHz, DMSO-d 6) 6 10.445 (s, 1 H, imide), 9.200 (s, 1 H, amide),
8.245 (br t, 1 H, amide), 8.115 (s, 1 H), 8.075 (d, 1 H,J = 8.1 Hz), 7.486 (d, 1 H,J = 8.1 Hz), 7.398 (m, 3 H),
7.177 (t, 1 H,J = 7.5 Hz), 4.969 (s, 2 H), 3.770 (d, 2 H,J = 10.5 Hz), 3.389 (s, 2 H), 3.318 (d, 2 H,J = 10.2 Hz),
3.040 (q, 2 H,J = 6.5 Hz), 2.375 (d, 2 H,J = 14.1 Hz), 2.205 (d, 1 H,J = 12.6 Hz), 1.487 (d, 2 H,J = 14.7 Hz),
1.425 (q, 2 H,J = 6.9 Hz), 1.328 (d, 1 H, J = 12.9 Hz), 0.839 (t, 3 H,J = 7.5 Hz); HRMS (FAB in 3-nitrobenzyl
alcohol) calcd for C29H35N407 (M+H), 551.2506; found, 551.2510.
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N-(Carboxymetyl)-3-[((cis, cis-2,4-dioxo-1,5, 7-tripropyl-3-azabicyclo[3.3. l]non-7-yl)carbonyl)amino]
carbazole (Z)
To a solution of ester A30 (399 mg, 0.713 mmol) in THF (5 mL) and EtOH (10 mL) was added 1 N NaOH (1
mL, 1.4 equiv). TLC analysis indicated that the starting material had been completely consumed after 3 h of
stirring at room temperature. At this time, solvents were removed by rotary evaporation and the residue
dissolved in water (10 mL). Acidification to pH 1-2 with 10% HCI produced a beige precipitate, which was
isolated by filtration and dried to give solid A37 (365 mg, 94%) which was used without further purification.
1,2-Bis{N-[3-[((cis,cis-2,4-dioxo-1,5, 7-tripropyl-3-azabicyclo[3.3. 1]non-7-yl)carbonyl)amino]
carbazolyl]methyl)carbonyl)aminojethane (A8)
Tripropyl carbazole monoimide acid A37 (285 mg, 0.522 mmol) was stirred in anhydrous THF (10 mL) with
catalytic DMF under argon and (COCI) 2 (5.5 equiv) was added via syringe. The reaction was stirred for 1 h, and
then solvent was removed, and the residue dried under vacuum for 2 h. The acyl chloride was then dissolved in
anhydrous THF (10 mL) under argon and a solution of ethylenediamine (0.254 mmol) and TEA (2.152 mmol)
in THF (5 mL) was added dropwise from an addition funnel. Additional THF (5 mL) was passed through the
addition funnel and the reaction was stirred under argon for 2 h. The reaction was quenched with water (1 mL)
and partitioned between CHC13 and 1 N HCI: The organic layer was washed with brine and dried over Na2SO4.
After removal of solvent under reduced pressure, the residue was triturated in MeOH to isolate a pink solid
which was passed through a short column (THF) to remove slow-eluting starting material. The residue was
again triturated in MeOH to isolate a pink solid; 43 mg (15%): IR (KBr) 3352, 2958, 2932, 2871, 1696, 1661,
1537, 1492, 1465, 1430, 1321, 1193, 797, 746 cm-1; 1H NMR (500 MHz, DMSO-d6) 8 10,398 (s, 2 H, imide),
9.199 (s, 2 H, amide), 8.316 (br t, 2 H, amide), 8.104 (s, 2 H), 8.096 (d, 2 H,J = 7.6 Hz), 7.463 (d, 2 H, J = 8.3
Hz), 7.38 (m, 6 H), 7.177 (t, 2 H,J = 7.8 Hz), 4.952 (s, 4 H), 3.161 (s, 4 H), 2.641 (d, 4 H,J = 13.9 Hz), 2.028
(d, 2 H,J = 12.1 Hz), 1.8-1.1 (m, 30 H), 0.866 (t, 12 H,J = 7.1 Hz), 0.797 (t, 6 H,J = 7.3 Hz); HRMS (FAB in
3-nitrobenzyl alcohol) calcd for C66H 83N80 8 (M+H), 1115.6334; found, 1115.6322.
1,2-BisfN-[3-[((cis,cis-2,4-dioxo-1,5, 7-tris(benzyloxy)methyl)-3-azabicyclo[3.3. 1]non-7-yl)carbonyl)
amino]carbazolyl]methyl)carbonyl)aminojetbane (A9
Oxalyl chloride (100 gL, 5.35 equiv) was added to a solution of acid A32 (167 mg, 0.214 mmol) and catalytic
DMF (<1 gIL) in anhydrous THF (9 mL). The solution was stirred at room temperature for 1.5 h, solvent was
removed by rotary evaporation, and the residue dried under vacuum. The acid chloride was dissolved in
anhydrous THF (5 mL) and cooled on ice, under Ar. To this via cannula was added an ice-cooled solution of TEA
(100 l, 0.7175 mmol) and ethylenediamine (7.2 uL, 0.1077 mmol) in anhydrous THF (5 mL), followed by
additional THF (4 mL) rinse. After stirring on ice for 15 min and at room temperature for 10.5 h, solvents were
removed by rotary evaporation. The product was isolated by chromatography (5% MeOH/CH2CI2) followed by
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preparative TLC (3% MeOH/CH 2Cl2, 2 mm plate, eluted twice) to give an off-white powder (75 mg, 44%): IR
(KBr) 3331, 2922, 2859, 1702, 1590, 1529, 1493, 1465, 1232, 1198, 1099, 745, 698 cm-1; 1H NMR (300 MHz,
DMSO-d6) 10.662 (s, 2 H, imide), 9.3351 (s, 2 H, amide), 8.319 (s, 2 H, amide), 8.076 (s, 2 H), 8.063 (d, 2 H,
J = 7.8 Hz), 7.5-7.1 (m, 40 H), 4.956 (s, 4 H), 4.504 (s, 8 H), 4.460 (s, 4 H), 3.768 (d, 4 H,J = 9.0 Hz), 3.450
(s, 4 H), 3.399 (d, 4 H,J = 9.3 Hz), 2.540 (d, 4 H,J = 15.3 Hz), 2.344 (d, 2 H,J = 13.2 Hz), 1.602 (d, 6 H,J =
14.7 Hz); HRMS (FAB in 3-nitrobenzyl alcohol) calcd for C96H95N8014 (M+H), 1583.6968; found, 1583.6963.
1,2-Bis{N-[3-[((cis,cis-2,4-dioxo-1,5, 7-tris(hydroxymethyl)-3-azabicyclo[3.3. 1]non-7-yl)carbonyl)amino]
carbazolyl]methyl)carbonyl)amino]ethane (A40)
The benzyl-protected cleft (65 mg, 40.99 jmol) was dissolved in HCOOH, stoppered, and cooled on ice for 45
min. HBr(g) was bubbled through the solution for 7 min, followed by Ar(g) for 3 h. Solvent was removed by
rotary evaporation and the residue pumped dry (KOH trap). The solid was dissolved in MeOH (4 mL) and
precipitated with ether (6 mL). Following filtration, the solid was triturated in THF (4 mL) for 0.5 h, filtered, and
dried under vacuum to give A40 (39.1 mg, 92%) as a faintly yellow solid: IR (KBr) 3366, 2934, 2873, 1692,
1537, 1492, 1465, 1431, 1325, 1200, 1056, 806, 751 cm-1; 'H NMR (300 MHz, DMSO-d6) 5 10.429 (s, 2 H,
imide), 9.190 (s, 2 H, amide), 8.323 (br s, 2 H, amide), 8.129 (d, 2 H,J = 0.9 Hz), 8.076 (d, 2 H,J = 7.3 Hz),
7.464 (d, 2 H,J = 8.1 Hz), 7.393 (m, 6 H), 7.178 (t, 2 H,J = 7.3 Hz), 4.957 (s, 4 H), 4.0 (br s, 6 H, hydroxyl),
3.770 (d, 4 H,J = 10.5 Hz), 3.387 (s, 4 H), 3.319 (d, 4 H,J = 10.5 Hz), 3.172 (s, 4 H), 2.371 (d, 4 H,J = 13.2
Hz), 2.209 (d, 2 H, 12.9 Hz), 1.488 (d, 4 H, J = 13.8 Hz), 1.326 (d, 2 H, J = 13.2 Hz); HRMS (FAB in 3-
ntirobenzyl alcohol) calcd for C54H59N8014 (M+H), 1043.4151; found, 1043.4154.
6.3 Extractions
Extractions were performed by vigorously shaking 2 mL of a saturated aqueous solution of the nucleoside
derivative with 2 mL of a 1 mg/mL solution of A24 or A27 in chloroform for 1 minute, drying the organic layer
over Na2SO4, removing solvent under reduced pressure, and dissolving the residue in DMSO-d6. Equivalents
were calculated by integration of host and guest signals in the 1H NMR spectrum. Extractions were run in
duplicate. The absolute quantity of nucleoside extracted by the host was calculated by assuming 100% recovery
of the receptor from the original extraction experiments. Blank extractions were performed similarly, but with
no substrate in the chloroform. The absolute amount of nucleoside derivatives extracted was quantified using
3,6-dinitrocaaole (1.14 mM in DMSOd 6) as an internal standard.
6.4 Titrations
'Reverse' NMR titrations were performed at 250 MHz on a Bruker AC-250 instrument in a 5 mm NMR tube at
ambient temperature (approximately 22 °C) by treating 400 or 500 gL of purine (1-2 mM) with aliquots of
scorpion (4-6 mM) and monitoring the changes in the chemical shift of the substrate protons. For 'forward'
titrations, scorpions (4 mM) were titrated with 9-ethyladenine (40 mM) in CD30D.
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Nonlinear least squares regression curve fitting was used to determine binding constants, along with the final
chemical shift of each of the monitored protons. In all cases, at least 50% of saturation was experimentally
observed. The association constants given are the average of the binding constants obtained for each of the
protons on the purine ring system. On the basis of our previous results,l4 the calculated values are expected to
be no more accurate than within 10% of the actual value. For chloroform titrations, where association constants
are extremely large, a concentration correction was introduced into the regression analysis. The variations in
concentration so determined were less than 1%, but resulted in a significantly better fit of the data.
6.5 NMR Spectroscopy
Processing and analysis of spectra were done on instrument. Experiments performed on Bruker instruments
used shifted sinebell FID weighting while those done on Varian instruments employed a Gaussian multiplication
of FID's. Except for the BrukerAC-250, which used time proportional phase increments (TPPL), 62 phase cycling
was accomplished through the use of hypercomplex data.63
Longitudinal relaxation times (T1) were measured using the inversion-recovery method as implemented in the
Varian software (VNMR version 3.1).
Proton resonance assignments of A24 were made in DMSO-d6 from DQF-COSY6465 (AC-250, 256 x 512 data
points, 292 Hz spectral width, zero-filled to 512 x 512) and NOESY29,66,67 (UN-300, mixing time of 1 s, 512 x
4K data points, 3919 Hz spectral width, zero-filled to 2Kx 4K).
Assignment of resonances in the proton NMR spectrum of the one-to-one complex of A24 and 9-ethyladenine
in CDCl 3were based on a DQF-COSY experiment on UN-300 (150 x 512 data points, 1220 Hz, zero-filled to
512 x512).
Low temperature studies were performed with A24 in CDCl 3 on a Varian GE-300 (2.1 and 12.2 mM in
chloroform) and with the one-to-one complex of A24 and 9-ethyladenine on a Varian VXR-500 in CDCl 3 (5.5
mM) and in CD30H (2 mM). Hydroxyl protons of CD30H were suppressed using 1:3:3:1 binomial solvent
suppression. 40,68
Peak assignments and through-space correlation of the one-to-one complex of A27 and 9-ethyladenine in
CD2C12were made on the basis of TOCSY (mixing time of 30 ms, 512 x 4K data points, 4500 Hz, zero-filled to
2Kx 4K) and NOESY (mixing time of 500 ms, 384 x 4K data points, 4425 Hz, zero-filled to 2Kx 4K) on UN-300.
Peak assignments and through-space correlations of the one-to-one complex of A24 and 9-ethyladenine in
CD2C12 were made on the basis of TOCSY28 ,69 (mixing time of 25 ms, 512 x 4K data points, 4200 Hz in col and
5434 Hz in Co2, zero-filled to 2K x 4K) and NOESY (mixing times of 250 ms and 500 ms, 256 x 4K data points,
4200 Hz in co and 5434 Hz in 2, zero-filled to a 2K x 4K) experiments on AMX-300. These experiments were
performed at the Universitat de les Illes Balears by Prof. Pablo Ballester of U.I.B. and Dr. Alain Pagelot of Sadis
Bruker Spectrospin SA
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Low temperature (-50 °C) peak assignments of the complex of A24 and 9-ethyladenine in CDCl 3were made
on the basis of TOCSY (mixing time of 30 ms, 2Kx 300 data points, 1800 Hz, zero-filled to 2Kx 1K) and NOESY
(mixing time of 500 ms, 4K x 666 data points, 8000 Hz, zero-filled to 4K x 2K) experiments on a Varian VXR-500
spectrometer equipped with a 5-mm H/19F inverse detection probe and an Oxford VTC-4 temperature
controller.
6.6 Molecular Modeling
All molecular modeling was performed on Silicon Graphics Personal Iris workstations (4D25G+ or 4D30G+)
using MacroModel 3.5X70 Stochastic dynamics71 simulation of A24 and 9-ethyladenine in chloroform was run
in the MacroModel version of the AMBER72 force field (AMBER*) at 300K with GB/SA continuum solvation,73
extended non-bonded distance cutoffs, constrained bond length (SHAKE), and a 1.5-fs timestep using a
minimized conformation of the complex as the starting point. After a 5.0-ps initialization period, structures were
sampled every 0.2 ps for 60 ps. The 300 structures generated during the stochastic dynamics simulation were
minimized using the MULT routine in MacroModel to yield 31 unique conformations, using 0.4 A as the
maximum allowed deviation for comparison of all heavy atoms.
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B. NUCLEOTIDE RECOGNITION
1. INTRODUCTION
As the keystone of DNA backbone structure, the chemistry of the phosphate group dominates transcription,
replication, translation, and energy transfer processes. Molecular recognition studies targeted for phosphates or
nucleotides have a number of ultimate goals, including the sequence-specific recognition of DNA and transport
of RNA or various nucleoside-based drugs across cell membranes. A receptor for the phosphate diester must
provide both hydrogen-bond complementarity to the two phosphoryl groups and charge complementarity to the
single negative charge. The molecular shapes that have been employed for this include protonated aza crown
ethers,7 '74 bicyclic guanidinium cations,7 5,76 expanded porphyrins,77 bis(acylguanidiniums),78 and
bis(alkylguanidiniums).54
Pr
NHr
Figure B.1.1. First-generation nucleotide transport agents.
When these phosphate recognition elements are coupled with subunits for recognition of nucleobases, the
molecular recognition of nucleotides is possible. Aromatic groups based upon DNA intercalators are often used
for this purpose, 7,79but hydrogen-bonding complementarity has also been employed. 8 Nucleotide receptors
have been used for transport of nucleotides across liquid membranes 77 ,80 82 and for the catalysis of
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phosphodiester formation74 and cleavage.7 ,8385
The carbazole-diimide cleft can be combined with a bicyclic guanidinium75 to yield a nucleotide receptor specific
for adenosine nucleotides. Specifically, esterification of diimide A5 with a guanidinium alcohol gave receptor I
(Figure B.1.1) which was found to extract adenosine nucleotides from aqueous solution into chloroform.l 9 The
span of the recognition could be extended by linking two carbazole-diimide receptors to the guanidinium diol
(II, Figure B.1.1) yielding a receptor specific for adenosine dinucleotides. 18 These receptors were developed
in collaboration with Javier de Mendoza of the Universidad Autonoma de Madrid, Spain. The structures of the
complexes of these two receptors with their targets were determined by 1H NMR ROESY experiments. In both
complexes, the nucleotide is bound by the receptor through charge-charge interactions at the guanidinium-
phosphate salt-bridge and hydrogen-bonding in the diimide cleft.
H
H
3,0 -UMivir
2',3'-cAMP
Figure B.1.2. Adenosine nucleotide targets.
As the first rung in the ladder of adenosine-specific nucleotide recognition, receptors I and II are quite
successful. However, tuning of the architecture of these receptors will allow greater control of the binding
process (e.g. to gain greater specificity). The linkage between carbazole and guanidinium contains a significant
amount of flexibility; there are four free rotors between the two recognition motifs. This allows the
guanidinium moiety to explore a wide range of conformation space with concomitant entropy losses on binding
caused by the freezing out of these rotors. This conformational flexibility, when extended to longer nucleotide
systems, can complicate the binding process and examination of it.
One of the ways in which this conformational flexibility can be reduced is to replace the methylene spacer of I
and II with a phenyl spacer. This would serve to reduce the space swept out by these rotors from a cone to a
cylinder. This greatly reduces the amount of space explored by the bicyclic guanidinium and, as a consequence,
the entropy lost by restricting this group during binding. The geometry of apara-substituted phenyl group
allows purely 'in-line' displacement of guanidinium from the carbazole; the bond angles of a spacer based on
tetrahedral carbon will not allow this. In addition, the phenyl group provides a slightly expanded space for
recognition, which should allow more freedom for the adenine to bind completely within the diimide cleft. The
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more rigid geometry of a receptor with a phenyl group could confer an advantage in both mononucleotide
binding, in the form of specificity, and receptors for longer nucleotides, in the form of better preorganization of
the binding geometry. In addition to the structural advantages to a phenyl spacer, there will also be greater
chemical stability to esters of this type. The alkyl esters of I and II have been found to be quite labile in
hydroxylic or polar organic media; significant hydrolysis of this spacer occurs within minutes in methanol.
2. SELECTIVE CYCLIC MONOPHOSPHATE BINDING
Preliminary molecular modeling of a simple mononucleotide receptor based upon a phenyl-substituted
carbazole yielded an exciting prediction. This simple receptor may be able to selectively bind 2',3'-cAMP over
3',5'-cAMP. The origin of this behavior would be a salt-bridge hydrogen-bond that could only be formed in the
complex with 2',3'-cAMP. With the rigidity imparted by receptor and the substrates, this salt-bridge interaction
should not form in the complex with 3',5'-cAMP.
Figure B.2.1. Predicted structure of B9 complexed with 2',3'-cAMP (stereoview).
Figure B.2.2. Predicted structure of B9 complexed with 3',5'-cAMP (stereoview).
Figures B.2.1 and B.2.2 show the predicted structures of the complex between both cyclic adenosine
monophosphate derivatives and a diimide-guanidinium receptor containing a phenyl spacer. These structures
were generated by minimization of structures sampled during the course of stochastic dynamics simulations in
continuum aqueous solution.70 In the complex with 2',3'-cAMP, there is a hydrogen bond between the
phosphoryl groups and the guanidinium NH groups in a salt-bridge geometry whereas with 3',5'-cAMP, the
planar phosphate and guanidinium functional groups are perpendicular. Only a single phosphate oxygen can
bound, in a bifurcated sense, by the guanidinium in this complex. It is noteworthy that structures with bifurcated
hydrogen bonding to a single oxygen also appear in the simulation of the complex of 2',3'-cAMP. That is, the
salt-bridge is not the sole conformation of this complex However, the contribution of such an interaction was
predicted to be the source of selective binding of 2',3'-cAMP over 3',5'-cAMP.
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Scheme B.2.1. Synthesis of phenylscorpion.
The synthesis of a phenyl-substituted diimide cleft is summarized in Scheme B.2.1. Previous synthetic
investigations by Neil Branda showed us how to place substituted phenyl rings on carbazole. Ullman coupling86
of methyl 4-iodobenzoate with carbazole gave the substituted carbazole B2. Nitration of this with nitric acid
proceeded easily to dinitro B3. Hydrogenation in previous conditions (Section A.2) were accompanied by much
decomposition. Similarly, reduction with Fe/HCI in ethanol gave only moderate yield of diamine B4. However,
hydrogenation simply in pure THF as a solvent gave a satisfactory yield of pure diamine. Acylation with the
tripropyl Kemp's imide acid chloride 22 gave the phenyl-substituted cleft B5. The free acid can be satisfactorily
generated by hydrolysis of the methyl ester, but SN2-type dealkylation 87 with methyl thiolate proceeded much
more cleanly with no competing cleavage of the aromatic amide.
The cyclic AMP cleft was generated by conversion of acid B6 to the corresponding acyl chloride with oxalyl
chloride and catalytic DMF. Thionyl chloride was completely unsuitable for this purpose and led to destruction of
the imide group. Acylation of the mono-deprotected bicyclic guanidinium88 with the acid chloride gave the cyclic
adenosine monophosphate receptor B9. The silyl-protected receptor B9 was used for all titration studies. The
stability of B9 in methanol is significantly enhanced relative to receptor I - no degradation of the ester occurred
H2, F
THF
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Bover the course of hours. Receptor B10 was assembled using a naphthoylated bicyclic guanidinium diol as an
analog of receptor I for use in transport studies (Section B.4).
B6
1. (COCI)2, DMF, THF
2. DMAP, Et3N, THF,
CIl
HO H H R
D7. R-tonoo
Ul , RI.- Lt'ol
B8; R=naphthoyl
Scheme B.2.2. Assembly of guan-phenylscorp.
The binding affinity of B9 for 9-ethyladenine and the cyclic-AMP isomers in CD30D (Table B.2.1) was
determined using the 'reverse' 1H NMR titration protocol of Section A.2 by adding the receptor to a solution of
the nucleotide. The binding affinity of the diimide cleft for 9-ethyladenine is -3.25 kcal/mol. This is the sum of
hydrogen-bonding and aromatic stacking contributions in methanol. The cAMP isomers have affinity 1.1-1.6
kcal/mol higher than this as a result of the attractive phosphate-guanidinium electrostatic interaction. The
predicted selectivity of the receptor manifests itself as a 0.5 kcal/mol preference for binding 2',3'-cAMP over
3',5'-cAMP.
nucleotide Ka (M-1) AG (kcal/mol) AAG (kcal/mol)
1H method 2',3'-cAMP 3825 4.88
3',5'-cAMP 1557 4.35 0.53
9-ethyladenine 241 -3.25
31p method 2',3'-cAMP 396 -3.54
3',5'-cAMP 241 -3.25 0.29
Table B.2.1. Association constants of receptor B9 with cyclic AMP (Na + salt) in CD30D.
As the selectivity is based upon two separate titrations with no control of pH or ionic strength in the 1H NMR
titrations, a competition titration was performed in CD30D by simultaneously monitoring the 31p NMR signals
of both cAMP isomers at 25 mM ionic strength (NaBr). The monophosphate isomers have dramatically
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different chemical shifts in this solvent system -- 143.093 ppm (2',3'-cAMP) and 122.222 ppm (3',5'-cAMP) as
referenced to PPh3 (118 ppm). This titration was performed by adding the receptor to the solution containing
both cyclic-AMP isomers (maintained at 1 mM each) and monitoring the 31p chemical shift of the phosphate
group. Only small (0.3 and 1.0 ppm) chemical shift changes occur over the course of the titration because
phosphate oxygens are already significantly hydrogen-bound in methanolic solution. On complexation, only a
small net change in hydrogen-bonding occurs. Despite these small changes, the titration curve of each
phosphate fits the 1:1 binding isotherm (Equation A.2.11). The strength of association is considerably reduced
(>1 kcal/mol) as a result of the high ionic strength, which reduces the influence of the ionic interaction on
binding relative to the hydrogen-bonding component. Nevertheless, as seen in the 1H NMR titration, there is
again a preference for binding to 2',3'-cAMP, but of only 0.29 kcal/mol.
It is interesting that the affinity of B9 for 3',5'-cAMP in 25 mM salt is the same as for 9-ethyladenine without
control of the ionic strength. However, since hydrogen-bonding does have an electrostatic component,45 it
would be unwise to over-interpret this to mean that no charge interaction remains in the complex with 3',5'-
cAMP at 25 mM ionic strength.
Titration of the cAMP isomers with a benzoylated bicyclic guanidinium gave association constants were less than
10 M-1. The chemical shift changes with the free guanidinium were much smaller than those when the cleft is
present and fit to a 1:1 binding isotherm is very poor. This indicates that the effects observed in the 31p titration
arise from binding within the cleft and not as a result of changes in the medium from the addition of
guanidinium.
To fully ascertain that the positioning of the bicyclic guanidinium is responsible for the observed selectivity, the
affinity of both cAMP isomers to methyl ester B5 should be known. It is possible that the phenylcarbazole-
diimide receptor itself has an inherent shape selectivity for 2',3'-cAMP. Unfortunately, methyl ester B5 is not
sufficiently soluble in methanol for NMR titration. Transfer of the system to a similar polar solvent, acetone, in
order to measure all of these interactions was not possible due to insolubility of the cyclic nucleotides.
In conclusion, we have been able to construct a receptor with specificity for 2',3'-cAMP on the basis of a
prediction from molecular modeling. The source of the specificity is predicted to arise from hydrogen-bonding
within a salt-bridge interaction, but could not be experimentally verified.
This receptor system can be transferred to aqueous systems using the tris((benzyloxy)methyl) derivative of
Kemp's triacid.42 Yoko Kato has made a water-soluble versions of B5 and B9 and studied their affinity for
adenosine and cyclic adenosine monophosphates in water.43 The selectivity of 2',3'-cAMP is reduced to
0.2 kcal/mol in this solvent system (at 50 mM ionic strength).
The strength (enthalpy) of a phosphate-guanidinium interaction in water can be extracted from the binding data
by making use of a free energy pathway to subtract all of the contributions from hydrogen-bonding and
hydrophobic interactions. Isolated guanidinium and phosphates show extremely low affinity (-0.2 kcamo189)
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for each other in free solution. This value is free of contributions from intermolecular translational and rotational
entropy as it based upon comparisons within a complex. The values obtained from this kind of study are more
representative of interactions in free aqueous solution than those determined from protein mutagenesis
studies 24 where the specialized, highly specific environment of a protein interior can be significantly different
from aqueous solution.
3. TRINUCLEOTIDE RECOGNITION
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Figure B.3.1. An adenosine trinucleotide receptor.
The utility of phenyl-substituted carbazole-diimide receptors for nucleotide recognition can be extended by
exploiting the rigid shape to provide divergence. For the recognition of longer nucleotides (i.e. trinucleotides),
two phosphate-binding guanidinium units and three adenosine recognition elements must be linked. A very
simple way to do this is to have a central adenine-binding cleft which joins two adenosine mononucleotide-
binding clefts of the form of B9. In collaboration with Javier de Mendoza, receptor B15 was proposed for this
purpose. The isophthaloyl substituent on carbazole N9 provides a method for linking two B9-like receptors
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together to provide recognition sites for two phosphates and three adenines, as shown in Figure B.3.1. The
keystone of receptor III is the central isophthaloyl-substituted diimide cleft. The two flanking units have
already been discussed in Section B.2.
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Scheme B.3.1. Synthesis of isophthaloylscorpion.
The synthesis of B15 is considerably more difficult than any of the other aromatic-substituted carbazole-diimide
receptors discussed here (Sections B.2 and C.3). Dimethyl 5-iodoisophthalate and carbazole were coupled
using Ullman-type conditions86 with copper(I) oxide. The reaction proceeded not at all using copper powder
and potassium carbonate. It is a general observation that cuprous oxide is a more successful reagent for Ullman-
type coupling of meta-substituted aromatic rings while copper powder is more appropriate for
para-substituted aromatic rings. The isophthaloyl carbazole B12 behaved much differently than previous N9-
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aromatic-substituted carbazole molecules. Nitration of this was very difficult, and complicated by extremely poor
solubility. Reaction with nitric acid did not cleanly give the 3,6-dinitro product. Harsher conditions led to
hydrolysis of the esters and tri-nitration of the carbazole. Finally, partially pure dinitrocarbazole B13 could be
produced by nitration with cupric nitrate. Purification was not possible.
Reduction of B13 was a major stumbling block. Any reduction conditions with alcohol present (Section A.2 or
Fe/HCl) gave no appreciable yield of B15 after the acylation reaction. However, the use of THF as solvent
allowed hydrogenation to occur cleanly. Diamine B14 is even more unstable than diamines A3, B4, or C12 and
coupling of this with tripropyl Kemp's imide acid chloride22 gives a lower yield of B15 than for the analogous
reactions. The binding affinity of this cleft with adenosine in CDC13was estimated as 105 M-1based on the
'reverse' titration protocol of Section A2.
1. NaOH, THF, EtOHB15
2. CDI, CH2C12
-I-
1. 70% HF-py, THF, O°C
B9
2. 3 h, rt
CH2C0 2, THF
H
Figure B.3.2. Assembly of trinucleotide receptor III.
The trinucleotide receptor III was assembled at the Universidad Autonoma by Armando Salmer6n inJavier de
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Mendoza's laboratory by hydrolysis of diester B15 and activation with carbonyl diimidazole, followed by acylation
of deprotected B9 to give receptor III (Figure B.3.2).
Receptor III is an extremely large molecule with multiple possible conformations. With 15 free rotors in the
receptor and 9 free rotors in its substrate, ApApA, the conformational flexibility of the complex makes modeling
and structural studies very difficult. Currently, 1H NMR investigation into the structure of the complex between
III and ApApA is in progress at the Universidad Autonoma (600 MHz ROESY).
4. NUCLEOTIDE TRANSPORT
A number of studies have been performed on the transport of nucleotides and nucleotide derivatives across
liquid membranes. The receptors used for this purpose have included quaternary ammonium salts80,81 and
expanded porphyrin derivatives.82,90 Early imide receptors from this laboratory have been used for the transport
of nucleoside derivatives across liquid membranes.16 With the addition of phosphate recognition, it is now
possible to transport nucleotides through liquid membranes using imide-based adenine receptors.
The transport of nucleotides across a liquid membrane is studied using a U-tube apparatus, shown in Figure
B.4.1. All transport studies were performed by Cecilia Andreu.91 The source phase contains an aqueous
solution of the nucleotide and the receiving phase is an aqueous salt solution, while the organic phase is
dichloroethane. As the amount of transport is affected by mixing at the organic-aqueous interface, stirring is
maintained at a constant rate.
source phase receiving phase
DCE
Figure B.4.1. U-tube apparatus for liquid membrane transport studies.
The transport that occurs through the liquid membrane is referred to as facilitated transport. 92 That is, simple
diffusion is not possible; nucleotides will not move through the bulk organic phase without the assistance of a
carrier. The concentrations of nucleotide in the source and receiving phase are assayed by UV/Vis spectroscopy
and typically follow the curves shown in Figure B.4.2. The concentration in the source phase decreases as that in
the receiving phase increases by the same amount. There are two concentration gradients - a nucleotide ion
gradient from the source to receiving phase and a chloride ion gradient from the receiving to the source phase.
The positively-charged carrier must exist as a salt in organic solution and so acts as a transport agent for both of
these anions. At the source-phase interface, the carrier releases chloride and complexes with nucleotide; the
converse occurs at the interface with the receiving phase. Initially, then, there are two driving forces for
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nucleotide transport. However, once the nucleotide concentration reaches equilibrium between the source and
receiving phase, it is the continuing movement of chloride ions that drives nucleotide transport against its
concentration gradient. This is active transport. The rates of initial and active transport are approximated from
the most linear data points immediately after time zero and equivalence, respectively.
16
14
12
10
-
a)
C
8
6
2
0
0 2 4 6 8 10
t(h)
Figure B.4.2. Liquid membrane transport concentration profile.
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4.1 Mononudeotides
The ability of receptor I to transport nucleotides through a dichloroethane liquid membrane was examined,
using a 10 mM NaCl solution in the receiving phase. The results of the transport study (Table B.4.1) show that
receptor I transports cAMP derivatives preferentially over the corresponding guanosine nucleotides. No
transport of adenosine monophosphate nucleotides is seen when adenine recognition is removed as in receptor
IV (Figure B.4.3). The lack of transport of the guanosine nucleotides reflects the lower affinity of the diimide
clefts for guanine (Section A.2.3) coupled with the much lower organic solubility of guanine.
[carrier] (mM) nucleotide initial transport active transport
(15 ) (pmol/h-cm2) (pmol/h-cm2)
7.5
25
2',3'-cAMP 2.194+0.016 1.2
3',5'-cAMP 1.820+0.040 0.9
2',3'-cGMP 0
3',5'-cGMP 0
3'-AMP 1.383+0.037 0.6
5'-AMP 0
Table B.4.1. Transport of mononucleotides by carrier I.
16+0.004
64±0.013
0
0
685+0.023
0
There is some selectivity in the transport of adenosine monophosphates. The positioning of phosphate on the
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5'-end reduces the effectiveness of transport. That is, 5'-AMP is not at all transported and 3',5'-cAMP is
transported less efficiently than 2',3'-cAMP.
01 1-
Iv
Figure B.4.3. Transport control.
Receptor BlO is an analog of receptor I with a phenyl spacer in place of methylene. This could have multiple
effects including selectivity as a result of reduced flexibility and improved positioning and additional solubilization
of hydrophilic nucleotides as a result of greater hydrophobic contacts with the phenyl ring.
Transport studies with B10 support these expectations (Table B.4.2). The receptor is more effective at
transporting nucleotides than receptor I. Under identical conditions (Table B.4.2, line 5), B10 is 55% more
efficient in the initial transport of 3'-AMP and 2.5 times more efficient in active transport. The binding selectivity
of receptor B9 for 2',3'-cAMP manifests itself as a decrease in transport (Table B.4.2, lines 2 and 3). Significantly
higher salt concentration is required in the receiving phase in order to extract bound 2',3'-cAMP from the organic
layer. That is, the receptor can efficiently take up 2',3'-cAMP from the source phase, but because of its binding
affinity, release to the receiving phase is more difficult. In addition, this receptor is now capable of transporting
cGMP derivatives (Table B.4.2, lines 6 and 7). As no transport of these was seen at all for receptor I, neither the
guanidinium nor the diimide, but increased hydrophobic contacts with the phenyl group, are responsible. The
greater hydrophobic nature of carrier B10 allows the possibility for transport of a greater variety of nucleotides
across liquid membranes.
nucleotide receiving phase initial transport
(15 M) [NaCI] (mM) (pmol/h-cm2 )
2',3'-cAMP 10 1.337±0.012
250 2.438-0.036
500 2.334±0.063
3',5'-cAMP 10 2.203+0.093
3'-AMP 10 2.151+0.077
2',3'-cGMP 10 2.246+0.017
3'5'-cGMP 10 2.442±0.029
Table B.4.2. Transport of mononucleotides by BlO.
active transport
(pmol/h-cm2)
0.536+0.13
1.419-0.015
1.476+0.068
1.518+0.001
1.699±0.004
1.387+0.039
1.448±0.122
[carrier] (mM)
4.5
7.5
25
35
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4.2 Dinucleotides
Having demonstrated the capability of linked diimide-guanidinium receptors to act as carriers for
mononucleotides, the transport of dinucleotides was examined. For this purpose, receptor V was used. The
results of these studies are summarized in Table B.4.3.
Bn
n
n
V
Figure B.4.4. Dinucleotide carrier V.
B
With a salt concentration in the receiving phase of 10 mM, receptor Vwas able to transport adenosine-containing
dinucleotides with varying efficiency. The deoxyadenosine dinucleotide was transported somewhat slower than
the corresponding mononucleotide (Table B.4.3, line 1). Transport of cytidine-containing dinucleotides or the
guanosine dinucleotide was not possible (Table B.4.3, lines 3,4, 5, and 9) but guanosine could be transported as
the mixed dinucleotide (Table B.4.3, line 8).
The improved transport ability of receptors bearing a phenyl group on carbazole N9 will be exploited for
dinucleotide transport in a similar fashion to the mononucleotide system. These studies will be carried out by
Yoko Kato and Cecilia Andreu. It would be expected that a wider variety of dinucleotides will be carried through
the liquid organic membrane by a receptor of this type.
[carrier] (mM) nucleotide initial transport active transport
(10 M) (pmol/h-cm2) (pmol/h-cm2)
7.5
10
12
20
d(AA)
d(AC)
d(CA)
d(CG)
dApT
TpdA
d(AG)
d(GG)
Table B.4.3.
1.027±0.004 0
0
0
0
1.058±0.053 C
0.910+0.001 C
0.360+0.004
0
Transport of dinucleotides by carrier V.
'.755+0.018
0
0
0
).792+0.041
0.484+0.002
0
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4.3 Trinucleotides
Keeping in mind the lessons of adenosine recognition and hydrophobic contact from smaller systems, we
examined the transport of trinucleotides with receptor III. The two bicyclic guanidinium units serve to
neutralize the charge of the two phosphates of a trinudeotide, and the adenosine recognition elements convey
hydrogen-bond specificity to adenine. As in the simpler systems (Sections B.4.1 and B.4.2), the extended
aromatic systems of receptor III should also contribute to the transport of non-adenosine nucleotides.
carrier [carrier] (mM)
III
VI
receiving phase
[NaCI] (mM)
250
500
10
5
20
Table B.4.4.
initial transport
(pmol/h-cm2)
0.621+0.041
1.018±0.006
1.075+0.008
Transport of ApApA (10 gM).
active transport
(pmol/h-cm2)
0.556±0.029
0.834+0.021
0.781+0.038
Preliminary results from studies of the transport of the adenine trinucleotide through liquid membranes show
that III is only a poor carrier of ApApA. The receptor, it seems, is too good at its job. Uptake into the organic
phase is very efficient, but release into the receiving phase requires high salt concentration. The interaction
between receptor III and ApApA is so strong in organic solvent that the nucleotide remains in that phase.
Efficient transport requires a compromise in binding affinity such that release occurs after the initial extraction.
VI
VII
Figure B.4.5. Controls for trinucleotide transport.
Receptor VI was prepared inJavier de Mendoza's laboratory and found to much more effective at the transport
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of ApApA through a dichloroethane liquid membrane. With only methylene spacer elements and lacking one
adenine-binding unit, the binding affinity for ApApA is moderated so that transport is possible. Charge-
stabilization alone, however, is not sufficient for transport as control VII, lacking all adenine-binding capability, is
ineffective for transport.
The overall lessons of these transport studies are that, in general, high sequence specificity is not desired as this
reduces the range of application for a carrier. Furthermore, the strength of molecular recognition in the organic
phase must be moderated such that transport, rather than mere extraction, occurs. Proceeding from this,
investigation into the transport of nucleotides of varying sequence and length are in progress.
5. EXPERIMENTAL
5.1 Synthesis
General
All commercially available compounds (Aldrich) were used without further purification unless otherwise
indicated. DMSO-d 6 (99.9% D, MSD Isotopes or Cambridge Isotope Labs) were used from freshly opened
vials. CDCl3 (99.8% D, MSD or CIL) was stored over molecular sieves and passed through dry basic alumina just
prior to use. Tetrahydrofuran used in anhydrous conditions were distilled from sodium-benzophenone ketyl;
dimethyl sulfoxide was distilled from sodium hydroxide and stored over molecular sieves (4 A). Thin layer
chromatography was performed on Merck Silica 60 F-254 precoated TLC plates. Column chromatography was
performed on Merck Silica Gel 60 (230400 mesh) according to Still et al.59 Glassware used for anhydrous
conditions was either 1) baked overnight at 150 oC, assembled hot, cooled under vacuum, and filled with argon;
or 2) was flamed dry under vacuum, cooled and filled with argon before use. Standard inert-atmosphere
techniques were used for solvent transfers by syringe .
1H NMR spectra were recorded on Varian XL-300, UN-300, and VXR-500 spectrometers in solvents as
indicated. Chemical shifts are reported as parts per million (5) relative to residual solvent protons. Melting
points were obtained on an Electrothermal IA9100 digital melting point apparatus and are calibrated. IR spectra
were recorded on a Perkin-Elmer series 1600 FT-IR spectrometer. High resolution mass spectra were
obtained on a Finnegan MAT 8200 mass spectrometer.
Methyl 4-Iodobenzoate (BL)
Thionyl chloride (10 mL) was added to a suspension of 4-iodobenzoic acid (7.54 g, 30.4 mmol) in dry MeOH
over 10 min. The reaction was refluxed for 1 h under a drying tube, cooled to room temperature and stirred for
22 h. Concentration and drying under vacuum afforded quantitative yield of methyl ester B1 which was used
without further purification: 1H NMR (300 MHz, DMSO-d6) 6 7.906 (d, 2 H,J = 8.7 Hz), 7.691 (d, 2 H,J = 8.4
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Hz), 3.832 (s, 3 H).
N-(4-(Methoxcarbonyl)phenyl)carbazole (B)
Carbazole (7.90 g, 30.15 mmol) and methyl 4-iodobenzoate B1 (1.016 equiv) were intimately mixed in a mortar
and pestle with K2CO3 (1.286 equiv) and catalytic Cu powder (202 mg). The mixture was refluxed with xylenes
(10 mL) with magnetic stirring for 2 days. The reaction was stopped and benzene (250 mL) was added while
the mixture was still warm (and liquid). The suspension was refluxed for 3 h, cooled, and filtered through Celite.
Solvent was removed by rotary evaporation and the resulting brown oil left to crystallize overnight. The crude
product was recrystallized from refluxing MeOH (200 mL) and EtOAc (10 mL) to give 6.057 g of white crystals.
The mother liquor was concentrated and recrystallized from MeOH to give 1.79 g of white crystals. The
combined yield of B2 was 7.847 g (86%): mp 120.7-121.5 °C; IR (KBr) 3050,2946, 1721, 1602, 1513, 1452,
1432, 1290, 1280, 1225, 1168, 1115, 1102, 767, 736, 723, 700 cm-1; 1H NMR (500 MHz, CDCI3) 6 8.289 (d, 2
H,J = 8.5 Hz), 8.149 (dd, 2 H,J = 7.5, 0.5 Hz), 7.689 (d, 2 H,J = 8.0 Hz), 7.477 (dd, 2 H,J = 8.2, 0.7 Hz), 7.430
(dt, 2 H, J = 7.6, 1.0 Hz), 7.319 (dt, 2 H, J = 7.2, 0.8 Hz), 3.995 (s, 3 H); HRMS (El) calcd for C20H15NO2,
301.1103; found, 301.1100.
N-(4-(Metboxycarbonyl)phenyl)-3,6-dinitrocarbazole (B)
Concentrated nitric acid (78 mL) was added dropwise to a suspension of carbazole B2 (7.63 g, 25.32 mmol) in
HOAc (120 mL) at 50 °C. Additional HOAc (50 mL) was added to thin the suspension and the temperature
raised to 70 °C. The suspension was stirred at this temperature for 11 h and cooled to room temperature for 2
h. Product was precipitated by addition of water (100 mL), isolated by filtration, and dried in a vacuum desiccator
to give 8.819 g (89%) of pale yellow powder B3, which was used without further purification: 1H NMR (300
MHz, DMSOd6) 6 9.654 (d, 2 H,J = 2.1 Hz), 8.421 (dd, 2 H,J = 9.1, 2.2 Hz), 8.297 (d, 2 H,J = 8.4 Hz), 7.913
(d, 2 H,J = 8.4 Hz), 7.621 (d, 2 H,J = 9.3 Hz), 3.941 (s, 3 H).
N-(4-(Methoxycarbonyl)phenyl)-3,6-diaminocarbazole (B4)
Dinitro carbazole B3 (224 mg, 0.5724 mmol) and 10% Pd-C (93 mg, 42 wt%) were suspended in THF (25 mL)
and hydrogenated under balloon pressure for 14 h. The suspension was filtered through Celite. An unstable
yellow solid was recovered by rotary evaporation, dried under vacuum, and used without further purification: 1H
NMR (250 MHz, CDC13) 6 8.223 (d, 2 H, J = 8.6 Hz), 7.632 (d, 2 H, J = 8.6 Hz), 7.326 (d, 2 H, J = 2.7 Hz),
7.315 (d, 2 H,J = 8.2 Hz), 6.820 (dd, 2 H,J = 8.7, 2.1 Hz), 3.970 (s, 3 H).
N-(4-(Methoxycarbonyl)phenyl)-3, 6-bis[((cis,cis-2,4-dioxo-1,5, 7-tripropyl-3-azabicyclo[3.3. 1]non- 7-yl)
carbonyl)amino]carbazole (B5)
The above diamine B4 (0.5724 mmol, theoretical) was refluxed with tripropyl Kemp's imide acyl chloride 22
(1.17 mol equiv) in pyridine (10 mL) with catalytic DMAP (0.04 equiv) for 7 h under an Ar balloon. Solvent was
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removed by rotary evaporation under reduced pressure. The residue was taken up in EtOAc (30 mL) and
washed with 1% HCI (10 mL), water (10 mL), and brine (10 mL) and dried over Na2SO4. Aftergravity
chromatography (10-20% EtOAc/CH2CI2), the cleanest fractions were triturated in MeOH (-3 mL) to afford
373 mg (69%) of pale beige powder after filtration and drying: IR (KBr) 3379, 3214, 2958, 2871, 1696, 1605,
1514, 1466, 1281, 1196, 1105 cm-1; 1H NMR (300 MHz, DMSO-d 6) 8 10.366 (s, 2 H, imide), 9.247 (s, 2 H,
amide), 8.302 (d, 2 H,J = 1.5 Hz), 8.230 (d, 2 H,J = 8.1 Hz), 7.790 (d, 2 H,J = 8.1 Hz), 7.503 (dd, 2 H,J = 9.0,
1.8 Hz), 7.414 (d, 2 H,J = 9.0 Hz), 3.915 (s, 3 H), 2.678 (d, 4 H,J = 13.5 Hz), 2.029 (d, 2 H,J = 12 Hz), 1.78
(m, 4 H), 1.51 (m, 4 H), 1.4-1 (m, 22 H), 0.874 (t, 12 H,J = 6.9 Hz), 0.802 (t, 6 H,J = 7.3 Hz); HRMS (EI)
calcd for C56H71N508, 941.5303; found, 941.5304.
N-(4-Carboxyphenyl)-3,6-bis[((cis,cis-2,4-dioxo-1,5, 7-tripropyl-3-azabicyclo[33. 3.1]non-7-yl)carbonyl)
amino]carbazole (B)
Ester B5 (174 mg, 0.1847 mmol) and methyl thiolate (81 mg, 6.26 equiv) were dissolved in anhydrous DMSO
(5 mL) under argon at 78 °C in an oil bath. The reaction was stirred at this temperature for 1 h, cooled, and
quenched with 1 N HCl (10 mL). The suspension was extracted with CHCl3 (50 mL) and the organic layer was
washed with 1 N HCl (2 x 20 mL), water (30 mL), and brine (30 mL), and dried over Na2SO4. Solvent was
removed by rotary evaporation and the off-white solid dried under vacuum to give 168 mg (98%) of powder
which was used without further purification: 1H NMR (300 MHz, DMSO-d6) 6 10.341 (s, 2 H, imide), 9.232 (s,
2 H, amide), 8.299 (d, 2 H,J = 1.6 Hz), 8.206 (d, 2 H,J = 8.6 Hz), 7.747 (d, 2 H,J = 8.5 Hz), 7.499 (dd, 2 H,J =
9.0, 1.6 Hz), 7.403 (d, 2 H,J = 8.8 Hz), 2.681 (dd, 4 H,J = 14.7, 0.9 Hz), 2.029 (d, 2 H,J = 12.9 Hz), 1.78 (m, 4
H), 1.51 (m, 4 H), 1.4-1 (m, 22 H), 0.876 (t, 12 H,J = 6.9 Hz), 0.805 (t, 6 H,J = 7.2 Hz).
(2S,8S)-2-Hydroxymethyl-8-[[(tert-butyldipbenylsily)oxy methyl]-3,4,6, 7,8,9-hexaydro-2H-pyn'mido[1,2-
alpyrimidine Hydrochloride (B)
The tBDMS, tBDPS protected diol88 (2000 mg, 0.3399 mmol) was dissolved in THF (3 mL), water (3 mL), and
HOAc (10 mL) and stirred for 23 h at room temperature. Solvent was removed by rotary evaporation at room
temperature. Three times, toluene (-5 mL) was added and rotavapped to remove acetic acid. A white powder
was formed by slow evaporation of a hexanes/CH 2Cl2 solution. The solid was triturated in hexanes (-3 mL)
and the supernatant removed after settling. This was repeated and the solid dried under vacuum to give
quantitative yield of alcohol B7, which was used without further purification: 1H NMR (500 MHz, CDCl 3) 6
9.185 (s, 1 H, NH), 7.696 (s, 1 H, NH), 7.63 (m, 4 H), 7.41 (m, 6 H), 3.810 (dd, 1 H,J = 12.0, 3.5 Hz), 3.738 (d,
1 H,J = 5.0 Hz), 3.59 (m, 3 H), 3.51 (m, 1 H), 3.32 (m, 1 H), 3.24 (m, 3 H), 2.07 (m, 1 H), 1.91 (m, 3 H), 1.070
(s, 9H).
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8(2S,8S)-2-[[(2-Naphtbyloxy)carbonyl]metyl]-8-[[(tert-butyldiphenylsily)oxy]methyl]-3,4,6, 7,8,9-
hexahydro-2H-pyrimido[1,2-a]pyrimidine Hydrochloride (B)
Alcohol B8 (48 mg, 0.1012 mmol) was dissolved in anhydrous THF (4 mL) under argon and naphthoyl chloride
(1.45 equiv) was added, followed by TEA (50 }1L, 3.54 equiv). A precipitate of TEA* HCI forms within min. The
suspension was stirred at room temperature for 23 h and quenched with butylamine (1 drop). After filtration,
the solvent was removed by rotary evaporation and the residue purified by chromatography (5% MeOH/CHCl3)
to give 55 mg (86%) of a colorless oil that formed a powder on slow evaporation of a hexanes/CH 2Cl2 solution,
which was used without further purification.
Silyl guan-pbenylscorpion (B)
Acid B6 (104 mg, 0.1120 mmol) was dissolved in anhydrous THF (4 mL) with catalytic DMF (-2 pL) and oxalyl
chloride (9.21 equiv) was added. The solution was stirred under argon for 35 min and reduced by rotary
evaporation. After drying under vacuum, the acyl chloride was dissolved in anhydrous THF (10 mL) under Ar
with alcohol B7 (0.998 equiv) and TEA (19 equiv) was added. After stirring for 22 h at room temperature, the
suspension was filtered and the filtrate reduced by rotary evaporation under reduced pressure. Flash
chromatography (8% MeOH/CHC1 3) afforded 84 mg (56%) of an off-white powder: IR (KBr) 3265, 2958,
2871, 1701, 1628, 1465, 1271, 1198, 1112, 704 cm-1; 1H NMR (500 MHz, DMSO-d6) 5 10.636 (s, 2 H, imide),
9.255 (s, 2 H, amide), 8.300 (m, 4 H), 7.971 (m, 1 H), 7.818 (d, 2 H,J = 8.5 Hz), 7.615 (m, 6 H), 7.52-7.39 (m,
12 H), 4.444 (m, 1 H), 4.338 (m, 1 H), 3.868 (m, 1 H), 3.649 (m, 2 H), 3.590 (m, 1 H), 2.675 (d, 4 H,J = 13.4
Hz), 2.029 (d, 2 H, J = 13 Hz), 2.06 (m, 4 H), 1.78 (m, 6 H), 1.51 (m, 4 H), 1.4-1 (m, 22 H), 1.013 (s, 9 H),
0.875 (t, 12 H, J = 6.8 Hz), 0.801 (t, 6 H, J = 7.1 Hz); HRMS (FAB in 3-nitrobenzyl alcohol) calcd for
C80H103N80 9Si (M-CI), 1347.7617; found, 1347.7606.
Naphthoyl guan-phenylscorpion (Bel)
The acid chloride of acid B6 (84 mg, 90.5 pnmol) was prepared as above. The tBDPS-protected guanidinium B8
(55 mg, 87.54 pmol) was dissolved in anhydrous THF (4 mL) and treated with TBAF (1.0 M in THF, 300 L,
3.43 equiv) at room temperature for 2 h. The deprotected alcohol was added in situ via cannula to the acid
chloride, followed by a THF (2 x 2 mL) rinse of the alcohol flask. After 10 min, TEA (24 L, 2 equiv) was added.
No precipitate formed. After 5 h, solvent was removed by rotary evaporation. The residue was taken up in
CHC13, and washed with 0.1 N HCI (15 mL), water (10 mL), and brine (10 mL), and dried over Na2SO4.
Chromatography (8% MeOH/CHC13) gives 39.2 mg (34%) of pure B10: IR (KBr) 3379, 3147, 2958, 2932,
2871, 1705, 1630, 1465, 1276, 1196, 1100, 807, 780, 760 cm-1; 1H NMR (500 MHz, DMSO-d6) 6 10.329 (s, 2
H, imide), 9.244 (s, 2 H, amide), 8.7529 (s, 1 H, amine), 8.306 (d, 2 H, J = 8.5 Hz), 8.302 (s, 2 H), 8.142
(apparent d, 1 H,J = 8 Hz), 8.043 (s, 1 H), 7.985 (m, 3 H), 7.807 (d, 2 H,J = 8.5 Hz), 7.65 (m, 1 H), 7.59 (m, 1
H), 7.511 (dd, 2 H,J = 8.8, 2.0 Hz), 7.386 (d, 2 H,J = 8.8 Hz), 4.46 (m, 2 H), 4.32 (m, 2 H), 3.89 (m, 2 H), 3.44
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(m, 4 H), 3.00 (m, 1 H), 2.673 (d, 4 H,J = 13.4 Hz), 2.22 (m, 2 H), 2.0 (m, 4 H), 1.78 (m, 6 H), 1.51 (m, 4 H),
1.4-1 (m, 22 H), 1.013 (s, 9 H), 0.875 (t, 12 H, J = 6.8 Hz), 0.801 (t, 6 H, J = 7.1 Hz); HRMS (FAB in 3-
nitrobenzyl alcohol) calcd for C75H91N8010 (M-CI), 1263.6858; found, 1263.6860.
Dimethyl 5-Iodoisophthalate (B1 )
Thionyl chloride (55 mL) was added to a solution of 5-iodoisophthalic acid93 (23.34 g, 79.9 mmol) in methanol
(500 mL) on ice. After stirring for 22 h at room temperature, the mixture was refluxed for 9 h. Evaporation of
solvent under reduced pressure afforded quantitative yield (25.58 g) of diester B11: mp 100.9-102.7 °C; IR
(KBr) 3084, 2951, 1717, 1439, 1295, 1245, 996, 746 cm-l1; 1H NMR (500 MHz, CDCl3) 6 8.630 (t, 1 H,J = 1.5
Hz), 8.546 (d, 2 H,J = 1.5 Hz), 3.951 (s, 6 H).
N-(3,5-Bis(methoxycarbonyl)phenyl)carbazole (B12)
The iodoisophthaloyl diester B11 (18.3 g, 57.17 mmol) was melted in an oil bath (110 °C). Carbazole (9.5545
g, 0.9995 equiv) and Cu2O (25.55 g, 3.123 equivalents) were added with xylenes (2 mL). The reaction mixture
was stirred at 170-175 °C for 48 h. The reaction mixture was cooled and extracted with benzene (3 x 50 mL) by
refluxing, cooling and filtering. Flash chromatography (benzene) followed by recrystallization from refluxing
MeOH (100 mL) and EtOAc (450 mL) gave 10.39 g (51%) of pure solid B12: mp 202.4-203.1 °C; IR (KBr)
2948, 1718, 1602, 1460, 1373, 1246, 750 cm-1; 1H NMR (300 MHz, CDC13) 6 8.774 (t, 1 H,J = 1.5 Hz), 8.458
(d, 2 H,J = 1.5 Hz), 8.154 (d, 2 H,J = 7.8 Hz), 7.437 (m, 2 H), 7.38 (m, 2 H), 7.326 (m, 2 H), 3.986 (s, 6 H);
HRMS (EI) calcd for C22H17N104, 359.1158; found, 359.1155.
N-(3,5-Bis(methoxycarbonyl)phenyl)-3,6-dinitrocarbazole (B)
Carbazole B12 (2.15 g, 5.98 mmol) was added portion-wise over 35 min to Cu(N0O3)2 · 2.5H 20 (4.57 g, 3.29
equiv) in HOAc (20 mL) and Ac2O (40 mL) at 35 C in an oil bath. After stirring for 17 h under a drying tube,
the reaction mixture was added to 150 mL water, triturated for 30 min, filtered, and sucked dry to give
dinitrocarbazole B13 as an impure mixture which resisted purification. The estimated purity is 80%: 1H NMR
(300 MHz, d7-DMF) 6 9.726 (d, 2 H,J = 1.8 Hz), 8.772 (t, 1 H,J = 1.5 Hz), 8.649 (d, 2 H,J = 1.5 Hz), 8.488
(dd, 2 H,J = 9.1, 2.5 Hz), 7.745 (d, 2 H,J = 9.0 Hz), 4.011 (s, 6 I-I).
N-(3,5-Bis(methoxycarbonyl)phenyl)-3, 6-diaminocarbazole (B14
Dinitro B13 (955 mg, 2.125 mmol) was hydrogenated at balloon pressure in THF (166 mL) with 10% Pd-C
catalyst (23 wt%) for 10 h. Filtration through Celite, followed by evaporation of solvent under reduced pressure
gave an unstable yellow solid which was carried on immediately without further purification: 'H NMR (300 MHz,
CDCI3) 6 8.67 (t, 1 H), 8.41 (d, 2 H), 7.33 (d, 2 H), 7.22 (d, 2 H), 6.82 (dd, 2 H), 4.00 (s, 6 H).
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N-(3,5-Bis(methoxycarbonyl)phenyl)-3, 6-bis[((cis,cis-2, 4-dioxo-1,5, 7-tripropyl-3-azabicyclo[3.3. 1]non- 7-
yl)carbonyl)amino]carbazole (B)
Diamine B14 (827 mg, 2.125 mmol) and tripropyl Kemp's imide acyl chloride22 (1.450 g, 1.995 equiv) with
catalytic DMAP (11 mg) were refluxed in pyridine (50 mL) under argon for 10 h. The solvent was removed
under reduced pressure and the residue taken up in CHCI 3 and EtOAc. The solution was washed with 1 N HCl
and brine and dried over Na2SO4. Flash chromatography (10% EtOAc/CHCl3 and 5% MeOH/CHCI3) gave a
yellow foam which was precipitated as a yellow solid (619 mg, 29%) by trituration in MeOH (4 mL): mp 203dec
°C; IR (KBr) 3379, 2958, 1728, 1701, 1467, 1247 cm-1; 1H NMR (500 MHz, DMSO-d6) 6 10.373 (s, 2 H,
imide), 9.258 (s, 2 H, amide), 8.535 (t, 1 H, J = 1.4 Hz), 8.333 (d, 2 H, J = 1.5 Hz), 8.302 (d, 2 H, J = 1.8 Hz),
7.513 (dd, 2 H,J = 8.8, 1.9 Hz), 7.357 (d, 2 H,J = 8.8 Hz), 3.932 (s, 6 H), 2.675 (d, 4 H,J = 14.0 Hz), 2.029 (d,
2 H,J = 12.5 Hz), 1.79 (m, 4 H), 1.51 (m, 4 H), 1.29 (m, 14 H), 1.15 (m, 8 H), 0.873 (t, 12 H,J = 7.0 Hz), 0.807
(t, 6 H, J = 7.2 Hz); HRMS (FAB in 3-nitrobenzyl alcohol) calcd for C58H74N5010 (M+H), 1000.5436; found,
1000.5426.
5.2 Titrations
Association constants were calculated by non-linear least-squares regression fit of the data to the 1:1 binding
isotherm using Systat 5.2.35 While the final chemical shift and association constant were treated as variables; the
experimental value for the initial chemical shift was used.
'H monitored
1H titrations were performed at 298 K either at 500 MHz on a Varian VXR-500 instrument with a 5 mm 1H/19F
indirect detection probe and an Oxford VTC-4 temperature controller. A 1 mM solution of receptor B9 in
CD30D (99.8%-D, CIL, 700 pL) was titrated with a 10 mM solution of cyclic AMP in CD3OD while the chemical
shift of carbazole C4H was monitored. The total chemical shiftchanges were 0.19 ppm (3',5'-cAMP) and 0.22
ppm (2',3'-cAMP) downfield; 90-94% of the saturation curves were observed.
3Ip monitored
31p titrations were performed at 121.4 MHz on a Varian UN-300 instrument equipped with a 5 mm 1H/19F
broad band probe and an Oxford VTC-4 temperature controller. A solution of 2',3'-cAMP (1 mM), 3',5'-cAMP (1
mM), and NaBr (23 mM, I=25 mM) in CD30D (99.8%-D, CIL, 700 pL) was treated with a solution of B9 (10.4
mM), 2',3'-cAMP (1 mM), 3',5'-cAMP (1 mM), and NaBr (13 mM, 1=25.7 mM) in CD30D while the chemical
shift of the phosphate group was monitored. The total chemical shift change was 0.321 ppm upfield for 2',3'-
cAMP and 1.076 ppm upfield for 3',5'-cAMP; 61-73% of the binding curves were observed. Triphenylphosphine
was used as an internal shift standard.
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5.3 Modeling
Molecular modeling was performed on Silicon Graphics Personal Iris (4D25G+ or 4D30G+) machines running
MacroModel 3.5X.70 The AMBER* force field was used with GB/SA73 continuum water solvation. Stochastic
dynamics7l simulations were run for 65 ps at 300 K with a 1.5-fs timestep using the SHAKE algorithm to
constrain all bond lengths. The distance between the imide nitrogen's and the correspondingly-bonded adenine
nitrogen was restrained to 2.8±0.5 A with a 100 kJ/mol potential. After a 5-ps induction period, 300 structures
were sampled for the duration of the simulation.
Following the simulation, the sampled structures were minimized with the truncated Newton conjugate
gradient algorithm 94 (TNCG) to the default gradient (<0.05 kJ/mol-A), using the MULT routine in
MacroModel with 0.2 A as the maximum allowed deviation for comparison of all heavy atoms. For the 2',3'-
cAMP-bound receptor, 57 unique conformations were found within 31 kJ/mol of the global minimum. There
were 33 conformations within 10 kJ/mol of the global minimum. The 3',5'-cAMP-bound receptor showed a
total of 4 unique conformations, all within 4 kJ/mol of the global minimum.
5.4 Transport
Transport studies were performed by Cecilia Andreu using a U-tube with dichloroethane separating the
aqueous source and receiving solutions (2 mL). The source phase was a solution of the nucleotide and the
receiving phase was an NaCl solution, 10 mM, unless otherwise noted. The surface area of contact is 1.568 cm2
between aqueous and organic phases.
The rate of transport was followed by monitoring the concentration of nucleotide in aliquots from both aqueous
phases by UV/visible spectroscopy. Experiments were performed at least in duplicate.
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C. SELF-REPLICATING MOLECULES: A SECOND GENERATION
1. BACKGROUND
Reproduction is essential to life. 95 In prebiotic times, reproduction was merely the replication of stable
molecular assemblies drawn from the amino acids, 96 carbohydrates, 97-99 heterocyclic bases,10 and enzyme
cofactors10 10 3 expected under the conditions of early Earth. As such, the self-replication of molecular
structures lies at the heart of the molecular origins of life.
Molecular replication is simply an autocatalytic reaction where the product of a chemical transformation
acts to direct or catalyze that transformation. This typically manifests itself as a template effect. That is,
the reaction product brings the reactants together to accelerate the reaction through non-covalent
interactions. This has been implemented in the replication of physical structures and self-complementary
molecules.
The replication of physical structures is exemplified by the autocatalytic generation of micelles in a system
developed by Luisi. 104 Ethyl caprylate is hydrolyzed at the aqueous-organic interface in a two-phase
system to generated sodium caprylate which forms micelles in the aqueous layer. The hydrophobic ester
is solubilized by the micelles; this increases its exposure to base and accelerates hydrolysis by almost three
orders of magnitude. After an induction period, exponential growth in the concentration of sodium
caprylate occurs, a characteristic of autocatalytic reactions. This is an interesting system because it
suggests a mechanism for the development of cells outside of metabolism or information transfer.
(A) < (B) (< )
T + A + B (T:A:B) (2T)
Figure C.1.1. Schematic of self-complementary template-based autocatalysis.
Self-complementary autocatalysis relies on an efficient reaction within a termolecular complex. As shown
in Figure C.1.1 (from Edward Winter), two complementary components of a replicating structure (A and
B) react in an intermolecular fashion to form template (). Due to the now self-complementary nature of
the template, two additional units of A and B form a termolecular complex with the template.
Intracomplex reaction forms a dimer that dissociates to repeat the process. Ideally, some form of catalysis
occurs in the termolecular complex, but, typically, it is simply the reduction in entropy of bringing two
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reagents close together in a complex that enhances the reaction rate.
5'-CCG-3' + 5'-CGG-3' 5'-CCGCGG-3'
3'-GGC-5' + 3'-GCC-5'
+ 5'-CCGCGG-3'
termolecular complex 3'-GGCGCC-5'
5'-CCGCGG-3'
Figure C.1.2. Self-replication of DNA trimers.
The first self-replicating model system developed used self-complementary DNA as the basis for the
autocatalytic reaction. Trideoxynucleotides CCG and CGG were coupled in the presence of a water-
soluble condensation agent to form the self-complementary hexadeoxynucleotide by an autocatalytic
process (Figure C.1.2).105 Improvements involved the use of 5'-deoxy-5'-aminodeoxynucleotides to
accelerate nucleophilic attack to increase autocatalytic efficiency so that parabolic growth in the
hexadeoxynucleotide concentration could be seen, reflecting the exponential nature of an autocatalytic
process.106 Recently, a self-replicating system utilizing three DNA components has been developed to
investigate the role of competition in the self-replication of a DNA model system. 107
+ H2
II
'PFP
O
Figure C.1.3. The first abiotic self-replicating system.
The first self-replicating system designed from extrabiotic structures was reported by this laboratory. l8
The hydrogen-bonding recognition of adenine and a Kemp's triacid imide provided the driving force for
supramolecular recognition. The autocatalytic reaction is diagrammed in Figure C.1.3 as the reaction
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between imide-bearing naphthoyl ester I and aminoadenosine II to generate the self-complementary
template III. While the catalytic efficiency within the termolecular complex is insufficient to observe
exponential growth of the template, the autocatalytic nature of the reaction is evident from the rate
acceleration caused by seeding the reaction with its product.
A number of control studies were performed to ascertain that the template effect is responsible for the
autocatalytic rate acceleration (Figure C.1.4).10 9 The reactions were monitored by following the initial rate
of product formation through HPLC analysis of a 2 mM chloroform solution of starting materials with 0.5
equiv (1 mM) of the 'catalyst' added in the presence of excess triethylamine (72 mM). Under these
conditions, addition of template produced a 50% increase in the reaction. The N-methylated imide IV
presents all of the functionality of the template, but precludes binding through imide-adenine molecular
recognition. As a result, no rate enhancement, within 2% experimental error, results when this is added
to the reaction. Furthermore, an abbreviated analog, naphthoylated adenosine V, is also ineffective and
even exhibits marginal inhibition of the reaction. It has been reported that primary, secondary, and
tertiary amides are capable of catalyzing aminoacylation reactions by acting as O-acylation catalysts.110 The
amides presented in the context of these systems do not appear to act in this fashion.
VI
,rInnt LiWVWw 1
VII
Figure C.1.4. Controls for catalysis by self-replication.
Under these same conditions, valerolactam, VI, produced a 16% rate enhancement. This is not
surprising. Menger has established that in aprotic organic solvents the breakdown of the tetrahedral
intermediate is the rate-determining step in the acylation of amines.11' Valerolactam can interact with the
tetrahedral intermediate to facilitate the required proton transfers for product release. The role of
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bifunctional catalysts in acylation reactions ll 2 and glucose mutarotation'l 3 is well known. Figure C.1.5
depicts the role we envisage for the lactam in catalysis. It is likely that primary or cis-amides could
catalyze the aminoacylation reaction in much the same way.ll4 Catalysis by valerolactam through an 0-
acylation mechanism is also a distinct possibility.1l0 Clearly, though, the amide in autocatalytic template
III does not at all contribute to catalysis outside of complexation. Interestingly, imide VII is also
ineffective as a catalyst, despite presenting functionality in much the same way as valerolactam. The
aromatic group, roughly parallel to the imide, apparently lies too close to allow interaction between the
imide and tetrahedral intermediate. If the operative mechanism is catalysis through O-acylation, then the
lower basicity of the carbonyl in the imide group may also be the reason for this.
h H
Figure C.1.5. Schematic of lactam catalysis of tetrahedral intermediate breakdown.
It may be possible that in the termolecular complex between I, II, and III, the amide on III exerts some
catalytic effect on the tetrahedral intermediate. It has been postulated that the appropriate placement of
electrostatic fields in enzyme active sites is, in large part, responsible for enzymatic catalysis.l 5 This type
of effect occur in this system, but the control studies performed make it clear that this could play a role
only within the termolecular complex.
Figure C.1.6. Control for fit-constraints in self-replication.
The phenyl-based imide, VIII, was used as a probe of the strictness of fit in the termolecular complex.
The molecule dimerizes in solution with an association constant of approximately 800 M-1, much similar to
the naphthyl-based template.l16 Molecular modeling suggested that, while phenyl VII and naphthyl III
do not associate well as a mixed 'dimer', the phenyl template may form a complex with the tetrahedral
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intermediate that forms between amine II and ester I. This could, in fact, become the basis for efficient
catalysis, since complications from product inhibition may be reduced. However, within the limits of
experimental error, VII showed no catalysis at all under our conditions.
One of the complications of the original naphthoyl-based self-replicating system is that coupling between
amine and ester can occur within a complex of the two precursors, to form a cis-amide, which isomerizes
to the trans-amide to form active template. This pathway is accessible whether the adenosine is bound in
the Watson-Crick or Hoogsteen mode. Figure C.1.7 shows end-on views of the Hoogsteen (left) and
Watson-Crick (right) complexes with the amine in close approach to the ester. This pathway dominates
over autocatalysis for template formation.116 The first step towards restricting this involved changing the
spacer element to a biphenyl, 17 where the ester and amine are moved away from each other.
Intracomplex reaction can only occur if the adenosine is bound in the Watson-Crick mode (Figure C. 1.8).
By reducing the amount of preassociative catalysis, the effect of the autocatalytic pathway can be seen as a
slight sigmoidality in the initial rate of growth of product. This has been exploited for the study of
competition and mutation using N6-CBz derivatives of adenosine.118
Figure C.1.7. Intracomplex reaction in the naphthoyl self-replicating system.
Figure C.1.8. Intracomplex reaction in the biphenyl self-replicating system.
In order to optimize these self-replicating systems, then, the preassociative bimolecular pathway must be
restrained. The spacer element in the receptor must be sufficiently long to separate the amine and ester
in a bimolecular complex, regardless of the binding mode of adenine. Extending abiotic self-replication
into more polar solvents, and eventually water, would allow these systems to be evaluated on the same
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playing field as biologically-derived replicating systems. In order for this to be realized, the binding affinity
of the receptors to adenosine must be significantly enhanced so that molecular recognition occurs in
more competitive solvents.
Both of these criteria can be fulfilled by the diaminocarbazole-based diimide module. Not only is the
binding affinity for adenosine derivatives extremely high, but triplex-like chelation unambiguously fixes
the conformation of the bound adenine.
2. SELF-COMPLEMENTARY MOLECULES
A number of backbone geometries were explored in the process of developing a self-replicating system
based on the 3,6-diaminocarbazole spacer element. The first of these is the self-complementary derivative
of the original carbazole-diimide (A5). Condensation of 5'-amino-5'-deoxy-2',3'-isopropylideneadenosine
with acid A6 (Scheme C.2.1) provides 'template' C1.
XN
A6 + H2N
X=H, CH 3
o0 
xY
Scheme C.2.1. Synthesis of methylscorpion template.
The proton NMR spectrum of this molecule in CDCl 3 indicates that the diimide binding site is completely
occupied by adenine. As has been seen previously for these systems (Section A.2), the slow exchange in
these systems cause broadening of the resonances. At 25 °C, the 1H NMR spectrum of a 10 mM solution
of C1 at 500 MHz shows two broad imide signals centered on 13.25 ppm (Figure E.7d). Variable
temperature spectra from 0 °C to 40 "C (Figure E.7) show that the two imide peaks coalesce at 40 "C.
The rate of exchange between the two imides at this temperature can be calculated from the maximum
chemical shift difference between the two resonances. This is estimated as 93 Hz, from the spectrum at
O °C where the peaks are completely separated. Using standard dynamic NMR spectroscopy theory as
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outlined in Section A.2, at the coalescence temperature, the rate of interconversion, kr, is approximately
207 s-1 and the barrier to interconversion, AG, is 15 kcal/mol. This barrier is somewhat higher (1.4
kcal//mol) than for the complex of A24 and 9-ethyladenine.
No shift in the imide signal can be seen on dilution of this solution to 0.1 mM, but there appears to be a
broadening of the imides at high dilution (Figure E.8). This may be an artifact of the low signal-to-noise
ratio.
There are two possible interpretations for the dilution and variable temperature NMR studies. Though it
is clear that the molecule binds tightly to itself, it is not obvious whether this is in a inter- or
intramolecular sense. On the basis of molecular modeling, the shape of the backbone should allow the
adenine to fold back and bind within the diimide pocket with some distortion (Figure C.2.1). The
adenine and carbazole aromatic groups deviate significantly from coplanarity and the overlap between the
two groups is poor, forcing the bicyclic imide groups 'back' in order for binding to occur.
Figure C.2.1. Predicted geometry of the intramolecular conformation of C1 (stereoview).
On the other hand, dimerization is extremely strong in this solvent. An estimate of this can be made,
given the binding constant of a single diimide-adenosine association event. If there is no significant strain
in the dimerized structure (a key assumption), then the dimerization interaction energy will be at least the
sum of two individual association energies. In fact, the second binding event in dimerization should be
significantly more favorable than the first since the translational and rotational entropy between the two
molecules has already been overcome. However, if this increase in interaction energy, which has been
estimated to be worth 2-11 kcal/mol,119 is neglected, then,
Kdim Z e2 GRT = (e-AGaRT) 2 = 2 (C.2.1)
The individual components, 5'-amino-5'-deoxy-2',3'-isopropylideneadenosine and methyl ester A5 would
be expected to have an association constant on the order of 50000 M-1 (see Section A.3). This would lead
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to an estimated dimerization constant of 2.5 x 109 M-1. The following sequence (Equations C.2.2 to C.2.8)
illustrates the method by which the chemical shift of the imide can be simulated. The dimerization
constant, Kd, is defined in C.2.3 for the equilibrium represented in C.2.2.
A+A -- A2 (C.2.2)
K [A2] (C.2.3)
The total concentration of the self-complementary molecule is At and:
A, =[A]+ 2[A 2] (C.2.4)
By combining Equations C.2.3 and C.2.4 and solving for [A2], we get:
1+ 4 AtKd- l +8AKd
[A2] =1 + 4A - l + 8 A (C.2.5)
Since the amount of At as monomer is [A]/At, then the amount as dimer is 2[A2]/At, from C.2.4.
Therefore,
2[A2 ] -1 + 4AKd - 1 + 8AKd (C.2.6)
A, 4AKd
And the amount in solution as monomer is,
[A] 1 + 4 AKd- 41 + 8A(C2.7) (C.2.7)A, 4AKd
Using these two expressions, C.2.6 and C.2.7, the chemical shift, 6, of the imide can be estimated from the
chemical shifts of the free, 8f, and fully bound, 8b, species.
[A] + [A 2] S b (C.2.8)
A, A,
If we use values of 13.2 ppm for the shift of bound imide and 10.2 ppm for shift of 'free' imide, which
intramolecularly bound to the other imide when not complexed (see section A.2), and a dimerization
constant of 2.5 x 109 M-1, then the variation of chemical shift with concentration can be calculated and is
shown in Figure C.2.2.
This simulated data clearly shows that a binding constant of this magnitude will require concentrations as
low as 10 pM to see a 0.01 ppm change in the imide chemical shift. This is far below the sensitivity of
NMR spectroscopy, therefore dilution studies should be considered of only limited use in discerning
dimerization from intramolecular association when binding constants are large.
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Figure C.2.2. Simulation of imide chemical shift with concentration.
Control C2 was synthesized to ascertain the association stoichiometry of C1. The methyl group on the
exocyclic amine of adenosine prevents simultaneous complexation in the Watson-Crick and Hoogsteen
binding modes and reduces binding to a single imide-adenine contact, an association constant of 165 M-1
(Section A.3). The dimerization of such a species would then be estimated to be approximately 27000 M-1.
By applying the analysis of equations C.2.2 to C.2.8, the imide proton would be expected to move 0.15
ppm upon dilution to 0.1 mM if the system was dimerized. The H NMR spectrum showed no change in
the solitary imide resonance at 11.7 ppm on dilution from 11.25-0.085 mM in CDCl 3 (Figure E.9). This
chemical shift is the average of the bound (13.2 ppm) and uncomplexed (10.2 ppm) imide shifts,
indicating rapid imide exchange between bound and unbound states. The insensitivity to dilution
suggests that the self-complementary molecule based on the framework of A5 associates through an
intramolecular process.
Additional support for intramolecular association comes from vapor pressure osmometry (VPO)
measurements performed by Ivan Huc. The apparent molecular weight of a 3 mM solution of C1 in
chloroform is 833 amu, 72% of the actual value (1154.6 amu), using a sample of B5 as a standard. The
accuracy of the VPO method is notoriously poor as the technique works optimally for non-associating
molecules. Systems with polar functionality tend to give higher-than-theoretical molecular weights due to
nonspecific aggregation. 20 The slight mismatch of the standard and sample contributes to the
underestimation of the weight. (it has been seen that on the basis of a single phenyl ring, B5 and C13
generate different standard lines121).
A water-soluble version of C1 was produced by coupling the benzyloxymethyl derivative of A6, made by
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Kazuya Kobiro, with 5'-amino-5'-deoxy-2',3'-isopropylideneadenosine (Scheme C.2.2). The organic-soluble
precursor, C3, behaved similarly to the propyl derivative C1 by NMR spectroscopy with a single imide
peak at 13.43 ppm from 0.13-9.94 mM in CDC13. It is significant that only one imide signal is observed at
25 C. The two hydrogen-bonding modes are in more rapid exchange with this molecule than in the
propyl derivative. This increased exchange rate may arise from accelerated complex-opening due to the
extra bulk of the benzyloxymethyl groups. Hydrogenolysis with formic acid and palladium black
catalyst122 produces the water-soluble self-complementary C4.
Bn
B
)Bn
NH 2
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Scheme C.2.2. Synthesis of tris(hydroxymethyl) methylscorpion template.
Phenylscorpion B5 was employed for the synthesis of a self-complementary scorpion, C5, that features
the adenosine group more remotely positioned from the diimide cleft.
Due to the limited utility of dilution studies, none were performed, but a variable temperature 1H NMR
study indicated that C5 exists in a very stable conformation (Figure E.10). In contrast to the molecule
with a biphenyl spacer (see Section C.3.1), the two imide proton signals remain conspicuously sharp and
separated even at 50 °C in CDCl3. On cooling, these two resonances broaden slightly and, from -20 °C,
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four small additional imide signals arise. With slightly broadening at low temperature and sharpening at
high temperature, along with no coalescence in the range of accessible temperatures, the behavior of the
split imide doublet is completely unlike either C1 or C15 (Section C.3).
NH 2
B6 + H2N . N N
Scheme C.2.3. Synthesis of phenylscorpion template.
he origin of this complex behavior is not clearly understood. There appear to be multiple species in
solution, with one preferred and others forming at lower temperatures. In addition to the dimerization
expected for a self-complementary molecule, molecular modeling indicates that it is possible for the
molecule to fold shut if the amide bond is in a cis conformation. The predicted structure of the folded
structure is shown in Figure C.2.3. It can be seen that the aromatic moieties retain coplanarity and four
hydrogen bonds are formed. The Hoogsteen face of the adenine is bound in a bifurcated sense by
rotation of one of the imides in relation to the plane of the carbazole.
The formation of a cis-amide in this system is not unlikely. The trans-amide conformation of N-
methylacetamide is predicted to be only 2 kcal/mol more stable in solution than the cis-amide. 123 Despite
this apparent low barrier, non-proline cis-amide bonds occur only infrequently (0.05%) in protein
structures, though bias during structure solving may influence this somewhat.' 24 The energetic cost of a
secondary cis-amide was predicted to be 5 kcal/mol based on a recent protein mutagenesis study
incorporating a glycyl cis-amide in place of a proline residue.125 Even so, the steric environment of the
aromatic to adenosine amide bond in C5 is much more forgiving than in peptides and the interaction
energy associated with adenine-diimide binding, 6.4 kcal/mol for the phenylscorpion (see Section B.2),
should be well in excess of the cis-trans energy difference. Moreover, the interaction energy would be
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expected to be even stronger for intramolecular association, since intermolecular translational and
rotational entropy need not be overcome. It is quite possible that the unfavorable conformational energy
of a cis-amide bond is more than offset by the binding energy of diimide-adenine recognition.
Unfortunately, infrared spectroscopy is unable to reveal any trace of the cis-amide, as the carbonyl region
of the spectrum is dominated by other functionalities.
Figure C.2.3. Predicted structure of folded C5 (stereoview).
The large changes in translation and rotational entropy inherent to intermolecular associations will, in
general, cause them to be more sensitive to temperature than the corresponding intramolecular process.
A likely interpretation of the NMR data is that an equilibrium exists in solution between the cis-amide
intramolecularly-bound conformation and the dimeric species. At higher temperature, the intramolecular
complex is preferred and maintains a tight fold, but as the temperature decreases, the equilibrium shifts
to multimolecular aggregation.
Vapor pressure osmometry measurements only tentatively support this. The molecular weight
determined, using B5 as a standard, was 2000 amu. This is 164% of the expected value for a monomeric
species (1216.5 amu). This is the same margin of error seen for the biphenylscorpion C15 (Section C.3),
a case with known binding stoichiometry. While this is not hard evidence, it can be used to suggest that
the system is monomeric in solution. A contributing factor to the VPO error may be the nonspecific
aggregation of the monomeric species through the cis-amide. The dimerization constant of a cis-amide
(as exemplified by a p-lactam) is approximately 24 M-1.126
Since the self-complementary scorpions have shown the ability to form folded structures, a molecule was
designed with a backbone that would exist predominantly in a folded conformation with little distortion of
the binding cleft of backbone.
The purpose of this was to simplify the formation of crystals of a complex between the diimide cleft and
adenine. As the carbazole-diimide module is stubbornly non-crystalline, it was hoped that suitable crystals
could be obtained for atomic structure determination by forming individually closed structures. Molecular
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modeling of the target system indicates that the two aromatic moieties are coplanar with a trans-amide
when the adenine and diimide cleft are intramolecularly-bound. As they are designed to snap shut, these
molecules are, in a sense, molecular jackknifes.
H2
Figure C.2.4. A molecular jackknife.
As well, the methyl Kemp's triacid derivatives were employed to exploit their greater crystallinity.
Unfortunately, all attempts to form crystalline material were unsuccessful, though the solubility of both C6
and C7 was found to be poor.
Figure C.2.5. Predicted structure of the molecular jackknife.
3. AUTOCATALYSIS
The intramolecular folding of self-complementary molecules reduces their application to autocatalytic
processes in two ways: i) the folding reduces or removes the amount of molecule that can act as a
template in an autocatalytic process and ii) if the molecule, as a whole, can fold, then the possibility of the
preassociative bimolecular pathway occurring is significantly enhanced. The efficiency of the termolecular
catalytic can easily be hidden if the intracomplex reaction dominates. In order to design an optimum
autocatalytic system, then, the reactive centers within the complex should be held apart, unable to react
with each other. 'That is, reaction should only occur in an intermolecular sense or in the termolecular
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complex.
Figure C.3.1. The complex between the biphenylscorpion and aminoadenosine.
REACTION I:
H'
HEA
HF/CHCI3
+ N H2
H2N N
/r"O
o ,,o
Figure C.3.2. The autocatalytic reaction.
The previous section showed that existing backbone structures are unable to separate the amine and
reactive ester moieties within the complex. A biphenyl substituent on N9 of the carbazole-diimide is ideal
to enforce this separation. Figure C.3.1 shows the predicted geometry of a bimolecular complex between
5'-amino-5'-deoxy-2',3'-isopropylideneadenosine and biphenylscorpion C13 with the amine and ester
separated by a significant distance, 5.86 A. This is a well-defined distance as there is only limited motion
of diimide-bound adenine within the complex. Since the two reactive centers cannot approach each
other, then reaction to form the template molecule must occur in an intermolecular sense.
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This new architecture features both the high affinity of the carbazole-diimide module and elimination of
the preassociative bimolecular pathway for the proposed autocatalytic reaction shown in Figure C.3.2.
The self-complementary product has a backbone geometry that does not allow any intramolecularly
folded species, regardless of the conformation of the amide bond.
carbazole, Cu
K2 CO3, xyler
COOR
C8; R=H 2
CQ R=CHo-
H
COOCH 3 COOCH 3
Scheme C.3.1. Synthesis of N-(4-(4'-(methoxycarbonyl)phenyl)phenyl)-3,6-dinitrocarbazole.
Synthesis of the biphenylscorpion proceeded through Ullman coupling 86 of iodobiphenyl derivative C9
and carbazole followed by nitration to give the aromatic backbone C11 (Scheme C.3.1).
Reduction followed by condensation with.the tripropyl derivative of Kemp's triacid imide acid chloride22
gave the autocatalytic precursor C13. Hydrolysis of the methyl ester proved to be problematic, due to
both reduced reactivity and solubility of the biphenyl substituent. Acid C14 was produced in quantitative
yield by SN2 dealkylation 87 of the methyl ester with thiolate anion. Formation of the acid chloride was
unsuccessful with thionyl chloride due to destruction of the imide group, but proceeded at room
temperature using oxalyl chloride. Condensation with 5'-amino-5'-deoxy-2',3'-isopropylideneadenosine
produced the self-complementary reaction template C15.
The biphenylcarbazole-diimide structure provides very high affinity for 2',3'-isopropylideneadenosine. As
the large size of the molecule leads to highly broadened 1H NMR spectra during titration, the binding
constant in CDCl3 can only be estimated as 105 M-1, The system is readily soluble in tetrahydrofuran and
the association constant between C13 and 2',3'-isopropylideneadenosine was measured by 1H NMR
titration in THF-d8 to be 576 M-' at 298 K, based on the downfield shift of the imide proton from 9.65 ppm
to 12.87 ppm. Titration in methanol was not possible due to limited solubility of ester C13.
With an association constant on the order of 105 M-1 in chloroform, the dimerization constant could be
expected to on the order of 1010 M-1. Variation of the temperature of a 5 mM CDCI3 solution of
autocatalytic template C15 shows two sharp imide peaks in the 1H NMR spectrum centered at 13 ppm at
-55 °C. The imide resonances begin to broaden at -25 °C, with greater broadening in the downfield imide
(predicted to be the Hoogsteen-bound imide based on the structural studies of Section A.2.2), and
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Scheme C.3.2. Synthesis of tripropyl biphenylscorpion template.
coalesce to a single broad resonance between 35 C and 45 C (Figure E.llb). With a maximum v of
311 Hz (-55 C), the barrier to conversion between the two imides at the coalescence temperature (taken
to be 40 C) is approximately 14.3 kcal/mol (using equations A.2.1 and A.2.2). Since no other binding
modes are possible, this behavior can be considered the paradigm for a purely dimeric system. Using C13
as a reference, vapor phase osmometry indicates a molecular weight in solution of 4205 amu, 163% of the
value expected for a dimeric species (2585.1 amu). Again, the VPO measurement overestimates the
weight of a polar species due to nonspecific aggregation.
In THF-d8, the dimerization constant would be expected to be in the vicinity of 3 x 105 M-1. While the 1H
NMR spectrum of C15 in THF-d8 does exhibit concentration dependence from 0.057-5.081 mM,
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broadening of the resonances makes it impossible to calculate a dimerization constant.
The dimerization of C15 appears so strong, in fact, that dimerization occurs even in DMSO, despite the
highly competitive nature of this solvent. A 1H NMR dilution study of the molecule in DMSO-d 6 from
0.068 mM to 6.13 mM was used to calculate a dimerization constant of approximately 169 M-1. Hydration
of DMSO makes it difficult to perform this at conditions of constant water content. Small variations of the
water content (0.14-0.42%, based on relative integration of water and solvent peaks) have a significant
effect on the shift of the imide proton. Comparison of the resonances of C15 from 0.068 mM to 19.41
mM in DMSO-d 6 , however, show the following chemical shift changes: ) downfield shift of the imide
proton, ii) upfield shifts of the adenine aromatic protons, iii) downfield shift of carbazole C4H, iv)
downfield shifts of the adenine NH2 protons, and v) upfield shifts of the ribose 1' and 2' protons. Though
the magnitude of these changes is very small (-0.01 ppm), these chemical shifts are typical of adenine
binding within the diimide pocket, on top of the carbazole and biphenyl surfaces. This is the first
observation of non-ionic hydrogen-bonding in DMSO seen in this laboratory.
The 'declawed' biphenylscorpion C16 was used to synthesize 'template' C18 (Scheme C.3.3) as a control
for the role of imide binding in autocatalysis.
pivaloyl chlC12
DMAP, pyr
NaSMe, DMSOI _ C16; R=CH 3
0 0
Scheme C.3.3. Synthesis of control for the biphenylscorpion autocatalytic system.
With all of the components in hand, kinetic examination of Reaction I (Figure C.3.2) ensued. All kinetic
studies were performed by Edward Wintner. These are still in progress.
The reaction is autocatalytic; addition of the product, C15, results in an increase in the reaction rate.
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Furthermore, this rate enhancement is solvent-dependent. Figure C.3.3 shows the rate enhancements
produced by addition of the product (0.5 equiv) to the reaction between 5'-amino-5'-deoxy-2',3'-
isopropylideneadenosine and the dinitrophenyl ester of C14. This system was examined under dilute
conditions (0.07 mM ester, 0.4 mM amine, 8 mM TEA) by monitoring the release of dinitrophenol using
UV/Vis spectroscopy. When there is no THF in the reaction mixture, the rate enhancement resulting from
the addition of 0.5 equiv of template is reasonably small. The rate enhancement increases as the
proportion of THF in the solvent increases, but no rate enhancement at all is seen above 50% THF; that
is, there is no autocatalysis in these solvent conditions. This behavior can be assigned to a combination of
the strong dimerization of the template C15 and rate acceleration by polar solvent. In pure chloroform,
there would be little free template due to the very large association constant. As the percentage of THF
increases, dissociation of the dimer becomes less unfavored (the association constant between the two
starting materials is reduced to 576 M-1 in pure THF). However, simultaneously, the background reaction
rate increases with increasing solvent polarity. If the autocatalytic rate enhancement is small, then its
effect may get 'lost' as the rate of the background reaction increases.
15'
0o
0axC 0
|I 50% Tempate Added I~s%~pl~e 
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%THF
Figure C.3.3. Catalytic enhancement of autocatalysis in chlorofornTIHF mixtures.
Assuming that the rate enhancement is due to a template effect, the predicted structure of the tetrahedral
intermediate (Figure C.3.4) was generated by minimization of the neutral tautomer within MacroModel 70
using the Polak-Ribiere' 27 conjugate gradient algorithm and the AMBER* force field to a low energy
gradient (8.91 x 104 kJ/mol-A). It can be seen that the tetrahedral intermediate itself is in a relatively
. . W
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Figure C.3.4. Predicted structure of the autocatalytic tetrahedral intermediate (stereoview).
Figure C.3.5. Predicted structure of a tetrahedral intermediate in monoimide autocatalysis (stereoview).
hydrophobic environment, directly above the distal phenyl ring of the template and far removed from any
polar functional groups. This is in sharp contrast to the predicted tetrahedral intermediate structure of
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the naphthyl-monoimide self-replicating system (Figure C.3.5).108 6 If the breakdown of the tetrahedral
intermediate is the rate-limiting step,11' then a polar environment that facilitates proton transfer in the
tetrahedral intermediate would be advantageous. The hydrophobic environment of the termolecular
complex would seem to detract from the overall catalysis generated by the entropic contribution of a
template effect. The termolecular reaction rate would likely be less solvent-dependent than the
background reaction so that with an increase in the polarity of the medium, reaction within the
termolecular complex would become less important to the overall rate than the background reaction.
Detailed studies of the autocatalytic reaction were performed by monitoring the initial rate of product
formation by normal-phase analytical HPLC for the first 15-20% of reaction. The rates determined by
linear regression of peak area versus time are reproducible within 5%. Within a single experiment, the
correlation coefficient of the linear curve-fit is greater than 0.99. The concentrations of 5'-amino-5'-deoxy-
2',3'-isopropylideneadenosine and the pentafluorophenyl ester of C14 were 6.2 mM in 13% THF/CHC13.
The triethylamine concentration was 96 mM. The template, C15, behaved similarly by variable-
temperature 1H NMR in 13% THF-d8/CDC13 as in pure CDCl3, indicating that the addition of THF does not
significantly perturb the self-association of this molecule. Assuming that the effect of THF on binding is
linear from 0% (105 M-1) to 100% THF (576 M-1), then the association constant between diimide C14 and
adenosine can be expected to be approximately 87000 M-1 in 13% THF/CHCl 3.
added 'catalyst' (0.5 equiv) rate (10-3 mM/min) relative rate
nothing 1.695 1.00
C15 2.617 1.54
C13 1.468 0.87
C18 8.315 4.91
Table C.3.1. Reaction rate of aminoadenosine with pentafluorophenyl ester of C14 in 13% THF/CHCI 3.
The results of this study are shown in Figure C.3.6 and, in more detail, in Table C.3.1. Addition of the
reaction product C15 (0.5 equiv) produces a 54% increase in the reaction rate between the
pentafluorophenyl ester of C14 and 5'-amino-5'-deoxy-2',3'-isopropylideneadenosine. This is evidence for
the autocatalytic nature of the reaction.
A number of control studies were performed to identify the mechanism by which autocatalysis operates.
The addition of methyl ester C13 produces a marginal reduction in the reaction rate, due to binding of
free aminoadenosine to form an unproductive complex. There is only a minor effect from this addition as
the high binding affinity of the diimide cleft ensures that the aminoadenosine is already bound by the
active ester cleft. The distance between amino group and ester in the complex prevents these complexes
from providing a pathway for the formation of product. That is, there is no preassociative reaction
pathway.
Addition of valerolactam surprisingly produces no significant increase in reaction rate, unlike in the
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monoimide system discussed in Section C.1. It may well be that the presence of THF in the medium
accelerates the reaction sufficiently such that the contribution of valerolactam is minor. Certainly the lack
of effect by a known aminoacylation catalyst suggests that the trans-amides are not effective as catalysts in
this system.
O tBu template
A template a
o Me ester
o valerolactam
a
a
nothing
n.~ ~~ .. 0
A --- *
I I I 
0 50 100 150
time (min)
Figure C.3.6. Reaction rate of autocatalysis in 13% THF/chloroform.
It should be noted that in the normal-phase column used for these HPLC studies, all acylated-
aminoadenosine compound have approximately the same retention time. This means that in experiments
where a combination of C15 and C18 are present, the combined peak of the two compounds was
followed. There is the concern that this complicates the assay so that effects outside catalysis are
observed. UV spectra were measured (Figure E.12) for solutions of C15 and C18 (10 gmol in 4%
MeOH/CHCl3) to ensure no significant change in absorbance was responsible for the large catalytic effects
of these molecules. A combined spectrum of the two compounds was not at all significantly different
from the mathematical sum of the spectra of the two compounds alone.
The 'declawed' template C18 was added (0.5 equiv) was added as a control to ascertain that recognition
by the diimide cleft is a requirement for autocatalysis. This control accelerates the reaction significantly
1 .
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better, three-fold, than the actual product. This goes against previous results obtained for the monoimide
systems which show that neither the adenine nucleus nor amide groups in general catalyze
aminoacylation. If this molecule were acting only by releasing aminoadenosine from the diimide cleft by
its own complexation, then the reaction rate could not be more than the intrinsic background rate (see
below, Table C.3.2). In fact, this reaction rate is more than twice the intrinsic background.
The chemical behavior of the t-butylanilide group is unusual and suggests that there are interactions
occurring with the derivatives of C15 that do not occur with the cleft. There is partial decomposition of
C18 to a second product on standing over a period of weeks. This decomposition is not evident for any
of the carbazole-diimide clefts. Furthermore, the decomposition is independent of the adenosine end as
the pentafluorophenyl ester of C17 also decomposes and gives the same HPLC trace as C18 after reaction
with 5'-amino-5'-deoxy-2',3'-isopropylideneadenosine. Because of this behavior, any results obtained with
the 'declawed' scorpion C18 must be discounted.
REACTION II:
H-
TEA
THF/CHCI 3
HJ_
0
oyo
Figure C.3.7. The intrinsic background reaction for autocatalysis.
Due to the complication of high binding affinity and restricted access in these large complexes, kinetic
studies were performed on the background reaction, Reaction II (Figure C.3.7). The aminoacylation of
5'-amino-5'-deoxy-2',3'-isopropylideneadenosine with the pentafluorophenyl ester of C17 simply shows
the intrinsic chemical reactivity of the active ester, without any complexation effects. This data is shown
in Figure C.3.8 and, in detail, Table C.3.2. This reaction is over twice as fast as the reaction of the active
ester of C14. Complexation of aminoadenosine by the diimide cleft blocks approach to the nucleophile
from one side, thereby reducing access by the electrophile. This effect is reproduced by addition of C13
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(1 equiv) to the background reaction (Table C.3.2) where one equivalent of the diimide cleft binds the
aminoadenosine and causes a 44% reduction in reaction rate. The rate of the autocatalytic reaction itself
(Reaction I) is slower yet possibly because the active ester also exists in solution as a complex with both
hindered approach and a large molecular weight (-1500 amu). Addition of the reaction product C18 (0.5
equiv) causes a 17% improvement in the reaction rate relative to the diimide-inhibited rate, but not over
the background reaction. Since C18 is not much more than a large acylated-aminoadenosine, this can be
best assigned simply to a re-proportioning of adenines bound within the diimide cleft. The addition of
C18 with C13 (1 equiv) causes the amount of free, unencumbered, aminoadenosine in solution to
increase, thereby increasing the rate of coupling.
additive rate (10-3 mM/min) relative rate
nothing 3.350 1
C13 (1 equiv) 2.196 0.66
C13 (1 equiv) 2.564 0.77
C18 (0.5 equiv)
C13 (1 equiv) 4.971 1.484
C15 (0.5 equiv)
Table C.3.2. Reaction rates of aminoadenosine with pentafluorophenyl ester of C17 in 13% THF/CHC13.
Finally, the autocatalytic template C15 (0.5 equiv) was added with C13 (1 equiv) to ascertain whether the
net effect of this template is to simply to increase the concentration of free aminoadenosine. In fact, the
reaction is 1.5 times the rate of the intrinsic background reaction and almost twice as fast as the reaction
with C18. In these conditions, C15 should exist solely as the dimer. Even so, any monomer present
would be expected to have a net null effect, as the template contains both adenine and diimide-binding
subunits. Furthermore, even if we assume that C15 acts on Reaction II only by liberating free
aminoadenosine (the behavior ascribed to the catalytic effect of C18), the rate of reaction cannot exceed
the intrinsic background reaction. However, it is not unreasonable to expect that a complex that
corresponds, in size, to a peptide of -22 amino acids would have some effect on a general aminoacylation
reaction. Moreover, knowing that the chemistry of the t-butylanilide is unusual when combined with the
carbazole-diimide, little relevance can be assigned to this result.
We seem to have here a situation where the product from one reaction is a significantly better catalyst for
the other reaction rather than its own. This could be the basis for the creation of an artificial
hypercycle, 12 8 provided that molecular recognition could be shown as the origin of catalysis. The nature
of the acatalytic effect occurring between these two systems is currently unknown.
The role of the individual functional groups of template C15 in the rate acceleration by the template was
probed by investigating the effect of small, non-complexing additives on Reaction I. Imide VII provides a
test of the involvement of the imide group and the Kemp's anilide in autocatalysis. The affinity of the
monoimide for adenine is much lower than that of the carbazole-diimide, so it can be expected that the
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VII exists essentially free in the reaction solution. Amide IX (Figure C.3.9) presents the identical steric
and electronic environment as the central amide of C15, but avoids the involvement of complexation and
decomplexation effects. Litvinenko has shown that amides can act as catalysts in aminoacylation reactions
of acyl chlorides in benzene through 0-nucleophilic attack by the amide carbonyl at the reactive center. 10
Amide IX, then, provides a direct test of the catalytic effect of amides in the autocatalytic system. As all
results with 'declawed' template C18 are suspect, 9-ethyladenine was added to the reaction to investigate
the extent that complexation effects slow the intial reaction.
0.5
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Figure C.3.8. Control studies with the pentafluorophenyl ester of C17.
IX
Figure C.3.9. Additional control for autocatalysis.
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The results of this study are summarized in Figure C.3.10 and, in detail, in Table C.3.3. Imide VII has no
effect at all on the reaction rate. This demonstrates that neither the imide, nor the Kemp's anilide are
chemical catalysts of aminoacylations under these conditions. Furthermore, amide IX exerts no catalytic
effect on the reaction and is even slightly inhibitory. While the origin of this inhibition is unknown, this
demonstrates that a secondary amide in the same context as that in the template is not an aminoacylation
catalyst.
added 'catalyst' rate (10-3 mM/min) relative rate
nothing 1.722 1.00
VII (0.5 equiv) 1.728 1.00
IX (1 equiv) 1.511 0.88
9-ethyladenine (1 equiv) 2.263 1.31
Table C.3.3. Control reactions of aminoadenosine with pentafluorophenyl ester of C14 in 13% THF/CHCI 3.
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Figure C.3.10. The structural elements of the template are not catalysts, individually.
There was a small rate enhancement when 9-ethyladenine was added to the reaction. This is due to the
competition of 9-ethyladenine for the diimide sites originally occupied by aminoadenosine. The
decomplexed aminoadenosine reacts more rapidly with the active ester when free than when bound. The
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extent of acceleration, however, is significantly lower than seen when C18 was added. Once again, this
highlights the unusual nature of the chemistry of the 'declawed' scorpion moiety. It should be noted that
both amide IX and 9-ethyladenine were added to the reaction as a full equivalent. Under the standard
conditions (0.5 equiv added), the effect of these additives could be expected to be at least half as great.
When taken together, the results of this study indicate that the individual components of template C18
are not capable of catalyzing the reaction. In other words, the whole is greater than the sum of its parts.
This provides a strong case for autocatalysis through the involvement of molecular recognition and a
termolecular complex.
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Figure C.3.11. Variation of free substrate and termolecular complex concentration with starting concentration.
There is an important consideration that arises from the high binding affinity of these diimide clefts when
applied to autocatalysis. In the monoimide self-replicating systems, the dimerization of the template is of
the same order of magnitude as the single binding event (adenine to imide). This allows the formation of
the termolecular complex to compete with self-dimerization of the template. In the case of the diimide
cleft, where the dimerization seems extraordinarily strong, then the concentration of the termolecular
complex will be extremely small. In the solvent system used in these studies, the single binding event can
be estimated to be 87000 M-1 and the dimerization of the template taken to be the square of that value.
By inserting these values into a model of autocatalysis developed by James Nowick,116 the predicted
concentration of the termolecular complex can be calculated as a function of initial substrate
concentration with 0.5 equiv of template added (Figure C.3.11). Under the conditions of this study (6.2
mM substrate, 3.1 mM template), the concentration of the termolecular complex is predicted to be only
0.2 gmol. This is on the same order as the free (i.e. unbound) amine and ester. The reaction rate within
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the termolecular complex would have to be significantly enhanced for the autocatalytic to be apparent if
the termolecular complex is responsible for the rate enhancements seen.
Given that self-replication can be demonstrated as responsible for the autocatalysis observed here,
improvements to this system would address the issue of small concentration of the termolecular complex
by either moderating the dimerization of the template to levels more similar to the single binding event,
or by improving reaction within the termolecular complex sufficiently for its effect on rate to be more
important. Modifications along this line would require the placement of catalytic groups (e.g. cis- or
primary amides) on the distal phenyl ring in a position to interact with the tetrahedral intermediate as it
forms in the termolecular complex.
4. WATER-SOLUBILIZATION OF AN AUTOCATALYTIC SYSTEM
We attempted to extend this autocatalytic design to aqueous solution, both to alleviate complications
from excessively high affinity and to improve the relevance of the system to biological comparison. For
this, we exploit the tris((benzyloxy)methyl) derivative of Kemp's triacid,42 which can be deprotected by
brief treatment with HBr(g) to cleanly give the water-soluble tris(hydroxymethyl) derivative. Though the
strength of hydrogen bonding is minimal in water,42 the carbazole-diimide is capable of binding adenosine
derivatives in aqueous solution. We have shown that a water-soluble carbazole-diimide complexes with
adenosine with a binding affinity of 2.8 kcal/mol at 10 °C in water.43 Admittedly, though, the major driving
force for binding comes from hydrophobic, rather that hydrogen-bonding, forces.
Tris((benzyloxy)methyl) Kemp's triacid imide acid chloride was condensed with the 3,6-diaminocarbazole
C12 to give the protected cleft C19. Dealkylation of the ester, followed by coupling with amino-
adenosine, gave the protected version of the autocatalytic template, C21. Brief treatment of this with
HBr(g), gives the water-soluble reaction template C22.
Due both to solubility limitations and competition from hydrolysis, activated phenyl esters are not
appropriate for autocatalysis in aqueous solvents. Accordingly, the water-soluble acid C23 (Scheme C.3.5)
was used in conjunction with the water-soluble coupling reagent, EDC (1-(-dimethylaminopropyl)-3-
ethylcarbodiimide hydrochloride) for condensation with 5'-amino-5'-deoxyadenosine.
A significant complication is the competition from attack by water and primary and secondary hydroxyl
groups on the activated acid. Acid is regenerated when the nucleophile is water, but hydroxyl attack will
result in the formation of non-self-complementary ester by-products. This competition significantly
complicates the analysis of these systems. A trial reaction between acid C23 and 5'-amino-5'-
deoxyadenosine with EDC in DMF led to a complex mixture of products. Preparative reverse-phase HPLC
of this mixture gave only a low yield of template C22. However, it was hoped that, in aqueous conditions,
the small amount of template produced would be active enough as a catalyst to preferentially accelerate
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the target reaction over nonspecific processes.
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Scheme C.4.1. Synthesis of tris(hydroxymethyl) biphenylscorpion template
Analysis of this reaction was intractable. The low solubility of the biphenyl carbazole-diimide derivatives
mandated both high pH and dilute concentration (0.5 mM in pH 9.5 CHES buffer). These conditions
make NMR analysis of this system impossible, due to limits imposed by sensitivity and the base-catalyzed
exchange of imide and amide protons with bulk water. 129 HPLC analysis of the system proved
problematic because of aggregation on the column that precluded resolution of the reaction mixture.
En route to the water-soluble clefts, a tris(acetoxymethyl) derivative of Kemp's triacid imide was
synthesized with the goal of generating a precursor that could be made water-soluble under mild
conditions. The hexakis(acetoxy) cleft C24 was isolated in less than 30% yield from the mixture of
partially acetylated products resulting from HBr(g) treatment of the benzyl-protected acid C20 in the
presence of acetic anhydride. This mixture profile was reproduced by treatment of hydroxy acid C23 with
acetyl chloride. Unfortunately, the low yield of this conversion restricted the application of this approach.
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Scheme C.4.2. Masked deprotection of tris((benzyloxy)methyl) biphenyiscorpion.
5. EXPERIMENTAL
5.1 Synthesis
General
All commercially available compounds (Aldrich) were used without further purification unless otherwise
indicated. DMSO-d 6 (99.9%-D, MSD Isotopes or Cambridge Isotope Labs) were used from freshly opened
vials. CDCl 3 (99.8%-D, MSD or CIL) was stored over molecular sieves and passed through dry basic
alumina just prior to use. Tetrahydrofuran used in anhydrous conditions were distilled from sodium-
benzophenone ketyl; dimethyl sulfoxide was distilled from sodium hydroxide and stored over molecular
sieves (4 A). Thin layer chromatography was performed on Merck Silica 60 F-254 precoated TLC plates.
Column chromatography was performed on Merck Silica Gel 60 (230-400 mesh) according to Still et al.59
Glassware used for anhydrous conditions either was baked overnight at 150 °C, assembled hot, cooled
under vacuum, and filled with argon; or was flamed dry under vacuum, cooled and filled with argon
before use. Standard inert-atmosphere techniques were used for solvent transfers by syringe .
1H NMR spectra were recorded on Varian XL-300, UN-300, and VXR-500 spectrometers in solvents as
indicated. Chemical shifts are reported as parts per million () relative to residual solvent protons.
Melting points were obtained on an Electrothermal IA9100 digital melting point apparatus and are
calibrated. IR spectra were recorded on a Perkin-Elmer series 1600 FT-IR spectrometer. High resolution
mass spectra were obtained on a Finnegan MAT 8200 mass spectrometer.
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Adenosyl tripropyl methylscorpion (CL).
N-(Carboxymethyl)-3,6-bis[ ((cis, cis-2,4-dioxo-1,5,7-tripropyl-3-azabicyclo [3.3.1] non-7-yl)carbonyl)amino]
carbazole A6 (515.5 mg, 0.595 mmol) was stirred under Ar with CDI (1.09 equiv) in anhydrous THF for
3.3 h. 5'-Amino-5'-deoxy-2',3'-(isopropylidene)adenosine 13° (1.15 equiv) was added and the solution was
stirred at room temperature for 44 h. Solvent was removed by rotary evaporation and the residue purified
by flash chromatography (20-30% MeOH/CHC13) to yield 237.5 mg of pure cleft, after slow evaporation
from CH2CI2/hexanes. The mixed fractions were concentrated and triturated in MeOH to yield 76.6 mg of
pure cleft, after filtration and drying. The combined yield was 314.1 mg (46%): IR (KBr) 3377, 3214, 2959,
1700, 1696, 1647, 1533, 1468, 1201 cm-1; 1H NMR 300 MHz, DMSO-d 6) 6 10.685 (s, 2 H, imide), 9.118 (s, 2
H, amide), 8.306 (s, 2 H, amine), 8.130 (d, 2 H,J = 1.6 Hz), 8.051 (s, 1 H, amide), 7.39 (m, 4 H), 7.302 (s, 1
H), 7.272 (s, 1 H), 6.150 (d, 1 H,J = 2.9 Hz), 5.42 (m, 1 H), 4.946 (s, 2 H), 4.91 (m, 1 H), 4.21 (m, 1 H), 3.4
(m, 2 H), 2.680 (d, 4 H, J = 13.5 Hz), 2.041 (d, 2 H, J = 12.7 Hz), 1.8 (m, 4 H), 1.536 (s, 3 H), 1.51 (m, 4
H), 1.4-1 (m, 22 H), 1.309 (s, 3 H), 0.877 (t, 12 H,J = 6.9 Hz), 0.802 (t, 6 H,J = 7.2 Hz); HRMS (FAB in 3-
nitrobenzyl alcohol) calcd for C63H84Nl1010 (M+H), 1154.6403; found, 1154.6408. -
N6-Methyladenosyl tipropyl methylscorpion (C2)
The methylscorpion acid A6 (196.9 mg, 0.2273 mmol) was condensed with N6-methyl-5'-amino-5'-deoxy-
2',3'-(isopropylidene)adenosine (1.015 equiv, prepared according to Kolb et al.130 by J.-I. Hong) in the
presence of EDC (1.028 equiv) in anhydrous THF (3 mL) for 21.5 h at room temperature under Ar. After
removal of solvent under reduced pressure, the residue was purified twice by flash chromatography (1.5%
MeOH/25% EtOAc/CH 2CI2 and 45% EtOAc/CH 2CI2) to give 115.6 mg (44%) of white powder 25: IR (KBr)
3375, 2958, 1700, 1624, 1534, 1490, 1466, 1200 cm-1; 1H NMR (300 MHz, DMSO-d 6) 6 10.397 (s, 2 H,
imide), 9.142 (s, 2 H, amide), 8.570 (s, 1 H, amide), 8.343 (s, 2 H, amine), 8.293 (s, 1 H), 8.103 (d, 2 H,J =
1.8 Hz), 7.839 (s, 1 H), 7.427 (dd, 2 H, J = 8.8, 1.6 Hz), 7.329 (d, 2 H, J = 8.4 Hz), 6.184 (d, 1 H, J = 2.7
Hz), 5.48 (m, 1 H), 4.94 (m, 1 H), 4.18 (m, 1 H), 3.4 (m, 2 H), 2.948 (m, 3 H), 2.666 (d, 4 H, J = 13.2 Hz),
2.025 (d, 2 H, J = 12.3 Hz), 1.785 (m, 4 H), 1.54 (s, 3 H), 1.51 (m, 4 H), 1.4-1 (m, 22 H), 1.31 (s, 3 H), 0.88
(t, 12 H, J = 7 Hz), 0.80 (t, 6 H, J = 7 Hz); HRMS (FAB in 3-nitrobenzyl alcohol) calcd for C64H86N, 1010
(M+H), 1168.6559; found, 1168.6568.
Adenosyl tris((benzyloxy)methyl) methylscorpion ()
In an analogous fashion to C1, tris((benzyloxy)methyl) methylscorpion acid (102.2 mg, 0.07658 mmol,
prepared by K. Kobiro by condensing N-(methoxy carbonylmethyl)-3,6-diaminocarbazole A3 with
tris((benzyloxy)methyl) Kemp's acyl chloride4 2) was condensed with 1.21 equiv 5'-amino-5'-deoxy-2',3'-
isopropylideneadenosine using 1.1 equiv CDI in 10 mL THF. After two flash columns (2% MeOH/CHCl 3
and 1% MeOH/CHC13), 62 mg (50%) of a beige powder were recovered which was used without further
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purification: 1H NMR (500 MHz, DMSO-d 6) 6 10.831 (s, 2 H, imide), 9.312 (s, 2 H, amide), 8.442 (s, 1 H),
8.337 (s, 2 H, amine), 8.129 (s, 1 H), 8.109 (s, 2 H), 7.4-7.2 (m, 34 H), 6.166 (d, 1 H,J = 2.4 Hz), 5.45 (m, 1
H), 4.967 (s, 2 H), 4.925 (m, 1 H), 4.53 (m, 12 H), 4.21 (m, 1 H), 3.596 (dd, 8 H,J = 186, 8.8 Hz), 3.444 (s,
4 H), 3.38 (m, 2 H), 2.568 (d, 4 H, J = 14.2 Hz), 2.342 (d, 2 H, J = 12.2 Hz), 1.6 (m, 6 H), 1.526 (s, 3 H),
1.300 (s, 3 H).
Adenosyl tris(hydroxymethyl) methylscorpion (C4).
The benzyl-protected cleft C3 was dissolved in THF (2 mL) under Ar. Pd black (37 mL) and 6%
HCOOH/MeOH (3 mL) were added.122 The suspension was stirred at room temperature for 45 h then
filtered through Celite. Removal of solvent by rotary evaporation recovered 26.2 mg (97%) off-white
product: IR (KBr) 3363, 2935, 2871, 1695, 1653, 1647, 1473, 1206 cm-1; 1H NMR (500 MHz, DMSO-d6) 6
10.676 (s, 2 H, imide), 9.131 (s, 2 H, amide), 8.318 (s, 2 H), 8.178 (s, 2 H), 8.082 (s, 1 H), 7.397 (m, 3 H),
7.283 (d, 2 H,J = 8.5 Hz), 6.160 (m, 1 H), 5.443 (m, 1 H), 5.10 (m, 1 H), 4.94 (m, 2 H), 4.77 (m, 2 H), 4.21
(m, 1 H), 3.779 (d, 3 H,J = 9.5 Hz), 2.406 (d, 4 H,J = 13.5 Hz), 2.207 (d, 2 H,J = 13.0 Hz), 1.541 (s, 3 H),
1.490 (dd, 4 H, J = 13.5, 1.0 Hz), 1.332 (d, 2 H, J = 14.0 Hz), 1.318 (s, 3 H); HRMS (FAB in 3-nitrobenzyl
alcohol) calcd for C51H60 N 1016 (M+H), 1082.4220; found, 1082.4221.
Adenosyl tripropylphenylscorpion (_)
Phenyl scorpion acid B6 (156 mg, 0.168 mmol) and 5'-amino-5'-deoxy-2',3'-isopropylidene-adenosine1 3°
(1.023 equiv) were stirred in anhydrous THF (4 mL) with EDC (1.043 equiv) for 20.5 h. Solvent was
removed by rotary evaporation and the residue purified by flash chromatography (3% MeOH/CHC13) to
give 120.1 mg (58%) of cleft: IR (KBr) 3374, 2958, 1696, 1647, 1507, 1466, 1204, 1091 cm-1; 1H NMR (300
MHz, DMSO-d6) 6 10.345 (s, 2 H, imide), 9.218 (s, 2 H, amide), 8.806 (br t, 1 H, amide), 8.350 (s, 1 H),
8.288 (d, 2 H,J = 1.8 Hz), 8.114 (d, 2 H,J = 8.4 Hz), 8.106 (s, 1 H), 7.699 (d, 2 H,J = 8.4 Hz), 7.493 (dd, 2
H,J = 9.0, 1.8 Hz), 7.358 (d, 2 H,J = 8.7 Hz), 7.326 (s, 2 H, amine), 6.176 (d, 1 H,J = 2.7 Hz), 5.528 (dd, 1
H,J = 6.4, 2.5 Hz), 5.100 (dd, 1 H,J = 6.3, 3.3 Hz), 4.351 (m, 1 H), 3.585 (m, 2 H), 2.678 (d, 4 H,J = 13.2
Hz), 2.030 (d, 2 H,J = 12.9 Hz), 1.78 (m, 4 H), 1.546 (s, 3 H), 1.51 (m, 4 H), 1.33 (s, 3 H), 1.4-1 (m,. 22 H),
0.875 (t, 12 H, 7.0 Hz), 0.805 (t, 6 H, 7.3 Hz); HRMS (FAB in 3-nitrobenzyl alcohol) calcd for C68H86N 1010
(M+H), 1216.6559; found, 1216.6554.
Trimethyljackknife scorpion (C)
EDC (1.19 equiv) was added to a solution of trimethyl methylscorpion acid (425.8 mg, 0.610 mmol,
prepared by G. Deslongchamps) and 9-(2-aminoethyl)adeninel31 (1.06 equiv) in anhydrous DMF (15 mL)
under Ar. The reaction solution was stirred for 46 h at room temperature. Solvent was removed by rotary
evaporation under reduced pressure and the residue purified by flash chromatography (5% MeOH/CHCI 3)
to give C6 (215.4 mg, 41%) as an off-white solid: IR (KBr) 3393, 3204, 2970, 1693, 1654, 1521, 1465, 1315,
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1207 cm-l; H NMR (300 MHz, DMSO-d6) 68 11.155 (s, 2 H, imide), 9.187 (s, 2 H, amide), 8.125 (d, 2 H,J =
1.8 Hz), 8.002 (br t, 1 H, amide), 7.925 (s, 1 H), 7.879 (s, 1 H), 7.418 (dd, 2 H,J = 8.8, 1.9 Hz), 7.310 (s, 2
H, amine), 7.140 (d, 2 H,J = 9.0 Hz), 4.816 (s, 2 H), 4.179 (t, 2 H,J = 5.7 Hz), 3.598 (q, 2 H,J = 3.9 Hz),
2.774 (d, 4 H, J = 13.5 Hz), 1.942 (d, 2 H, J = 12.9 Hz), 1.436 (d, 2 H, J = 12.9 Hz), 1.263 (d, 4 H, J = 14.4
Hz), 1.218 (s, 6 H), 1.155 (s, 12 H); HRMS (EI) calcd for C45Hs 1Nll0 7 , 857.3973; found, 857.3968.
Tripropyljackknife scorpion (C)
Tripropyl methylscorpion acid A6 (198.9 mg, 0.2296 mmol) and 9-(2-aminoethyl)adenine3l (1.097 equiv)
were stirred at room temperature under Ar with EDC (1.04 equiv) in anhydrous THF (5 mL) for 22 h.
Following removal of solvent by rotary evaporation, flash chromatography (0-1% MeOH/50%
EtOAc/CH 2CI2) yielded 81.1 mg (34%) of pure C7: IR (KBr) 3382, 3213, 2930, 1695, 1653, 1528, 1467,
1307, 1208 cm-1; H NMR (300 MHz, DMSO-d6) 68 11.132 (s, 2 H, imide), 9.131 (s, 2 H, amide), 8.108 (d, 2
H,J = 1.6 Hz), 7.982 (br s, 1 H, amide), 7.922 (s, 1 H), 7.894 (s, 1 H), 7.420 (dd, 2 H,J = 8.8, 1.8 Hz), 7.305
(s, 2 H, amine), 7.132 (d, 2 H, J = 8.8 Hz), 4.813 (s, 2 H), 4.172 (br t, 2 H), 4.169 (br s, 2 H), 2.700 (d, 4 H,J
= 14.0 Hz), 2.054 (d, 2 H, J = 12.5 Hz), 1.79 (m, 4 H), 1.54 (m, 4 H), 1.4-1 (m, 22 H), 0.88 (t, 12 H, J = 7
Hz), 0.80 (t, 6 H, J = 7 Hz); HRMS (EI) calcd for C57H75N,107, 1025.5851; found, 1025.5842.
4'-Iodo-4-biphenylcarboxylic acid (C8)
Iodination of 4-biphenylcarboxylic acid was performed according to Merkushev and Yudina.132
Methyl 4'-odo-4-biphenylcarboxylate (9
Thionyl chloride (50 mL) was added slowly dropwise over 2 h to a suspension of acid C8 (14.49 g, 44.707
mmol) in dry MeOH under a drying tube. The suspension was refluxed for 4 h and stirred at room
temperature for 24 h. Solvents were removed by rotary evaporation and then under vacuum. The crude
was recrystallized from refluxing EtOAc (100 mL) and CHCl3 (200 mL) to give 10.63 g (70%) of off-white
platelets: 1H NMR (500 MHz, CDCl3) 68.102 (d, 2 H,J = 8.5 Hz), 7.796 (d, 2 H,J = 8.8 Hz), 7.617 (d, 2 H,J
= 8.5 Hz), 7.356 (d, 2 H, J = 8.5 Hz), 3.943 (s, 3 H).
N-(4-(4'-(Methoxycarbonyl)pbenyl)phenyl)carbazole (CO).
Iodobiphenyl C9 (5.26 g, 31.43 mmol), carbazole (1.001 equiv), K2CO3 (1.001 equiv), and Cu powder
(0.127 equiv) were intimately mixed with mortar and pestle. The solids were suspended in xylenes (20
mL) and mechanically stirred under reflux for 2 days. The reaction was slightly cooled, then briefly
refluxed with benzene (250 mL). The suspension was cooled, stirred overnight, then filtered through
Celite and reduced by rotary evaporation under reduced pressure. The residue was recrystallized from
refluxing MeOH (50 mL) and EtOAc (200 mL) to give 5 g of off-white flaky crystals. The mother liquor was
concentrated and again recrystallized from refluxing MeOH (30 mL) and EtOAc (60 mL) to give 1.11 g
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product. The second mother liquor was concentrated and purified by chromatography (50%
hexanes/CHC13) to give 269 mg of pure product. The combined yield of crystalline C10 was 6.379 g
(54%): mp 191.7-192.7 C; IR (KBr) 2949, 1721, 1604, 1528, 1496, 1450, 1276, 1230, 1178, 1110, 835, 774,
753, 724 cm-1; 1H NMR (300 MHz, CDC13) 6 8.181 (d, 2 H, J = 8.6 Hz), 8.169 (d, 2 H, J = 7.5 Hz), 7.864 (d,
2 H,J = 8.6 Hz), 7.770 (d, 2 H,J = 8.6 Hz), 7.684 (d, 2 H,J = 8.8 Hz), 7.489 (d, 2 H,J = 7.7 Hz), 7.439 (td,
2 H, J = 7.5, 1.2 Hz), 7.315 (m, 2 H), 3.976 (s, 3 H); HRMS (El) calcd for C26H19NO2, 377.1416; found,
377.1416.
N-(4-(4'-(Methoxycarbo nyl)penyl)-3,6-dinitrocarbazole (Cl).
Carbazole C10 (3.03 g, 8.03 mmol) was suspended in HOAc (60 mL) and brought to 70 °C in an oil bath.
HNO 3 (conc., 30 mL) was added dropwise over 0.5 h under a drying tube. The yellow suspension was
stirred at this temperature for 5 h and brought to room temperature for 3 h. The suspension was stirred
with water (200 mL), filtered and dried to give 3.635 g (97%) yellow powder C11 which was used without
further purification: H NMR (500 MHz, DMSO-d6) 9.642 (d, 2 H, J = 2.5 Hz), 8.419 (dd, 2 H, J = 9.5, 2.5
Hz), 8.116 (d, 2 H,J = 8.5 Hz), 8.103 (d, 2 H,J = 8.0 Hz), 7.984 (d, 2 H,J = 8.5 Hz), 7.860 (d, 2 H,J = 8.5
Hz), 7.605 (d, 2 H,J = 9.5 Hz), 3,896 (s, 3 H).
N-(4-(4'-(Methoxycarbonyl)phenyl)phenyl)-3, 6diaminocarbazole (C12)
A suspension of dinitro C11 (887 mg, 1.897 mmol) and 10% Pd-C (22 wt%) in THF (150 mL) was
hydrogenated at balloon pressure for 26 h. After filtration through Celite, solvent was removed by rotary
evaporation and the unstable yellow solid was carried on immediately: 1H NMR (500 MHz, CDC13) 6 8.157
(d, 2 H,J = 8.5 Hz), 7.801 (d, 2 H,J = 9.0 Hz), 7.744 (d, 2 H,J = 8.5 Hz), 7.651 (d, 2 H,J = 9.0 Hz), 7.333
(d, 2 H, J = 8.5 Hz), 7.277 (d, 2 H,J = 2.5 Hz), 6.986 (s, 2 H, amine), 6.767 (dd, 2 H,J = 8.7, 2.2 Hz), 3.98
(s, 3 H).
N-(4-(4'-(Methoxycarbonyl)phenyl)phenyl)-3, 6-bis[((cis,cis-2, 4-dioxo- 1,5, 7-tripropyl-3-azabicyclo[3.3. 11
non-7-yl)carbonyl)amino]carbazole (2).
Diamine C12 and tripropyl Kemp's acyl chloride 22 (2.05 mol equiv) were refluxed with catalytic DMAP
(0.1 equiv) in pyridine (50 mL) for 16 h under Ar. Solvent was removed by rotary evaporation under
reduced pressure and the residue taken up in EtOAc (200 mL) and CHCl3 (25 mL). The combined organic
layers were washed with 1 N HCI (40 mL), and brine (50 mL) and dried over Na2SO4. After concentration,
the crude product was purified by gravity chromatography (2.5% MeOH/CHC13), followed by trituration in
MeOH (20 mL). The yellowish solid was triturated a second time in MeOH (20 mL) to give 1.129 g (58%)
of beige solid: IR (KBr) 3378, 3210, 2958, 1700, 1466, 1280, 1198, 1113, 774 cm-l; 1H NMR (500 MHz,
DMSO-d 6) 6 10.368 (s, 2 H, imide), 9.232 (s, 2 H, amide), 8.312 (d, 2 H,J = 1.7 Hz), 8.096 (d, 2 H, J = 8.5
Hz), 8.048 (d, 2 H, J = 8.5 Hz), 7.966 (d, 2 H, J = 8.5 Hz), 7.738 (d, 2 H, J = 8.3 Hz), 7.494 (dd, 2 H, J =
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9.0, 1.7 Hz), 7.379 (d, 2 H, J = 8.8 Hz), 3.892 (s, 3 H), 2.682 (d, 4 H, J = 13.9 Hz), 2.031 (d, 2 H, J = 12.7
Hz), 1.78 (m, 4 H), 1.51 (m, 4 H), 1.4-1.1 (m, 22 H), 0.876 (t, 12 H,J = 7.1 Hz), 0.807 (t, 6 H,J = 7.2 Hz);
HRMS (FAB in 3-nitrobenzyl alcohol) calcd for C62H76N508 (M+H), 1018.5694; found, 1018.5690.
N-(4-(4'-Carboxyphenyl)phenyl)-3, 6-bis[((cis,cis-2,4-dioxo-l,5, 7-tnipropyl-3-azabicyclo[3.3. 1]non- 7-yl)
carbonyl)amino]carbazole (C14).
Anhydrous DMSO (10 mL) was added via syringe to ester C13 (402 mg, 0.3948 mmol) and NaSMe (5.2
equiv) under Ar and the pale yellow solution was stirred at 80 C for 1 h. After cooling to room
temperature, the reaction was taken up in CHCl 3 (50 mL) and washed with 1 N HCI (2 x 30 mL), water (2 x
50 mL), and brine (50 mL), and dried over Na2SO4. Solvent was removed by rotary evaporation. The pale
yellow solid was dried under vacuum to give 375 mg (95%) of acid C14 which was used without further
purification: 1H NMR (500 MHz, DMSO-d 6) 6 10.365 (s, 2 H, imide), 9.230 (s, 2 H, amide), 8.312 (d, 2 H, J
= 1.5 Hz), 8.072 (d, 2 H,J = 8.5 Hz), 8.036 (d, 2 H,J = 8.5 Hz), 7.931 (d, 2 H,J = 8.0 Hz), 7.730 (d, 2 H,J
= 8.0 Hz), 7.491 (dd, 2 H, J = 8.5, 2.0 Hz), 7.377 (d, 2 H,J = 8.5 Hz), 2.682 (d, 4 H,J = 14.0 Hz), 2.030 (d,
2 H,J = 12.5 Hz), 1.80 (m, 4 H), 1.51 (m, 4 H), 1.35-1.1 (m, 22 H), 0.874 (t, 12 H,J = 7.0 Hz), 0.805 (t, 6 H,
J = 7.2 Hz).
Activated phenyl esters of N-(4-(4'-carboxypenyl)phenyl)-3,6-bis[((cis,cis-2,4-dioxo-1,5, 7-tripropyl-3-
azabicyclo[3.3. 1]non-7-yl) carbonyl)amino]carbazole (typical conditions).
Anhydrous THF (-5 mL/100 mg acid) was added to a round-bottomed flask with acid C14, phenol (1.7-
2.5 equiv), EDC (1.1-2.8 equiv), and DMAP (catalytic). The reaction mixture was stirred overnight at room
temperature under Ar. Solvent was removed by rotary evaporation and the residue chromatographed on
silica using EtOAc/CH 2CI2. Yields were typically 70-85%. Purity was estimated to be >95% by HPLC.
Tripropyl biphenylscorpion template (5)
Acid C14 (100 mg, 0.0996 mmol) was dissolved in anhydrous THF (7 mL). Oxalyl chloride (50 L, 5.76
equiv) and catalytic DMF (1 L) were added. The yellow solution was stirred under Ar at room
temperature for 1 h and solvent was removed by rotary evaporation under reduced pressure. The acid
chloride was pumped dry for 4 h. 5'-Amino-5'-deoxy-2',3'-isopropylideneadenosine 3° (1.18 equiv) was
added to the reaction vessel and anhydrous THF (6 mL) was added to dissolve the reagents.
Triethylamine (70 L, 5.04 equiv) was added to the reaction solution accompanied by immediate
formation of a white precipitate. After stirring at room temperature under Ar for 20.5 h, the reaction was
filtered and solvents removed by rotary evaporation. Flash chromatography (4% MeOH/CHC13) gave
partially pure product which was precipitated from an acetone solution (1 mL) with hexanes (5 mL) to
give 78 mg (53%) of beige solid C15: IR (KBr) 3374, 3214, 2958, 1696, 1647, 1491, 1465, 1204, 1079 cml;
1H NMR (500 MHz, DMSO-d6) 8 10.380 (s, 2 H, imide), 9.230 (s, 2 H, amide), 8.361 (s, 1 H), 8.318 (s, 1 H),
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8.114 (d, 2 H,J = 1.5 Hz), 8.032 (d, 2 H,J = 8.5 Hz), 7.983 (d, 2 H,J = 8.5 Hz), 7.901 (d, 2 H,J = 8.5 Hz),
7.720 (d, 2 H, J = 8.0 Hz), 7.492 (dd, 2 H, J = 9.0, 1.5 Hz), 7.442 (br s, 2 H, amine), 7.373 (d, 2 H, J = 8.5
Hz), 6.174 (d, 1 H,J = 2.5 Hz), 5.507 (dd, 1 H,J = 6.0, 2.5 Hz), 5.086 (dd, 1 H,J = 6.2, 3.2 Hz), 4.344 (m, 1
H), 3.567 (m, 2 H), 2.686 (d, 4 H, J = 13.5 Hz), 2.030 (d, 2 H, J = 12.5 Hz), 1.78 (m, 4 H), 1.540 (s, 3 H),
1.51 (m, 4 H), 1.326 (s, 3 H), 1.35-1.1 (m, 22 H), 0.876 (t, 12 H, J = 7.0 Hz), 0.807 (t, 6 HJ = 7.0 Hz);
HRMS (FAB in 3-nitrobenzyl alcohol) calcd for C74H9 0 N11010 (M+H), 1292.6872; found, 1292.6860.
N-(4-(4'-Methoxycarbonylphenyl)phenyl)-3, 6-bis(pivaloylamino)carbazole (C16
Pyridine (23 mL) was added to amine C12 (1.1 mmol), trimethylacetyl chloride (350 p.L, 2.6 equiv), and
DMAP (catalytic) in a dry round bottom flask under argon. The resulting solution was stirred at room
temperature for 21 h under a drying tube, then taken up in EtOAc (100 mL). The solution was washed
with water (40 mL), 1 N HCI (3 x 70 mL), water (30 mL), and brine. After drying over Na2SO4, solvent was
removed by rotary evaporation. The residue was purified by flash chromatography on silica (10%
EtOAc/CH 2Cl2) followed by trituration in MeOH (8 mL) to give 256 mg (40% yield) of off-white powder: IR
(KBr) 3270, 2954, 1725, 1646, 1529, 1491, 1466, 1279, 1208, 1180, 1113, 807, 773 cm-1; H NMR (500 MHz,
DMSO-d6) 6 9.296 (s, 2 H, amide), 8.485 (d, 2 H,J = 2.0 Hz), 8.095 (d, 2 H, J = 8.5 Hz), 8.036 (d, 2 H,J =
8.5 Hz), 7.953 (d, 2 H, J = 8.5 Hz), 7.755 (d , 2 H, J = 8.5 Hz), 7.596 (dd, 2 H,J = 9.0, 2.0 Hz), 7.426 (d, 2
H, J = 9.0 Hz), 3.892 (s, 3 H), 1.270 (s, 18 H); HRMS (FAB in 3-nitrobenzyl alcohol) calcd for C36H38N304
(M+H), 576.2862; found, 576.2859.
N-(4-(4'-Carboxypbenyl)phenyl)-3,6-bis(pivaloylamino)carbazole (7)
Dealkylation of methyl ester C16 was performed in the same manner as for ester C13 to give quantitative
yield of acid C17 which was used without further purification: 1H NMR (300 MHz, DMSO-d 6) 6 9.299 (s, 2
H, amide), 8.488 (d, 2 H,J = 1.5 Hz), 8.074 (d, 2 H,J = 8.4 Hz), 8.026 (d, 2 H,J = 8.7 Hz), 7.919 (d, 2 H,J
= 8.4 Hz), 7.748 (d, 2 H, J = 8.7 Hz), 7.596 (dd, 2 H, J = 9.0, 1.8 Hz), 7.426 (d, 2 H, J = 9.0 Hz), 1.270 (s,
18 H).
Control template (CI)
Conversion of acid C17 (51 mg, 0.091 mmol) to the acid chloride, followed by condensation to with 5'-
amino-5'-deoxy-2',3'-isopropylideneadenosine (1.08 equiv) was performed according to the procedure for
template C15 to yield 41 mg (53%) of off-white powder following chromatography on silica (4.5%
MeOH/CHCl 3): IR (KBr) 3342, 2959, 1647, 1609, 1590, 1533, 1491, 1468, 1329, 1296, 1210, 1093, 866, 798
cm-'; 1H NMR (500 MHz, DMSO-d 6) 9.286 (s, 2 H), 8.737 (br t, 1 H, amide), 8.482 (d, 2 H, J = 2.0 Hz),
8.343 (s, 1 H), 8.098 (s, 1 H), 8.021 (d, 2 H, J = 9.0 Hz), 7.981 (d, 2 H, J = 8.5 Hz), 7,888 (d, 2 H, J = 8.5
Hz), 7.738 (d, 2 H,J = 8.5 Hz), 7.595 (dd, 2 H,J = 9.0, 2.0 Hz), 7.421 (d, 2 H,J = 9.0 Hz), 6.170 (d, 1 H,J
= 2.5 Hz), 5.512 (dd, 1 H,J = 6.2, 2.7 Hz), 5.087 (dd, 1 H,J = 6.2, 3.2 Hz), 4.338 (q, 1 H,J = 3.5 Hz), 3.568
.5 ExPefimental 121
122 G.5 Fyje~~~~~~~~~~~~~~ra
(m, 2 H), 1.270 (s, 18 H); HRMS (FAB in 3-nitrobenzyl alcohol) calcd for C48H52N90 6 (M+H), 850.4041;
found, 850.4033.
N-(4-(4'-(Methoxycarbonyl)phenyl)henyl)-3, 6-bis[((cis,cis-2, 4-dioxo-1,5, 7-tris((benzyloxy)metbyl)-3-aza
bicyclo[3.3. 1]non- 7-yl)carbonyl)amino]carbazole (C19
In a manner analogous to cleft C13, tris(benzyloxymethyl) Kemp's acyl chloride42 (3.62 mmol) and
diamine C12 (1.816 mmol) were refluxed in pyridine (10 mL) with catalytic DMAP to give 996 mg (37%) of
beige solid, following flash chromatography (15% EtOAc/CH 2Cl2): 1H NMR (500 MHz, DMSO-d6) 6 10.643
(s, 2 H, imide), 9.410 (s, 2 H, amide), 8.326 (d, 2 H,J = 1.0 Hz), 8.099 (d, 2 H, J = 8.5 Hz), 8.050 (d, 2 H, J
= 8.5 Hz), 7.966 (d, 2 H,J = 8.5 Hz), 7.748 (d, 2 H,J = 8.5 Hz), 7.488 (dd, 2 H,J = 9.0, 1.0 Hz), 7.393 (d, 2
H, J = 8.5 Hz), 7.36-7.23 (m, 30 H), 4.518 (s, 4 H), 4.509 (s, 4 H), 4.466 (s, 4 H), 3.893 (s, 3 H), 3.784 (d, 4
H,J = 9.0 Hz), 3.464 (s, 4 H), 3.415 (d, 4 H,J = 9.5 Hz), 2.582 (dd, 4 H,J = 14.5, 0.5 Hz), 2.342 (dd, 2 H,J
= 12.5, 0.5 Hz), 1.613 (d, 4 H,J = 14.0 Hz), 1.597 (d, 2 H,J = 13.0 Hz).
N-(4-(4'-Carboxyphenyl)phenyl)-3,6-bis[((cis,cis-2,4-dioxo-1,5, 7-tris((benzyloxy)methyl)-3-azabicyclo
[3.3. 1]non-7-yl)carbonyl)amino]carbazole (C20).
The ester C19 (520 mg, 0.347 mmol) and NaSMe (6.2 equiv) were stirred in anhydrous DMSO (8 mL)
under Ar for 1 h at 80 °C. The solution was cooled and taken up in CHCl 3 (50 mL). The organic layer was
washed with 1 N HCI (25 mL), sat'd NH4Cl (2 x 25 mL), and brine (50 mL), and dried over Na2SO4. The
combined organic layer was concentrated and purified by chromatography (5% MeOH/CHC13) to give 362
mg (70%) of pale yellow acid C20: IR (KBr) 3369, 3179, 2858, 1700, 1466, 1099, 735, 698 cml1; 1H NMR
(500 MHz, DMSO-d6) 6 10.640 (s, 2 H, imide), 9.409 (s, 2 H, amide), 8.327 (d, 2 H, J = 1.7 Hz), 8.068 (d, 2
H, J = 8.3 Hz), 8.024 (d, 2 H,J = 8.5 Hz), 7.886 (d, 2 H,J = 8.1 Hz), 7.729 (d, 2 H,J = 8.5 Hz), 7.486 (dd, 2
H,J = 8.9, 1.6 Hz), 7.388 (d, 2 H,J = 8.8 Hz), 7.36-7.23 (m, 30 H), 4.519 (s, 4 H), 4.509 (s, 4 H), 4.467 (s, 4
H), 3.786 (d, 4 H, J = 9.0 Hz), 3.466 (s, 4 H), 3.417 (d, 4 H, J = 8.8 Hz), 2.585 (d, 4 H, J = 13.9 Hz), 2.344
(d, 2 H,J = 13.7 Hz), 1.619 (d, 4 H,J = 12.5 Hz), 1.599 (d, 2 H,J = 12.7 Hz); HRMS (FAB in 3-nitrobenzyl
alcohol) calcd for C91H86N5014 (M+H), 1472.6171; found, 1472.6154.
Tris((benzyloxy)methyl) biphenylscorpion template (C2
In a manner analogous to the formation of C15, acid C20 (135 mg, 0.091 mmol) was converted to the
acid chloride with oxalyl chloride (50 gL, 6.3 equiv) and catalytic DMF (1 gL) in anhydrous THF (10 mL).
5'-Amino-5'-deoxy-2',3'-(isopropylidene)adenosinel 3° (1.11 equiv) was added to the reaction vessel and
anhydrous THF (12 mL) was added to dissolve the reagents. Triethylamine (50 gL, 3.94 equiv) was added
to the reaction solution accompanied by immediate formation of a white precipitate. After stirring at
room temperature under Ar for 20 h, the reaction was filtered and solvents removed by rotary
evaporation. Flash chromatography (4% MeOH/CHC13) gave 117 mg (73%) of beige powder: IR (KBr)
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3333, 3200, 2859, 1701, 1648, 532, 1493, 1467, 1364, 1220, 1207, 1098, 737, 698 cm-l; 1H NMR (300 MHz,
DMSO-d 6) 6 10.63 (s, 2H, imide), 9.40 (s, 2 H, amide), 8.75 (br t, 1 H, amide), 8.369 (s, 1 H), 8.323 (d, 2 H,
J = 1.2 Hz), 8.123 (s, 1 H), 8.031 (d, 2 H,J = 8.7 Hz), 7.982 (d, 2 H,J = 8.1 Hz), 7.896 (d, 2 H,J = 8.1 Hz),
7.725 (d, 2 H,J = 8.4 Hz), 7.486 (d, 2 H,J = 8.4), 7.4-7.2 (m, 32 H), 6.177 (d, 1 H,J = 2.7 Hz), 5.508 (dd, 1
H,J = 5.8, 2.8 Hz), 5.086 (dd, 1 H,J = 6.9, 3.0 Hz), 4.514 (s, 8 H), 4.467 (s, 4 H), 4.342 (m, 1 H), 3.786 (d,
4 H,J = 8.8 Hz), 3.55 (m, 2 H), 3.466 (s, 4 H), 3.418 (d, 4 H, J = 9 Hz), 2.584 (d, 4 H, J = 14.1 Hz), 2.345
(d, 2 H, J = 13.5 Hz), 1.598 (m, 6 H), 1.541 (s, 3 H), 1.334 (s, 3 H); HRMS (FAB in 3-nitrobenzyl alcohol)
calcd for C104H102N12016 (M+H), 1760.7506; found, 1760.7491.
Tris(hydroxymethyl) biphenylscorpion template (C22)
The protected template C21 (24 mg, 0.0136 mmol) was dissolved in HCOOH (4.8 mL) and stirred on ice
for 0.5 h. HBr(g) was bubbled through the solution for 8 min followed by Ar for 2 h. Solvent was
removed by rotary evaporation under reduced pressure. The residue was suspended in MeOH (< 1 mL)
and precipitated with Et2O (2 mL). After filtering, the solid was triturated in THF (2 mL) for 1 h, filtered
and dried under vacuum to give 11.6 mg (73%) of beige powder: IR (KBr) 3331, 2938, 2874, 1692, 1641,
1609, 1529, 1494, 1466, 1202, 1056, 811, 772 cm-1; 1H NMR (500 MHz, DMSO-d6) 6 10.377 (s, 2 H, imide),
9.230 (s, 2 H, amide), 8.771 (s, 1 H), 8.7331 (br t, 1 H, amide), 8.5 (s, 2 H, amine), 8.451 (s, 1 H), 8.361 (s,
2 H), 8.029 (d, 2 H,J = 8.5 Hz), 8.000 (d, 2 H,J = 8.0 Hz), 7.905 (d, 2 H,J = 8.5 Hz), 7.723 (d, 2 H,J = 8.5
Hz), 7.494 (d, 2 H,J = 9.0 Hz), 7.367 (d, 2 H,J = 8.5 Hz), 5.964 (d, 1 H,J = 6.0 Hz), 4.700 (t, 1 H, J = 5.5
Hz), 4.54 (br, 6 H, hydroxyl), 4.217 (m, 1 H), 4.149 (q, 1 H,J = 3.5 Hz), 3.779 (d, 4 H,J = 10.5 Hz), 3.66
(m, 2 H), 3.404 (s, 4 H), 3.336 (d, 4 H,J = 10.5 Hz), 2.419 (d, 4 H,J = 14.0 Hz), 2.203 (d, 4 H,J = 13.0 Hz),
1.488 (d, 4 H, J = 14.0 Hz), 1.341 (d, 2 H, J = 13.0 Hz); HRMS (FAB in 3-nitrobenzyl alcohol) calcd for
C59H62N 1016 (M+H), 1180.4376; found, 1180.4379.
N-(4-(4'-Carboxyphenyl)phenyl)-3, 6-bis[((cis,cis-2,4-dioxo-1,5, 7-tris(hydrovymethyl)-3-azabicyclo[3.3. 1]
non-7-yl)carbonyl)amino]carbazole (3)
HBr(g) was bubbled through a suspension of acid C20 (362 mg, 0.244 mmol) in HCOOH (25 mL) at 0 °C
for 10 min. Solvent was removed by rotary evaporation under reduced pressure and the residue pumped
dry (KOH trap). The crude material was triturated in CHCl3 and filtered. The resulting orange solid (225
mg) was suspended in MeOH (12 mL) and pure white product (82.9 mg, 39%) was precipitated with
ether. The filtrate was concentrated and triturated in THF (1.5 mL) to give slightly less pure compound as
a beige powder (84.3 mg, 40%) after filtration and drying: IR (KBr) 3363, 2940, 2878, 1695, 1527, 1467,
1202, 1055 cm-1; 1H NMR (500 MHz, DMSOd 6) 6 10.408 (s, 2 H, imide), 9.242 (s, 2 H, amide), 8.372 (d, 2
H, J = 2.0 Hz), 8.073 (d, 2 H, J = 8.3 Hz), 8.035 (d, 2 H, J = 8.5 Hz), 7.928 (d, 2 H, J = 8.3 Hz), 7.733 (d, 2
H,J = 8.5 Hz), 7.490 (dd, 2 H,J = 8.9, 1.8 Hz), 7.381 (d, 2 H, J = 8.8 Hz), 3.781 (d, 4 H,J = 10.3 Hz), 3.38
(d, 8 H, J = 12 Hz), 2.417 (d, 4 H, J = 14.9 Hz), 2.205 (d, 2 H, J = 12.5 Hz), 1.484 (d, 4 H, J = 14.9 Hz),
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1.336 (d, 2 H, J = 13.2 Hz); HRMS (FAB in glycerol) calcd for C49H50N50 14 (M+H), 932.3354; found,
932.3359.
N-(4-(4'-Carboxyphenyl)phenyl)-3, 6-bis[((cis,cis-2, 4-dioxo-1,5, 7-tris(acetoxymethyl)-3-azabicyclo[3.3. 1]
non-7-yl)carbonyl)amino]carbazole (C24).
Benzyl-protected acid C20 (35.2 mg, 0.0237 mmol) was dissolved in HOAc (5 mL) and Ac20 (0.4 mL, 178
equiv). HBr(g) was bubbled through the solution for 10 min followed by Ar for 30 min as purge. Solvent
was removed by rotary evaporation under reduced pressure and under vacuum (KOH trap) and the
residue purified by flash chromatography (5-100% MeOH/CHC13) to give an off-white solid identified as
partially-pure product: 1H NMR (500 MHz, DMSO-d6) 6 10.944 (s, 2 H, imide), 9.569 (s, 2 H, amide), 8.238
(d, 2 H, J = 1.5 Hz), 8.074 (d, 2 H, J = 8.0 Hz), 8.038 (d, 2 H, J = 8.5 Hz), 7.925 (d, 2 H, J = 8.0 Hz), 7.739
(d, 2 H,J = 8.5 Hz), 7.480 (dd, 2 H,J = 8.5, 2.0 Hz), 7.406 (d, 2 H,J = 9.0 Hz), 4.353 (d, 2 H,J = 11.0 Hz),
4.131 (s, 2 H), 4.056 (d, 2 H,J = 11.0 Hz), 2.684 (d, 4 H,J = 14.0 Hz), 2.239 (d, 2 H,J = 13.0 Hz), 2.033 (s,
12 H), 2.007 (s, 6 H), 1.604 (d, 4 H, J = 14.0 Hz), 1.565 (d, 2 H, J = 13.0 Hz); HRMS (FAB in glycerol) calcd
for C61H61N5020, 1183.3910; found, 1183.3911.
5.2 Spectroscopy
Dilution and variable-temperature 1H NMR studies were performed at 500 MHz using Varian VXR-500
NMR spectrometers equipped with Oxford VTC-4 temperature controllers and either 5 mm direct or
indirect detection 1H/19F probes. Temperatures are not calibrated. DMSOd6 (99.9%-D), THF-d8 (99.5%-
D), and "100%" CDCl 3 (99.96%-D) were supplied by Cambridge Isotope Labs.
5.3 Titrations
1H titrations were performed at 298 K at 300 MHz on a Varian UN-300 instrument with a 5 mm
1H/19F/broad band probe and an Oxford VTC4 temperature controller (THF) or at 500 MHz on a Varian
VXR-500 instrument with a 5 mm 1H/ 19F indirect detection probe and an Oxford VTC-4 temperature
controller (CDCI 3).
In THF-d8 (99.5%-D, CIL), the imide proton was followed through a 3.22 ppm downfield change in
chemical shift as 2',3'-isopropylideneadenosine (10 mM) was added to a 2 mM solution of
biphenylscorpion C13 (700 gL). In CDCl3 (99.8%-D, CIL), the upfield shift of adenine aromatic protons
was monitored as a solution of C13 (2 mM) was added to 2',3'-isopropylidene (1 mM).
Association constants were calculated by non-linear least-squares regression fit of the data to the 1:1
binding isotherm using Systat 5.2. The final chemical shift and association constant were treated as
variables; the experimental value for the initial chemical shift was used.
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5.4 Molecular Modeling
Predicted structures are generated by molecular mechanics minimization on a Silicon Graphics 4D30G+
Personal Iris running MacroModel 3.5X70 using a modified AMBER 72 force field (AMBER*) and the
truncated Newton conjugate gradient algorithm 94 (TNCG) to the default gradient of less than 0.05 kJ/A.
Chloroform solution was simulated using the Generalized Born/Surface Area method (GB/SA).73
5.5 Vapor Phase Osmometry
All molecular weight determinations were performed by Ivan Huc at 30 °C with a Wescan Model 233 vapor
pressure osmometer in the laboratory of George Whitesides at Harvard University. Standards were
measured at 1, 3, 6, and 10 mM and molecular weights determined at 3 mM in HPLC grade glass-distilled
chloroform from Aldrich. There is approximately a +20% margin of error for the measurements.
5.6 Kinetics
All kinetic measurements were performed by Edward Wintner. Reaction rates for reaction between active
ester derivatives of C14 and 5'-amino-5'-deoxy-2',3'-isopropylideneadenosine 13 were measured by HPLC
monitoring of product formation at 266 nm with a Waters 490E multiwavelength detector run by a 600E
System controller equipped with 717 Autosampler and controlled by Baseline 810 HPLC software or by
monitoring ester consumption (2,4-dinitrophenyl ester) at 450 nm with a Perkin-Elmer Lambda2
UV/Visible spectrometer controlled by PECCS UV/Vis software at room temperature (23 °C).
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E. SPECTRA
Figure E.1 500 MHz 1H NMR spectrum at 25 °C of A24 (9.98 mM) in CDCI3 (a) before and (b) after addition
of 1.036 equiv of 9-ethyladenine.
Figure E.2 500 MHz 1H NMR spectrum of A24 (5.47 mM) and 9-ethyladenine (5.57 mM) in CDCl3 at (a)
-50 C, (b) -20 C, (c) 0 °C, (d) 35 °C, and (e) 45 C.
Figure E.3 300 MHz 1H NMR TOCSY spectrum at 25 °C of the complex of A27 (5.00 mM) and 9-
ethyladenine (5.01 mM) in CD2CI2.
Figure E.4 300 MHz 1H NMR NOESY spectrum at 25 °C of the complex of A27 (5.00 mM) and 9-
ethyladenine (5.01 mM) in CD2C12 showing (a) the full spectrum, (b) imide-aromatic
correlations, and (c) aromatic-aliphatic correlations.
Figure E.5 500 MHz 1H NMR TOCSY spectrum at -50 °C of the complex of A24 (10.2 mM) and 9-
ethyladenine (10.4 mM) in CDCl 3.
Figure E.6 500 MHz 1H NMR NOESY spectrum at -50 °C of the complex of A24 (10.2 mM) and 9-
ethyladenine (10.4 mM) in CDC13 showing (a) the full spectrum, (b) imide-aromatic
correlations, (c) aromatic correlations, and (d) aromatic-aliphatic correlations.
Figure E.7 500 MHz 1H NMR spectra of C1 (11.2 mM) in CDC13 at (a) 0 °C, (b) 10 °C, (c) 20 °C, (d) 25 C,
(e) 30 °C, and (f) 40 C.
Figure E.8 The imide region of the 500 MHz 1H NMR spectrum at 25 C of C1 in CDC13 at varying
concentrations.
Figure E.9 500 MHz 1H NMR spectra of C2 in CDC13 at 25 C showing (a) the full spectum at 11.25 mM and
(b) the imide region with varying concentration.
Figure E.10 500 MHz 1H NMR spectra of C5 (6.7 mM) in CDC13 at 20 C (a) and showing the imide region at
varying temperature (b and c).
Figure E.11 500 MHz 'H NMR spectra of C15 (5 mM) in CDC13 at 25 °C (a) and from -50 °C to 50 "C (b, imide
region only).
Figure E.12 UV/visible spectra for C15, C18 and C15 with C18 (10 p.mol of each) in 4% MeOH/CHC1 3. The
mathematical sum of the individual spectra is also plotted.
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